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Abstract 
 
 
 
During development oligodendrocyte progenitor cells (OLPs) are responsible for the 
production of oligodendrocytes.  Cells with similar antigenic properties to 
developmental OLPs persist throughout postnatal life, beyond the cessation of 
“developmental” myelination.  These postnatal cells are often referred to as “NG2 
cells” because they (and their perinatal counterparts) express the NG2 proteoglycan, 
but little is known about their function in the adult brain. 
 
Experiments documented in this Thesis use transgenic lineage tracing technology to 
characterize the in vivo behavior of OLPs in the brain at various ages.  Fate mapping 
of OLPs revealed that they give rise to oligodendrocytes throughout life.  In addition, 
OLPs were shown to generate a small proportion of the projection neurons present in 
the posterior piriform cortex, while no evidence for astrogliogenesis from OLPs was 
found. 
 
Cumulative in vivo labelling of OLPs with thymidine analogues (BrdU and EdU) 
showed that they proliferate continuously throughout life with an increasing cell 
cycle time with age.  At all ages examined, there was a proportion of OLPs that 
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never underwent cell division, indicating that there are cycling and non-cycling 
populations of OLPs in the mouse brain that persist throughout life. 
 
The observed contribution of adult-born oligodendrocytes to myelinating the brain 
was surprisingly large, and raised intriguing questions as to the necessity and 
function of these new myelinating cells.  To investigate this directly, I generated a 
new transgenic mouse line that when crossed to a transgenic mouse that expresses an 
inducible form of Cre, can be used to selectively ablate the myelinating 
oligodendrocytes produced in adult life. 
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Chapter 1: Introduction 
 
 
 
1.1  Oligodendrocyte morphology and function 
The central nervous system (CNS) contains 3 major neural cell types: neurons, 
astrocytes and oligodendrocytes (Fig. 1.1).  Oligodendrocytes are found throughout 
the CNS.  However, as they are the myelinating cells of the CNS, it follows that they 
are in greatest abundance in the white matter, where the necessity for myelination is 
greatest.  Their cell bodies are small in size but they can form as many as 50 separate 
myelin segments, each wrapping an axon in multispiral membrane myelin (Bunge et 
al., 1961; Bunge et al., 1968; Simons and Trotter, 2007; Fig. 1.2). 
 
In addition to myelin formation, oligodendrocytes provide mechanical protection for 
axons and trophic support for neurons (reviewed in McTigue and Tripathi, 2008).  
For instance, it has been shown that oligodendrocytes promote survival of 
developing cortical neurons by secreting insulin-like growth factor (IGF)-1 and that 
they modulate phosphorylated neurofilament levels by secreting glial cell line-
derived neurotrophic factor (GDNF) (Wilkins et al., 2001; Wilkins et al., 2003).  
Furthermore, the secretion of brain-derived growth factor (BDNF) and neurotrophin-
3 (NT-3) by oligodendrocytes has been shown to promote the survival of cholinergic 
neurons of the basal forebrain (Dai et al., 2003).  Dai et al. (2001) provided evidence  
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Figure 1.1 Cells in the CNS. Oligodendrocytes form myelin sheaths. Astrocytes extend 
processes that surround the vasculature, the synapse, and the node of Ranvier. 
Oligodendrocyte precursors (NG2 cells) extend processes to nodes of Ranvier in white 
matter and form synapses with axons in gray matter. In addition to these neuroectoderm- 
derived cells, resting ramified microglia are thought to originate in the mesoderm and 
subsequently take up residence in the CNS. (Diagram taken from: Nishiyama et al., 2007) 
 
 
 
Figure 1.2 Transmission electron micrograph of a myelinated axon (image provided by 
Kaylene M. Young) 
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that K
+
 channels present in neurons and glutamate and carbachol secreted by neurons 
influence the amount of the nerve growth factor (NGF), BDNF and NT-3 that is 
secreted by oligodendrocytes (Dai et al., 2001), suggesting that the expression of 
neurotrophic factors by oligodendrocytes depends on neuron-derived signals. 
 
Oligodendrocytes also support neuronal function by secreting soluble mediators that 
cause channel clustering along the axon (Kaplan et al., 2001).  Sodium channel 
clustering is vital for rapid saltatory conduction (Kaplan et al., 1997; Dupree et al., 
2004).  Therefore, oligodendrocytes are essential for the rapid propagation of 
neuronal signals and are hence hugely important for the maintenance and proper 
functioning of the CNS.  
 
1.2  Myelination 
Myelin consists of ~70% lipids  and ~30% proteins by mass, of which the proteolipid 
protein (PLP), the myelin basic protein (MBP), the myelin oligodendrocyte 
glycoprotein (MOG), the 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) and 
the myelin associated glycoprotein (MAG) are the most abundant (reviewed in 
Dubois-Dalcq et al., 1986).  
 
Myelination starts at birth in the mouse spinal cord and occurs rostrocaudally, while 
in the brain developmental myelination starts in the hindbrain region and extends 
caudally and rostrally from there (Baumann and Pham-Dinh, 2001).  Myelination is 
initiated after glial processes have attached to the axon and polarization of the plasma 
membrane has been triggered (Simons and Trotter, 2007).  Though it has been shown 
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that the presence of axons is necessary to trigger the expression of myelin genes in 
oligodendrocytes and myelin formation in vivo (Goto et al., 1990), evidence from in 
vitro studies suggest that oligodendrocytes are able to express myelin genes and form 
myelin-like structures in the absence of neurons (Dubois-Dalcq et al., 1986; Saneto 
and de Vellis, 1985; Knap et al., 1987; Zeller et al., 1985; Hudson et al., 1989; 
Nussbaum et al., 1988).  Nevertheless, myelination in vivo requires neuron-glia cell 
recognition, which in turn triggers myelin formation.  The constituents of the nodal 
and paranodal junctions are well understood, but the molecules involved in myelin 
initiation and nodal formation and the way these molecules get targeted to the 
appropriate domains is still unclear (reviewed in Sherman and Brophy, 2005).   
 
There are several molecules present on naked axons that are proposed to be involved 
in initiating myelination, including cell adhesion molecules, such as integrins, 
neurofascins and laminins.  So far none have been shown to directly drive myelin 
formation, but the downregulation of the polysialic acid neural cell adhesion 
molecule and the adhesion molecule Lingo-1 is required for initiating axonal 
myelination (Sherman and Brophy, 2005; Laursen and ffrench-Constant, 2007).  Park 
et al. (2008) have also reported that the Nectin-Like 1 adhesion molecule is crucial 
for axon-oligodendrocyte recognition and adhesion at the initial stages of myelin 
formation in the CNS (Park et al., 2008).  The role of laminin signalling via integrin 
receptors is well established for PNS myelination, and, while its role is less clear for 
the CNS (Sherman and Brophy, 2005; Laursen and ffrench-Constant, 2007), it 
appears to promote oligodendrocyte differentiation and survival (Sherman and 
Brophy, 2005; Taveggia et al., 2010).  In addition to cell adhesion molecules, other 
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signalling systems are important in this process, for example, neuregulin signalling 
has been linked with the decision to myelinate a particular axon and the number of 
myelin wraps that will surround it (Sherman and Brophy, 2005; Laursen and ffrench-
Constant, 2007).  Initiating myelination also requires glial recruitment and 
differentiation, which may involve semaphorins and netrins present on axons, 
interacting with their receptors present on oligodendroglial cells (Taveggia et al., 
2010).  Fyn kinase is associated with Tau and α-Tubulin and has been reported to 
promote oligodendroglial process growth and to initiate myelin wrapping (Klein et 
al., 2002).  Therefore, multiple parallel signalling pathways appear to coordinate in 
order to initiate CNS myelination and there are distinct from those regulating PNS 
myelination. 
 
1.3  Developmental Oligodendrogenesis 
 During CNS development, oligodendrocytes are generated by oligodendrocyte 
progenitor cells (OLPs), which are in turn derived from ventricular zone (VZ) stem 
cells in the embryonic brain and spinal cord (reviewed by Woodruff et al., 2004; 
Richardson et al., 2006).  OLPs are characterized by the expression of the NG2 
proteoglycan and the mitogenic growth factor receptor, platelet-derived growth 
factor receptor (alpha subtype, PDGFRα).  In the spinal cord, most (~80%) of OLPs 
are produced by a specialized group of SOX10+/OLIG2+ progenitors in the ventral 
VZ (the same progenitors that earlier generate motor neurons).  The other ~20% are 
produced from more dorsal parts of the VZ (Vallstedt et al. 2005; Cai et al., 2005; 
Fogarty et al., 2005; reviewed by Richardson et al., 2006). 
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NG2 is a chondroitin sulphate proteoglycan, first identified in the late 1970‟s 
(Wilson et al., 1981).  It is a highly conserved protein expressed by a range of cells 
including glial cells, vascular mural cells, such as pericytes in the brain, cells of 
mesenchymal lineages, such as immature chondrocytes, osteoblasts and myoblasts, 
and stem cells in the skin (Levine et al., 1986; reviewed in Trotter et al., 2010).  NG2 
has been widely used as a marker for oligodendrocyte progenitor cells in the 
mammalian CNS and it is down-regulated when cells start to differentiate (Stallcup 
et al., 1987; Nishiyama et al., 1996). 
 
The human platelet-derived growth factor (PDGF) is a 30kDa cationic 
transmembrane protein, which stimulates the proliferation of various cultured cells, 
including oligodendrocyte progenitors (OLPs; Richardson et al., 1988), and a number 
of connective tissue-derived cells, e.g., arterial smooth muscle cells and human 
fibroblasts (Heldin et al., 1981; reviewed by Hoch and Soriano, 2003).  In the CNS, 
the alpha receptor for platelet-derived growth factor (PDGFRα) is preferentially 
expressed in OLPs and not in neurons or astrocytes (Pringle et al., 1992) and it is 
down-regulated very rapidly following cell differentiation (Hall et al., 1996; 
Nishiyama et al., 1996b).  Loss of PDGF-A in PDGF-A knockout mice results in 
significant loss of PDGFRα+ cells and subsequently of oligodendrocytes and myelin, 
though not uniformly throughout the brain (Fruttiger et al., 1999).  It is important to 
note that PDGF-A does not directly affect oligodendrogenesis and myelination. 
Overexpression of PDGF-A causes increased production of OLPs but does not affect 
the final number of postmitotic, differentiated oligodendrocytes (Calver et al., 1998; 
van Heyningen et al., 2001).  This is because PDGF-A only affects the proliferation 
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of OLPs, while oligodendrocyte differentiation and survival is influenced by other 
factors, including axon-derived factors (Barres and Raff, 1999). 
 
Another marker protein expressed by OLPs, as well as primary Schwann cells and 
mature oligodendrocytes, is the transcription factor SOX10 (Kuhlbrodt et al., 1998).  
SOX10 is characterized by a high-mobility-group DNA-binding domain (Wegner et 
al., 2001). Expression of SOX10 starts early in oligodendrocyte lineage development 
and, once turned on, it persists throughout life in all cells of the lineage (Wegner et 
al., 2001).  
 
OLIG1 and OLIG2 are basic helix-loop-helix (bHLH) transcription factors expressed 
very early in development under the control of the extracellular ventralizing signal, 
Sonic hedgehog (Shh) (Lu et al., 2000). They are the only cell type-specific bHLH 
proteins known to be expressed by oligodendrocyte lineage cells (Wegner et al., 
2001) and their expression is strongly restricted to cells of this lineage throughout 
life.  The OLIG proteins are not thought to be expressed outside of the CNS 
(Rowitch et al., 2002). 
 
1.3.1  Oligodendrogenesis in the Spinal Cord 
Pdgfra transcripts (and OLPs), are first detected at the ventricular surface of the 
cervical spinal cord on embryonic day 12.5 (E12.5) in the mouse (E14 in rat, E7 in 
chick) (Pringle and Richardson, 1993; Pringle et al., 1996).  OLPs are therefore 
generated after neurogenesis is complete (motor neurons in the mouse are generated 
from ~E9-E12, for example). Most OLPs are generated in the ventral VZ under the 
influence of sonic hedgehog secreted from the notochord and floor plate (Poncet et 
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al., 1996; Pringle et al., 1996; Orentas et al., 1999).  At first, there are only a few 
OLPs on each side of the central canal, but they soon increase in number and migrate 
from the midline into the parenchyma of the cord.  By E17 (in the mouse), 
PDGFRα+ OLPs are distributed more-or-less evenly throughout the spinal cord and 
their number reaches an approximate steady-state (Richardson et al, 2000).  A study 
by Nishiyama et al. (1996) has shown that NG2 expression is detectable on 
PDGFRα+ cells outside the VZ but not on PDGFRα+ cells in the VZ, suggesting that 
PDGFRα expression precedes NG2 expression during OLP development in the 
spinal cord (Nishiyama et al., 1996). Just before birth, spinal cord OLPs begin to 
generate oligodendrocytes and they continue to do so during the first few postnatal 
weeks (Richardson et al., 2000).  This process requires the cell to pass through 
several distinct stages of maturation.  The cells down-regulate PDGFRα and NG2 
when they start to differentiate. They maintain their expression of markers such as 
the transcription factors SOX10 and OLIG2, but they additionally begin to produce 
the myelin proteins CNPase, MBP and MOG. These myelinating oligodendrocytes 
are generated from P0/P1 and later (Richardson et al., 2000), peaking in the second 
and third postnatal weeks in mice. It is during postnatal life that the CNS becomes 
mature and functional. 
 
1.3.2  Oligodendrogenesis in the Brain 
Oligodendrocyte development has also been studied in the forebrain and its 
embryonic predecessor the telencephalon.  The process of OLP development is 
similar, albeit more complex with OLPs being generated from most parts of the 
embryonic neuroepithelium in a temporal wave from ventral to dorsal.  In the mouse, 
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the first OLPs are generated from the medial ganglionic eminence (MGE) and 
anterior entopeduncular area in the ventral telencephalon from E11.5, then from the 
lateral and caudal ganglionic eminences (LGE and CGE) from E15 and finally from 
the cortex after birth (Kessaris et al, 2006).  OLP specification in the ventral 
telencephalon depends on sonic hedgehog as in the ventral spinal cord (Kessaris et 
al., 2001).  Consistent with the timing of NG2/PDGFRα expression in the spinal 
cord, NG2 is expressed in the postnatal brain by PDGFRα+ cells outside the SVZ but 
not in the SVZ (Nishiyama et al., 1996). The time course of oligodendrocyte 
differentiation and maturation is similar in the brain and spinal cord. 
 
1.4  Adult OLPs (“NG2 cells”) 
Adult OLPs were first identified in the rat optic nerve and later in other parts of the 
adult mammalian CNS (ffrench-Constant and Raff, 1986; Wolswijk and Noble, 
1989, Engel and Wolswijk, 1996; Reynolds and Hardy, 1997; Chang et al., 2000; 
Horner et al., 2000; Reynolds et al., 2002).  In vitro studies have shown that adult 
OLPs are able to generate either oligodendrocytes, GFAP+ “type-2 astrocytes” or 
neurons, depending on the composition of the culture medium (Raff et al., 1983; 
Kondo and Raff 2000).  Both perinatal and adult OLPs are characterized by the 
expression of NG2 and PDGFRα (Shi et al., 1998).  PDGF-A also controls the 
number of OLPs in the adult CNS as it does during development (van Heyningen et 
al., 2001; Woodruff et al., 2004).  In addition, like perinatal OLPs, adult OLPs 
respond to PDGF-A by dividing and migrating in vitro (Wolswijk and Noble, 1989; 
Shi et al., 1998).  Conversely, a few prominent differences were identified when 
adult OLPs were compared to their perinatal counterparts.  These include their 
Chapter 1 Introduction 
 
29 
 
morphology, cell cycle length and their migration and differentiation rates (Wolswijk 
and Noble, 1989).  However, if their intracellular levels of cAMP are elevated, OLPs 
can be induced to divide as rapidly as perinatal OLPs when cultured with PDGF and 
the glial growth factor (GGF), suggesting that adult OLPs have the capacity to 
proliferate and differentiate faster under the right conditions (Shi et al., 1998). 
 
Because of their obvious similarities to perinatal OLPs, adult OLPs have been widely 
presumed to be glial precursors, playing a role in CNS maintenance, replacing 
oligodendrocytes and possibly astrocytes that might die as a result of injury or 
disease or as a natural part of the ageing process.  However, they exist in significant 
numbers in the adult brain, comprising ~5% of all cells in the mature CNS (Pringle et 
al., 1992; Dawson et al., 2003).  In addition, in the spinal cord grey and white matter, 
the ratio of OLPs to myelinating oligodendrocytes was found to be 1:4, while in the 
grey matter forebrain it was found to be 1:1, suggesting that OLPs in the adult brain 
may yet make a greater contribution to oligodendrogenesis than in the spinal cord 
(Dawson et al., 2003), or else might fulfil another role(s) unrelated to myelination. 
 
OLPs are mitotically active throughout life as shown in studies using the thymidine 
analogue bromo-deoxyuridine (BrdU) (Levison et al., 1999; Horner et al., 2000; 
Dawson et al., 2003; Lasiene et al., 2009; Psachoulia et al., 2009).  Following single 
BrdU injections to adult rats, BrdU+ OLPs have been shown to persist in the adult 
brain (Dawson et al., 2003) and spinal cord (Horner et al., 2000) and to constitute the 
major cycling population of the adult rodent (Dawson et al., 2003) and human (Geha 
et al., 2010) CNS.  Apoptosis of these cells was minimal (Dawson et al., 2003).  This 
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observation and the fact that the number of BrdU+ OLPs was decreasing in parallel 
to the increasing number of BrdU+ oligodendrocytes in rats that received a single 
BrdU injection suggests that adult OLPs differentiate into oligodendrocytes in the 
adult CNS (Dawson et al., 2003; Horner et al., 2000; Gensent and Goldman, 1997). 
 
This presumed oligodendrogenic role does not preclude the possibility that OLPs 
might perform another more „physiological‟ role besides.  OLPs have a complex 
morphology in the adult CNS and they contact neurons at synapses and nodes of 
Ranvier, which is not what one might expect of a simple precursor cell, making the 
question of their adult function even more intriguing.  The finding that postnatal 
OLPs express ligand- and voltage-gated ion channels and receive synaptic input from 
neurons has encouraged the idea that OLPs participate in neural processing during 
adulthood (Gallo et al., 1996; Bergles et al., 2000; Lin and Bergles, 2002, 2004; Lin 
et al., 2005; Karadottir et al., 2005; Salter and Fern, 2005).  OLPs form 
glutamatergic synapses with unmyelinated axons in white matter tracts (Kukley et 
al., 2007; Ziskin et al., 2007) and there is evidence that OLPs are able to fire action 
potentials in response to an initial depolarizing trigger (Chittajallu et al., 2004; 
Karadottir et al., 2008), though this is still controversial (e.g. Lin and Bergles, 2002).  
Taking all of this evidence together, it seems possible that OLPs might participate in 
neural processing, by sensing neuronal activity and reporting this activity to 
neighbouring neurons or glia. 
 
Alternatively, or in addition, OLPs might be „listening in‟ to the electrical activity of 
their associated axons, which at some threshold might trigger their myelination 
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programme.  This could ensure that only active circuits are myelinated and might 
even contribute to circuit plasticity during adulthood (Fields, 2008).  It has been 
reported that only around 30% of corpus callosal axons are myelinated even in eight 
month-old mice (Sturrock, 1980).  This suggests that there is still plenty of scope for 
de novo myelination of axons to occur throughout life.  It has been observed that 
extensive piano practise during childhood can cause long-term changes to the 
structure of white matter tracts, including parts of the corpus callosum (Bengtsson et 
al., 2005).  Furthermore, both cognitive ability and white matter volume increase in 
parallel until the fourth decade of life, when both start to decline (Bartzokis et al., 
2001; Mabbott et al., 2006; Hasan et al., 2008; Ullen et al., 2008; Bartzokis et al., 
2008; Zahr et al., 2009), suggesting a causative link.  As there is a growing body of 
evidence to indicate that CNS plasticity and repair decreases with age, it is possible 
that this might result from an age-related decline in the ability of OLPs to proliferate 
and generate new oligodendrocytes (Rivers et al., 2008; Psachoulia et al., 2009; 
Lasienne et al., 2009; this Thesis). 
 
In addition to their putative role in normal neural plasticity, OLPs are thought to be 
crucial for remyelination following demyelinating injury or disease.  For example, 
during cytotoxin-induced focal demyelination and subsequent re-myelination of the 
mouse spinal cord, the dynamic behaviour of OLPs in and around the lesion suggests 
that they are a major source of remyelinating oligodendrocytes (Keirstead et al., 
1998; Watanabe et al., 2002; Dawson et al., 2003).  The efficiency of remyelination 
following experimental demyelination decreases with age, which might be attributed 
to an age-related decline in the regenerative properties of OLPs (Sim et al., 2002).  
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Therefore, OLP function is probably crucial, not only during normal healthy 
adulthood but also for tissue regeneration following demyelinating insults to the 
CNS.  The factors that cause these age-related changes are unknown but they could 
possibly be related to changes in the ability of OLPs to proliferate and generate new 
oligodendrocytes as the brain matures and ages.  How and why the behaviour of 
OLPs alters with age is a very important question, because it might become possible 
to manipulate the properties of OLPs in the mature and ageing brain so as to improve 
their regenerative capacity. 
 
Adult OLPs/NG2 cells have been described as the “4th major CNS cell type” (after 
neurons, oligodendrocytes and astrocytes; see polydendrocytes Fig. 1.1).  Despite 
their prominence in the adult CNS, many questions regarding their fate, behaviour 
and function have yet to be answered.  This is the focus of my PhD Thesis.  The 
major questions that I have addressed are the following: 
1. What are the fates and functions of OLPs in the young adult and ageing brain? 
2. Are there different functional subsets of OLPs in the adult brain? 
3. What is the function of adult-born myelinating oligodendrocytes? 
 
A major theme in my research has been to use the tools of mouse genetics and 
transgenesis to mark, follow and manipulate OLPs/NG2 cells in the adult mouse 
brain. 
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Chapter 2: Materials and Methods 
 
 
 
General 
General chemicals and reagents were purchased from Sigma-Aldrich Co Ltd, unless 
otherwise stated. 
All water used was purified using the Milli-Q system (Millipore). 
Sterilization of solutions was performed by autoclaving at 15lb/sq.in. for 15 minutes 
or by filtration through a 0.22μm filter (Millipore).  All solutions were stored at room 
temperature unless otherwise stated. 
Falcon sterile plastic-ware was purchased from Marathon Ltd unless otherwise 
stated. 
RNase/DNase free microcentrifuge tubes were purchased from Starlab. 
 
 
2.1  DNA extraction and Amplification 
 
2.1.1  Small scale plasmid preparation 
Small quantities of purified plasmid DNA (1-2mg) were obtained by inoculating 5ml 
of Luria broth (LB) containing the appropriate antibiotic with a single colony of 
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transformed bacteria (see 2.4.3) and incubating overnight in a shaking incubator at 
37ºC.  1.5ml of the bacterial culture was transferred to a Microcentrifuge tube and 
centrifuged for 1 minute at maximum speed (13000rpm) in a microfuge.  The 
supernatant was removed, another 1.5ml of the culture was added and centrifugation 
repeated.  The bacterial pellet was resuspended in 100μl Solution 1 (50mM glucose, 
25mM Tris-HCl, pH 8.0 and 10mM EDTA, pH 8.0) by vortexing. 200μl of fresh 
Solution 2 (0.2N NaOH, 1% w/v SDS) was added and the cells lysed by gentle 
mixing.  150μl of Solution 3 (3M potassium acetate and 11.5% v/v glacial acetic 
acid) was added and after gentle mixing, the tube was centrifuged at 13,000rpm for 
10 minutes.  The supernatant was next transferred to a new Microcentrifuge tube 
containing 900μl of absolute ethanol (-20ºC), and centrifuged at 13,000rpm for 10 
minutes.  The precipitated DNA was subsequently washed with 200μl of 70% 
ethanol and centrifuged for 1 minute.  The ethanol was removed and the DNA pellet 
was resuspended by adding 50μl of MilliQ water and incubating at 55ºC in a water 
bath for 10 minutes.  The purified DNA was stored at -20ºC. 
 
Alternatively, plasmid DNA (excluding BAC DNA) was isolated using the 
QIAGEN® MiniPrep kit according to the manufacturer‟s instructions.  The bacterial 
cells were pelleted as previously described, resuspended in 250μl Buffer P1 (RNase 
A solution added) and transferred to a 1.5ml microcentrifuge tube. 250μl Buffer P2 
was added and mixed thoroughly to lyse the cells. 350μl of Buffer N3 was added, 
mixed and centrifuged at 13,000rpm for 10 minutes.  The supernatant was transferred 
to a QIAprep spin column, which was then centrifuged at 13,000rpm for 1 minute.  
The flow-through was discarded and the column was washed with 0.5ml of Buffer 
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PB, followed by a 1 minute centrifugation at 13,000rpm.  0.75ml of Buffer PE was 
added to the column, before a 1 minute centrifugation at 13,000rpm.  The flow-
through was discarded and the column was centrifuged again to remove residual 
wash buffer.  DNA was eluted from the column by the addition of 50μl of MilliQ 
water to the centre of the column, incubation for at least 1 minute at room 
temperature and centrifugation for 1 minute.  The spin column was transferred to a 
new microcentrifuge tube. 
 
2.1.2  Large scale plasmid preparation 
Large quantities of plasmid DNA (≥ 1mg) were prepared using one of the two 
following methods.  For the first method, 400ml of LB media containing 
chloramphenicol was inoculated with 500μl of a starting culture (grown overnight at 
32ºC, 225rpm) and grown overnight, shaking at 32ºC, 225rpm overnight.  The 
culture was transferred to a 50ml falcon tube and centrifuged at 3,750rpm for 10 
minutes at 4ºC.  The supernatant was removed and the pellet resuspended in 8ml of 
P1 solution (50mM glucose, 25mM Tris pH8.0 and 10mM EDTA pH8.0) with 100 
µg/ml RNase A.  8ml of freshly prepared P2 solution (0.2N NaOH and 1% w/v SDS) 
was then added and the mixture was gently mixed by inversion and incubated for 5 
minutes at room temperature. 8ml of P3 solution (0.3M Potassium Acetate and 
11.5% v/v glacial acetic acid) was added, mixed and centrifuged at 3,750rpm for 15 
minutes at 4ºC.  The supernatant was passed through a double sheet of autoclaved 
muslin before the DNA was precipitated by the addition of an equal volume (~24ml) 
of ice-cold isopropanol.  After mixing and spinning at 3,750rpm for 15 minutes at 
4ºC, the pelleted DNA was washed with ~5ml of 70% ethanol (v/v in MQ water) and 
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centrifugation at 3,750rpm for 1 minute.  The supernatant was removed, and the 
DNA resuspended in 1ml of Tris-EDTA (TE) and then pooled into 4 x 1.5ml 
microcentrifuge tubes using cut autoclaved P1000 tips to avoid DNA shearing.  
500μl of Phenol/Chloroform pH7.9 was added to each tube and the contents mixed 
gently by inverting ~8 times.  They were then centrifuged for 5 minutes at 
13,000rpm and the top phase was transferred to a new 1.5ml tube.  The phenol-
chloroform extraction was repeated.  500μl of Chloroform:IAA was next added and 
the tube inverted 8 times before centrifugation for 5 minutes at maximum speed.  The 
top phase of the supernatant was removed to a new 1.5ml microcentrifuge tube, 1ml 
of ice-cold absolute ethanol was added to each tube and mixed by inverting.  At this 
stage, 3 tubes were stored at -20ºC and the fourth tube was centrifuged for 10 
minutes at 13,000rpm at 4ºC.  The pelleted DNA was next washed with 70% ethanol 
and centrifuged for a further 5 minutes.  The supernatant was removed and the DNA 
pellets air dried at room temperature.  Finally, 100μl of MilliQ water was added and 
the DNA resuspended by incubation in a 55ºC water bath for 30 minutes before 
storing at 4ºC, until the DNA completely dissolved. 
 
Alternatively, DNA purification was performed using the QIAGEN
®
 Plasmid Midi 
Kit (25) (Cat no. 12143) according to the manufacturer‟s instructions.  The pelleted 
bacteria were resuspended in 20ml of Buffer P1, followed by the addition of 20ml of 
Buffer P2.  The tube was inverted vigorously 4-6 times before incubating at room 
temperature for 5 minutes.  20ml of chilled Buffer P3 was added and mixed 
immediately and thoroughly.  The tubes were then incubated for 30 minutes on ice 
and were next centrifuged for 30 minutes at 20,000g at 4ºC.  The supernatant was 
Chapter 2 Materials and Methods 
 
37 
 
passed through a double sheet of autoclaved muslin and was then precipitated by the 
addition of 42ml of isopropanol. After centrifugation at 15,000g for 30 minutes at 
4ºC, the DNA pellet was redissolved in 500μl TE buffer, pH8.0.  4.5ml of Buffer 
QBT was added and the solution was centrifuged for 15 minutes at 6,000g and the 
supernatant applied to a QIAGEN-tip, already equilibrated with Buffer QBT.  The 
DNA solution was allowed to enter the resin by gravity flow, before washing twice 
with 10ml of Buffer QC.  The DNA was removed from the column with 5ml of 
Buffer QF (65ºC) and was precipitated with 3.5ml of isopropanol and centrifugation 
at 15,000g for 30 minutes at 4ºC.  The DNA pellet was washed with 70% ethanol 
(v/v) in MQ water and centrifuged at 15,000g for 10 minutes.  Once the supernatant 
was removed, the DNA pellet was air-dried at room temperature and then dissolved 
in 50μl of MilliQ water by incubating for 15 minutes in a 55ºC water bath.  DNA 
was subsequently stored at -20ºC. 
 
2.1.3  DNA gel extraction 
QIAquick gel extraction Kit was used according to the manufacturer‟s instructions.  
DNA fragments were separated by agarose gel electrophoresis (see 2.3.1) and the 
required bands were illuminated by UV excitation.  The required DNA band was 
excised from the agarose gel using a clean scalpel blade, and placed inside a 1.5ml 
microcentrifuge tube.  The agarose was solubilized by the addition of a volume (ml) 
of Buffer QG equal to 3x the weight of the agarose fragment (mg), and incubation at 
55ºC in a water bath for 15 minutes.  The liquid sample was then transferred to the 
QIAquick column and centrifuged at 13,000rpm for 1 minute.  The flow-through was 
discarded and the column was washed with 0.5ml of Buffer QG, followed by a 
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further 1 minute centrifugation.  The column was further washed with 0.75ml of 
Buffer PE and centrifuged twice for 1 minute.  The DNA was eluted with the 
addition of 40μl of MilliQ water to the centre of the column, incubation for at least 1 
minute at room temperature and centrifugation at 13,000rpm for 1 minute. 
 
2.1.4  Extraction of genomic DNA from mouse tails 
Mouse genomic DNA was extracted from mouse tail tips.  Each sample was 
collected into a  1.5ml microcentrifuge tube and was incubated overnight in a 55ºC 
water bath with 250μl of DNA Extraction buffer (100mM Tris-HCl, pH8.5, 5mM 
EDTA, pH8.0, 200mM NaCl, 0.2% w/v SDS) containing 0.48mg/ml Proteinase K.  
The following day, 100μl 0f 6M ammonium acetate was added and the tube 
vortexed, before incubating on ice for 15 minutes.  The samples were then 
centrifuged at 4ºC for 10 minutes at 13,000rpm.  The supernatant was transferred to a 
new tube with 250μl of isopropanol, vortexed and centrifuged for 3 minutes at 
13,000rpm.  The isopropanol was removed, 250μl of 70% v/v ethanol in MQ H2O 
was added and the tubes were centrifuged for 3 minutes at 13,000rpm.  The ethanol 
was removed with a P200 pipette and the DNA pellets allowed to dry at room 
temperature.  50μl of MilliQ water was added before incubating in a 37ºC water bath 
for ~2 hours.  The genomic DNA was stored at 4ºC. 
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2.2  Polymerase chain reaction (PCR) 
 
2.2.1  Amplification of genomic DNA 
PCR was used to amplify regions of genomic DNA.  Reactions were carried out in 
0.2ml PCR tubes, each reaction containing 2.5μl 10x PCR buffer (500mM KCl, 
100mM Tris-HCl pH 9.0, 1% (v/v) Triton X-100; Promega), 25mM MgCl2, 0.2mM 
dNTPs (dATP, sCTP, dGTP, dTTP; Amersham Pharmacia Biotech), 10pmol of each 
primer, 0.5μl of TAQ DNA Polymerase (purified by Matthew Grist) and MQ water 
to give a final volume of 23μl, to which 2μl of genomic DNA (prepared as above) 
was added.  Tubes were then placed in either a Microcentrifuge Mastercycler 
Gradient or an MWG-Biotech Primus 96 PCR machine.  Reactions were initially 
denatured at 94ºC for 4 minutes, followed by 35 cycles of denaturing for 30 seconds 
at 94ºC, then annealing for 45 seconds at 62ºC (this varies according to the optimum 
annealing temperature for each primer - see Table 2.1), and finally an extension of 
45 seconds at 72ºC.  The final extension step of 10 minutes at 72ºC was stopped by 
cooling to 4ºC. 
 
2.2.2  Amplification of vector DNA 
To amplify a DNA sequence for cloning, PCR was carried out using a DNA 
polymerase with proof reading compatibility.  The PCR reaction included 5x 
PfuUltraII Buffer (contains 10mM Mg
2+
), 0.56mM dNTPs, 0.1μl each primer, 1μl of 
PfuUltra II HS DNA Polymerase (Roche), ~100ng of purified template DNA and 
MQ water up to 25μl.  The amplification program comprised a 2 minute denaturation 
step at 95ºC,  35-38 cycles through a program of 95ºC for 20 seconds, 62ºC (±5ºC  
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Transgene Forward Primer 5' to 3' direction Reverse Primer 5' to 3' direction
Annealing 
temperature
Product 
size
IresVenus GCGTATTCAACAAGGGGCTG CCTTGATGCCGTTCTTCTGCTTGT 62°C 700bp
DsRed
TCTAGATAATATTGGCCACAACCA
TGGCCTCC
CTCGAGCCCCAGGAACAGGTGGT
GGCGGC
66°C 700bp
GFP
CCCTGAAGTTCATCTGCACCAC TTCTCGTTGGGGTCTTTGCTC
62°C
iCre GAGGGACTACCTCCTGTACC TGCCCAGAGTCATCCTTGGC 62°C 630bp
Cre
CAGGTCTCAGGAGCTATGTCCAAT
TTACTGACCGTA
GGTGTTATAAGCAATCCCCAGAA 59°C 500bp
AAAGTCGCTCTGAGTTGTTAT GGAGCGGGAGAAATGGATATG 59°C 550bp
GCGAAGAGTTTGTCCTCAACC AAAGTCGCTCTGAGTTGTTAT 59°C 250bp
Olig2 GCCAGCTATCAACTCGCGCCC GTGGAAGACGTGGCCGCC 61°C 400bp
Rosa26
 
 
 
Table 2.1 Table showing the primer sequences used to genotype the transgenic mice used 
and also the annealing temperature and the size of the amplified DNA product obtained 
required. 
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according to primer Tm) for 45 seconds and 15 seconds at 72ºC, before a final 
extension step of 10 minutes at 72ºC, followed by cooling to 4ºC. 
 
2.3  Analysis of DNA 
 
2.3.1  Agarose gel electrophoresis 
The gel tray and combs used were from peqlab Biotechnologie GmbH.  1% Agarose 
w/v in 1x TAE buffer (0.04M Tris, 1mM EDTA, 0.35% v/v glacial acetic acid) was 
microwaved until all agarose was dissolved and cooled to 55ºC before adding 
0.5μg/ml ethidium bromide.  Once the gel was set, the sample DNA was diluted 5:1 
with loading buffer (Bioline Cat no. BIO-37045) was loaded into the wells of the gel 
alongside 10μl of Hyperladder 1 (Bioline Cat no. HYPL1500), which is a mixture of 
a variety of DNA fragments of known sizes (200bp-10kb) and known amounts 
(15ng-100ng).  Agarose gel electrophoresis was performed using a horizontal gel 
tank by peqlab Biotechnologie GmbH powered by a BioRad Power Pac 300 at 150V.  
Visualization of DNA within the gel by the presence of ethidium bromide was 
performed using a MultiImage™ Light Cabinet and processed by the AlphaImage™ 
1220 Documentation & Analysis system. 
 
2.3.2  Pulse Field Gel Electrophoresis of BAC DNA 
Pulse field gel electrophoresis (PFGE) was performed to separate DNA fragments 
larger than 10kb, e.g. BAC DNA.  It was conducted in a Bio-Rad contour-clamped 
homogenous electric field electrophoresis cell connected to a CHEF DR II control 
module and CHEF DR II drive module, both from Bio-Rad.  Electrophoresis of DNA 
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samples was carried out using 1% w/v agarose gels in 0.5x TBE (stock: 45mM Tris-
borate, 1mM EDTA, pH8.0).  Prior to electrophoresis, 2mm of Pulse Marker™ (0.1-
200kb) was placed in the first lane and sealed with additional 1% w/v agarose to act 
as a standard marker.  The DNA was loaded with loading buffer (see above).  Gels 
were run for 12 hours in approximately 2 litres of 0.5x TBE which was kept 
recirculating via a peristaltic pump.  Electrophoresis was at 4ºC in a 6V/cm field with 
an initial switch time of 2.1 seconds and a final switch time of 10 seconds.  Gels 
were stained in 0.5µg/ml ethidium bromide in MQ H2O for 10 minutes and rinsed 
once with MQ water before being visualized on a UV transilluminator. 
 
2.3.3  Quantification of DNA 
The concentration of DNA was estimated by matching the intensity of the sample 
band DNA band to the intensity of bands of known quantity within the Hyperladder I 
on the same agarose gel.  Alternatively, DNA concentration was determined by 
measuring the absorbance of UV light by a DNA solution at a wavelength of 260nm 
using a UV Mini 1240 uv-vis spectrophotometer from Simadzu.  At this wavelength 
50mg of DNA free from RNA and protein contaminants has an absorbance of 1.0.  
The value obtained was used to calculate the DNA concentration. 
 
2.3.4  DNA Sequencing 
DNA sequencing was carried out by the Wolfson Institute for Biomedical Research 
(WIBR) Scientific Support Services on the Beckman Coulter CEQ 8000 Genetic 
Analysis System.  For sequencing, DNA prepared by Mini-Prep was produced at a 
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concentration of 9-16fmoles/µl and was used in conjugation with the Beckman 
Coulter DTCS quick start kit (Cat no. 608120) and the appropriate primers. 
 
2.3.5  Restriction Enzyme Digestion of DNA 
Restriction enzymes, buffers and 100xBSA solution were obtained from New 
England Biolabs.  DNA digestions were carried out using 1μl of restriction enzyme 
with 5μl of the appropriate buffer and 1xBSA if specified by the enzyme‟s 
manufacturer.   For analytical purposes, around 50ng of plasmid DNA was digested 
(10-15µl digest volume), while for cloning purposes, up to 1μg of DNA (15µl digest 
volume) was digested.   The reaction was incubated for 2 hours in a 37ºC water bath 
and was subsequently analysed by agarose gel electrophoresis or pulse field gel 
electrophoresis. 
 
2.4  Bacterial Biology 
 
2.4.1  Bacterial strains, growth and storage 
All plasmids were maintained in Escherichia coli (E. coli) strain XL1-Blue (recA1, 
endA1, gyrA96, thi-1, hsdR17, supE44, relA1, lac [F’ proAB, laclqZΔM15, Tn10 
[Tet
R
)]).   E. coli were grown in Luria Broth (LB; 10g bacto-tryptone, 5g yeast 
extract, 10g NaCl per litre) at 37ºC and 225rpm incubator (New Brunswick 
scientific; innova 4300, shaking incubator).  Alternatively, cells were grown on LB-
agar plates (LB + 15g/l bacto-agar).  When selecting with ampicillin (Ampicillin 
sodium salt; Cat no A9518) or kanamycin (Kanamycin Solution; Cat no K0129), 
these were added to the LB or molten LB-agar at a final concentration of 100μg/ml 
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(ampicillin; 100mg/ml stock in water stored at -20ºC).  When selecting with 
chloramphenicol, this was added at a final concentration of 44 μg/ml (34mg/ml stock 
in ethanol at -20ºC). 
 
For long term storage of bacterial strains and clones, glycerol was added to the 
overnight cultures at a final concentration of 15% (v/v) and 1ml aliquots were stored 
at -80ºC. 
 
2.4.2  Preparation of electro-competent bacteria 
E. coli strain XL1-Blue was made electro-competent as follows:  1ml of an overnight 
liquid culture of bacteria (grown from a single colony) was used to inoculate 1 litre 
of LB until it was in mid-log growth phase (OD600 of ~0.6; OD: Optical Density).  
The culture was then chilled on ice for ~10 minutes, and then centrifuged at 3000g, 
at 4ºC for 10 minutes.  The bacterial pellet was resuspended in 1ml of ice-cold 
autoclaved MQ water, centrifuged and finally resuspended in 200μl of ice-cold 10% 
(v/v) sterile glycerol in LB.  50μl aliquots were snap frozen in liquid nitrogen and 
stored at -80ºC. 
 
2.4.3  Transformation of electro-competent bacteria 
E. coli bacteria aliquots were thawed on ice, mixed with 2-6μl of purified DNA (see 
2.5.1.3 and 2.1.3) and transferred to a chilled disposable 0.1cm electroporation 
cuvette (Bio-Rad Laboratories Ltd).  Bacteria were electroporated using a Gene 
Pulser electroporator equipped with Pulse Controller (Bio-Rad Laboratories Ltd) set 
to 2500V, 200Ω, 25μF, producing a time constant of between 4.5-6 seconds.  The 
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bacteria were then incubated in a 37ºC water bath for 1 hour with 250µl of LB before 
plating on LB-agar plates with suitable antibiotic.  Plates were incubated in a 37ºC 
oven overnight to allow colonies of transformed bacteria to grow.  The plates used 
had Kanamycin or Ampicillin resistance, as well as a mixture containing 90μl MilliQ 
water, 10μl Isopropyl-Beta-d-Thiogalactopyranoside (IPTG) and 20μl Xgal.  White 
colonies (negative for ß galactosidase product) were selected. 
 
2.4.4  Preparation and transformation of electrocompetent EL250 cells 
The E. coli EL250 strain (available via MTA from Neal G. Copeland) is a modified 
DH10B strain [Gibco] containing a replication defective lambda prophage (Yu et al., 
2000) coding for the arabinose flpe gene (Lee et al., 2001).  E. coli EL250 bacteria 
were grown in 5ml of LB with no antibiotic at 32ºC, 225rpm in a shaking incubator 
overnight.  1ml of this culture was added to 50ml of fresh LB with no antibiotic and 
grown in a shaking incubator in an autoclaved flat bottom conical flask at 32ºC, 
225rpm until reaching an OD600= 0.5-0.8.  The flask containing the culture was then 
placed in ice water for 5 minutes to cool down, and centrifuged at 2,200rpm at 4ºC 
for 8 minutes.   The bacterial pellet was resuspended in 1ml of autoclaved MQ water, 
transferred to a microcentrifuge tube and centrifuged for 20 seconds at 13,000rpm.  
The pellet was washed thrice with MQ water before finally been resuspended in 50μl 
of sterile MQ water (or 50μl of 10% (v/v) glycerol in LB for long term storage at -
80ºC). 2-8μl of purified BAC DNA was added to the bacteria before the mix was 
transferred to a chilled 0.1cm disposable cuvette, which was then electroporated 
with1.8kV using a Bio-Rad gene pulser, 25uF with pulse controller set to 200Ohms 
[Ec1].  The cells were recovered by adding 250μl of LB and incubating at 32ºC in a 
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shaking incubator for 2 hours. 20% of the bacterial solution was spread onto one, and 
the remaining 80% onto a second LB-agar plate containing chloramphenicol 
(44µg/ml).  The plates were incubated overnight at 32ºC. 
 
2.5  Generation of transgenic mice 
 
2.5.1  Generation and characterization of Bacterial Artificial Chromosomes 
(BACs) 
 
2.5.1.1  Choosing the appropriate BAC 
The ermin gene is located on chromosome 2 in mice, has 3 exons and 2 introns and is 
distributed over 7.7kb (Fig. 5.1).  Using the BAC Map provided by Ensemble 
(www.ensemble.org; Fig. 5.1), 3 BACs were chosen that included the coding 
sequence for ermin.  Bacteria containing the BACs inside the pBACe3.6 vector were 
obtained from the CHORI BACPAC resources center (http://bacpac.chori.org).  The 
bacteria were cultured and DNA, extracted as previously described (see 2.1.2), was 
restriction enzyme digested and the DNA fragment sizes were analyzed by PFGE to 
confirm the identity of the BAC received.  The BAC DNA inside the pBACe3.6 
vector was subsequently electroporated into EL250 bacteria as described (see 2.4.4). 
 
2.5.1.2  Cloning/Purifying DNA fragments for the targeting vector 
DNA fragments for cloning were obtained by direct restriction digest of existing 
plasmid DNA, or following PCR amplification and cloning.  Fragments of interest 
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were then isolated by agarose gel electrophoresis followed by band purification as 
previously described. 
 
PCR amplified gel purified DNA was incorporated into the pCRII-TOPO
®
 vector 
using the TOPO TA cloning
®
 kit (Invitrogen Cat no. K4600-01).  This vector uses a 
backbone topoisomerase enzyme that rapidly links any PCR fragment into its 
covalently bound vector.  PCR amplified DNA was incubated for 10 minutes at 72ºC 
with 2mM dNTPs and 0.5μl DNA Polymerase.  DNA was then run on 1% (w/v) 
agarose gel in TAE and the DNA was purified (see 2.1.3).  2μl of the DNA, 0.25μl 
salt solution (provided in the kit), 1μl pCRII-TOPO® vector and 2μl MilliQ water 
were incubated for 10 minutes at room temperature.  2μl of the TOPO cloning 
reaction was used directly to transform E. coli cells (see 2.4.3).   
 
2.5.1.3  Ligation of DNA fragments 
Band purified fragments of DNA were digested with restriction enzymes that 
generated overhanging “sticky” ends.  Where specified, DNA fragments were blunt 
using T4 DNA polymerase (restriction enzyme digested DNA was incubated at 12ºC 
water bath for 15 minutes with 0.2mM dNTPs and 1µl of T4 DNA Polymerase 
followed by addition of 0.5µl EDTA and purification – see 2.1.3).  Ligation reactions 
were carried out using 50ng of vector DNA.  The amount of insert DNA required 
was calculated to give (insert DNA):(vector DNA) molar ratio of 3:1.  This could be 
calculated by applying the equation X = ((50/V) x I) x 3 where X is the amount of 
insert in ng, V is the length of the vector in base pairs and I is the length of the insert 
in base pairs.  The reaction mixture containing the calculated amounts of vector and 
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insert DNA in a total volume of 10μl with 40 cohesive end units/μl of T4 DNA ligase 
(New England Biolabs), 1x T4 DNA ligase buffer and 0.5 nM ATP, was incubated 
either at 16ºC overnight or at room temperature for 1 hour. 
 
2.5.2  BAC recombination 
 
2.5.2.1  Induction of recombination in EL250 cells 
EL250 cells that contained the BAC DNA were grown on LB agar plates 
supplemented by kanamycin (12.5µg/ml) at 32ºC overnight.  A single colony was 
selected and used to inoculate a 5ml starter culture that was again grown overnight, 
shaking at 32ºC (with kanamycin).  4ml of this overnight culture was used to 
inoculate 50ml of LB (without kanamycin) which was grown until OD600 reached 
0.5-0.8.  Recombination was induced by transferring 10ml of this culture to a 42ºC 
water bath for 15 minutes.  This culture was then cooled rapidly in ice water for 5 
minutes, alongside a 10ml of the non-induced (32ºC only) culture.  The non-induced 
culture acts as a negative control for the recombination.  Both induced and non-
induced cultures were spun at 1100g at 4ºC for 8 minutes and the bacterial pellets 
were resuspended in 1ml of ice cold autoclaved MQ water and transferred to a 1.5ml 
microcentrifuge tube and centrifuged at 13,000rpm for 20 seconds.  This was 
repeated three times and after the final wash, the pellets were resuspended in 100µl 
of autoclaved MQ water.  50µl of the induced and non-induced cells were 
electroporated with 100-300ng of the linear targeting vector DNA.  After 
transformation 500µl of warm LB was added to the cells and they were incubated at 
32ºC in a shaking incubator for 90 minutes.  Cells were then placed on LB agar 
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plates containing 20µg/ml ampicillin and LB agar plates containing 12.5µg/ml 
kanamycin as a control to demonstrate the presence of live cells in both the induced 
and non-induced cultures regardless of whether recombination had been successful.  
Colonies that have grown on the ampicillin plates from the induced cultures were 
used to inoculate overnight mini cultures.  BAC DNA was then purified (see 2.1.3), 
digested with restriction enzymes and PFGE was used to confirm that recombination 
had occurred. 
 
In addition to the temperature-inducible recombination events, it was also necessary 
to remove the kanamycin resistance cassette, prior to inserting the recombinant DNA 
into the mice.  To allow this the kanamycin resistance cassette was flanked by frt 
sites.  The EL250 bacteria contain an arabinose inducible flpe gene that can be used 
to excise the cassette.  To achieve this, 300µl of recombinant EL250 bacterial culture 
were used to inoculate 15 ml of fresh LB broth.  The bacteria were grown to an 
OD600 of 0.5-0.8 and the sterile arabinose was added to a final concentration of 0.2% 
(v/v).  The cultures were then incubated for 1 hour at 32ºC.  1ml of this culture was 
then used to inoculate 10ml of fresh LB broth and this was incubated for 2 hours at 
32ºC before plating on the appropriate selective LB agar, with ampicillin (20µg/ml) 
for recombinant bacteria and with kanamycin (15µg/ml) to indicate the efficiency of 
that recombination.  In theory, the recombination should be very efficient giving no 
colonies on the kanamycin-containing LB agar plate.  Again recombination was 
further verified by carrying out restriction enzyme digests and PFGE. 
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2.6  Creation of Transgenic Mice 
 
2.6.1  Linearization and Purification of recombinant BAC DNA 
Linear recombinant BAC DNA was used for in ovo injections.  This was obtained by 
firstly carrying out a large scale preparation of BAC DNA as described (see 2.1.2).  
The resulting DNA (100μl) was digested overnight with the restriction enzyme 
PISceI.  The BAC DNA fragments were subjected to PFGE by running 90% of the 
digested BAC DNA across 3-5 merged lanes, with additional lanes containing 2mm 
of Pulse Marker and 5% of the digested BAC DNA respectively were loaded.  After 
PFGE the marker lane, the 5% BAC DNA digest and ~1mm of the 90% BAC DNA 
were cut away from the gel with a scalpel blade and stained with 0.2µg of ethidium 
bromide in MQ H2O.  This revealed the relative locations of the liberated BAC DNA 
and the vector backbone without ethidium staining the DNA required for 
microinjection.  Using the stained BAC DNA as a guide, the vector DNA and the 
insert DNA were excised from the large lane and placed in a mini gel tray as shown 
in figure 2.1a.  4% (w/v) low melting point (LMP) agarose in TAE was poured into 
the tray until it just covers the bands.  The gel was allowed to set and was then run at 
50V for 9 hours at 4ºC (Fig. 2.1b).  The portion of the mini gel containing the vector 
band and ~1mm of the BAC insert band was then excised and stained with ethidium 
bromide to confirm that the DNA had accumulated into the 4% LMP agarose.  It was 
also used to determine the position of the insert DNA (Fig. 2.1c). 
 
A small block of LMP agarose containing the concentrated insert DNA of interest 
was equilibrated in TENPA buffer  (1M Tris-HCL pH 7.5,  0.5 EDTA  pH 8.0, 5M  
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Figure 2.1 (A) The arrangement of the excised bands in the mini gel tray. Hashed area 
indicates the location of the DNA.  (B) After running the DNA becomes concentrated in a 
small region of the 4% LMP agarose immediately adjacent to the original excised PFGE 
band.  The dashed line indicates where the vector DNA section of the mini gel should be cut 
away to allow it to be stained with ethidium bromide.  (C) Visualization of the vector band 
by UV illumination allows localization and removal of the BAC DNA of interest.  
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NaCl) containing 30μM spermine and 70μM spermidine while being agitated for 1.5 
hours.  The gel block was then placed in a microcentrifuge tube, incubated in a 65ºC 
water bath for 3 minutes, centrifuged briefly and incubated for a further 5 minutes.  
The tube was then transferred to a 42ºC water bath for 5 minutes.  Without removing 
the molten agarose from the water bath, 2 units of β-Agarase (New England 
Biosciences) was added per 100μl of molten agarose and the solutions were mixed 
by pipetting up and down with a wide bore pipette.  Agarose digestion took 3 hours 
at 42ºC and then the mixture was placed at room temperature.  If all agarose had 
fully digested the solution did not set.  In a 60x15mm Petri dish, 3 dialysis 
membranes (Millipore, pore size 0.025μm) were placed floating on a solution of 
microinjection buffer (1M Tris-HCL pH 7.5, 0.5M EDTA pH 8.0, 5M NaCl, filter 
sterilized) containing 30μM spermine and 70μM spermidine.  The DNA solution was 
pipetted directly on top of the three filters in equal volumes and the solutions were 
allowed to dialyse for 1 hour at room temperature.  The purified insert DNA was 
recovered from the top of the filters and stored at 4ºC.  A small volume of the DNA 
was analysed by PFGE along with an equivalent volume of control BAC DNA of 
which a known quantity had previously been microinjected and produced founder 
transgenic mice.  This gel was stained with 0.5µg/ml ethidium bromide in H2O and 
was used as a rough means of quantifying the DNA and checking its purity.  The 
stained DNA was microfuged and diluted in microinjection buffer (1:3000-1:100) on 
the day of microinjection.  DNA was generally used for microinjection within a week 
of purification. 
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2.6.2  In ovo injection of BAC DNA and transplantation 
Fertilized eggs were obtained from superovulated females. Superovulation was 
induced in 3-4 weeks old (B6 x CBA) F1 mice by injecting with 0.1ml of 50units/ml 
of follicle stimulating hormone (Folligon, from Intervet) in 0.9% NaCl at around 
5pm on day 1.  They were then injected with 0.1ml of 50units/ml of human chorionic 
gonadotrophin (hCG, Chorulon, from Intervet) in 0.9% NaCl around 45 hours later.  
After hCG injection, females were mated with (B6 x CBA) F1 fertile males. 4-6 
females typically yielded 100-200 fertilized ova. 
 
Microinjection of DNA was carried out by U. Dennehy (Richardson Lab, WIBR).  
Briefly, linear BAC DNA, suspended in microinjection buffer was injected into the 
pronuclei of the fertilized mouse ova.  Surviving 2 cell stage embryos were then 
transplanted into the oviducts of pseudopregnant foster mothers (18-22 embryos per 
mother).  Pseudopregnant mothers were prepared 24 hours previously by mating 6-
24 week old females in natural oestrous with vasectomized males. 
 
2.7  Neural Cell labelling, tracing and ablation 
 
2.7.1  Transgene labelling, tracing and ablation 
The following transgenic mice were bred and maintained: 
PDGFRα-CreERT2 transgenic (Rivers et al., 2008) express a tamoxifen inducible 
form of Cre recombinase under the regulation of the pdgfrα gene promoter. This 
transgenic line was maintained as a homozygous breeding colony. 
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Emx1-iCre (Kessaris et al., 2006), Gsh2-iCre (Kessaris et al., 2006) and Olig2-Cre 
(unpublished, Richardson laboratory) transgenic mice express a constitutively active 
form of Cre recombinase in Emx1-, Gsh2- and Olig2- expressing cells respectively.  
These transgenic lines were maintained as heterozygous breeding colonies and were 
genotyped for iCre and Cre as specified in table 2.1. 
Fgfr3-iCreER
T2
 transgenic mice (Young et al., 2010) were maintained as a 
heterozygous breeding colony and genotyped for expression of iCre (Table 2.1). 
Rosa26-YFP transgenic reporter mice (Srinivas et al., 2001), following 
recombination by Cre, express the yellow fluorescent protein (YFP) under the 
regulation of the ubiquitous Rosa26 promoter.  This transgenic line was maintained 
as a homozygous breeding colony. 
The Tau-mGFP transgenic reporter mice (Hippenmeyer et al., 2006) contain a lox-
STOP-lox-mGFP-IRES-NLS-LacZ-pA targeting cassette in exon 2 of the Tau 
genomic locus.  Following recombination by Cre, these mice express a membrane 
targeted form of GFP under the control of the Tau promoter.  They were maintained 
as a heterozygous breeding colony and genotyped using primers that identify the 
GFP coding sequence (Table 2.1). 
The Ermin-DTR transgenic mice detailed in Chapter 5 were maintained as a 
heterozygous breeding colony and genotyped using primers that identify the DNA 
coding sequences of Venus and/or DsRed (Table 2.1). 
 
All transgenic mice were housed under the standard animal housing conditions 
(23ºC, 48% humidity, 12h dark/12h light cycle) with food and water available ad 
libitum.  When specified, mice were transferred to running wheel cages (Lafayette 
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Neuroscience) and their running performance was monitored using the Monitoring 
Software (Lafayette Neuroscience). 
 
2.7.1.1  PCR Genotyping 
Genomic DNA was extracted from tissue biopsy and used for PCR amplification as 
described (see 2.1.4).  The primers used for genotyping the animals were designed 
specifically to amplify only stretches of DNA within the targeting construct. 
 
2.7.1.2  Cre mediated recombination 
To generate mice for experimental use, Ermin-DTR transgenic mice were crossed to 
Emx1-iCre transgenic mice.  iCre is expressed in all Emx1+ cells, e.g. stem cells in 
the embryonic VZ.  iCre binds to the loxP sites in the Ermin-DTR transgene and 
recombines them, thus removing the stop sequence and allowing expression of the 
Venus and DTR genes.  
 
2.7.1.3  CreER
T2
 mediated recombination 
Mice expressing an inducible form of Cre were crossed with one of two reporter 
mouse lines: Rosa26-YFP, Tau-mGFP (see previous section) (Fig. 2.2).  Cre 
recombination in adult CreER
T2
/reporter mice was induced when Tamoxifen (TM), 
an estrogen analogue, is administered to transgenic mice. When the enzyme cre-
recombinase is bound by the estrogen receptor (ER
T2
), it is held inactive in the cell 
cytoplasm.  Upon tamoxifen administration, tamoxifen will bind to the ER
T2
 
allowing Cre to translocate from the cytoplasm into the nucleus.  In the nucleus, 
activated Cre recognizes sequences in the DNA that correspond to lox-P sites and  
Chapter 2 Materials and Methods 
 
56 
 
 
 
 
 
 
 
Figure 2.2 Cre-mediated recombination of loxP sites in iCre(or)CreERT2/Rosa26-YFP 
double transgenic mice.  Orally administered tamoxifen to CreER
T2
/Rosa26-YFP double 
transgenics binds to cytoplasmic CreER
T2
, allowing it to translocate to the nucleous.  
CreER
T2
 locates loxP sites and recombines them, excising the stop sequence in between and 
thus switching on the expression of YFP.  For iCre/Rosa26-YFP double transgenics, 
tamoxifen administration is not needed as iCre is expressed in all cells that express Gene A 
throughout life. 
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recombines the lox-P sites, excising whatever DNA sequence lies between them 
(Fig. 2.2). 
 
Tamoxifen was administered orally to CreER
T2
/reporter mice.  40mg/ml TM was 
sonicated in corn oil for 55 minutes at 30ºC and administered by oral gavage into the 
stomach.  Adult mice received 300mg/kg body weight TM daily for 4 consecutive 
days. 
 
2.7.1.4  Diphtheria toxin (DT) administration 
DT (Merck) was administered to adult (P50) mice twice per day for 3 consecutive 
days.  100µl were intraperitoneally (i.p.) injected to the mice at a concentration of 
20µg/kg body weight. 
 
2.7.2  BrdU labelling of proliferating cells in vivo 
Bromodeoxyuridine (BrdU) is a thymidine analogue that is incorporated into the 
DNA of cells as they undergo DNA replication as part of the cell division process.  
BrdU was administered to P4 and to ≥ P60 mice by subcutaneous and i.p. injection 
respectively.  Alternatively, for mice ≥ P60 BrdU was administered via the surgical 
implantation of mini osmotic pumps or through the drinking water (Fig. 2.3).  For 
injections, BrdU (20mg/ml in PBS) was incubated for 60-90 minutes in a 55ºC water 
bath.  Pups received serial injections of ~20µl at 120mg/kg body weight every 3 
hours for up to 3 days, whereas adult mice were injected with a single dose of 100µl 
at 800mg/kg body weight.  Osmotic minipumps were implanted subcutaneously into 
adult mice by Leanne Rivers as described by van-Heyningen et al. (2001).  When 
BrdU was added to the drinking water of mice, BrdU was dissolved in MilliQ water  
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Figure 2.3 BrdU incorporation during DNA synthesis:  BrdU can be administered via 
various routes: injection, through the drinking water or via implanted osmotic mini-pumps.  
When a cell undergoes cell division the DNA strands are separated and new complementary 
strands are synthesized, resulting in two complete copies of the genome.  Nucleotides are 
added to synthesize the new DNA strands, and when BrdU is present, it is incorporated into 
the newly synthesized DNA strand in the place of thymidine (green ‘U’s).  The presence of 
BrdU in DNA can be detected by immunohistochemistry (see below).      
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to a concentration of 10mg/ml by incubation at 55ºC for 60-90 minutes, or until 
completely dissolved.  Once dissolved, tap water was added to make a final 
concentration of 0.8mg/ml, which was used to fill the water bottles.  Water bottles 
were covered with foil as BrdU is light sensitive. The BrdU/water solution was 
replaced every 2-4 days.  
 
2.7.3  EdU labelling of proliferating cells in vivo and in vitro 
5-ethynyl-2‟-deoxyuridine (EdU) (Invitrogen) is a second thymidine analogue that is 
incorporated into the DNA of cells as they undergo DNA replication as part of the 
cell division process. 
 
EdU was administered to mice either i.p., or via the drinking water and in the 
cultured cells medium.  Sterile filtered EdU (5μg/ml in PBS) was added into the 
SATO medium (Appendix I) to a final concentration of 10µM.  25% of the medium 
supplemented with new EdU was exchanged every 48 hours.  For i.p. injections, EdU 
was made up to 1mg/ml w/v in PBS and was administered to mice at a dose of 
25mg/kg body weight.  EdU was added in to the drinking water of mice at either 1, 
10, 100, 200, 500 or 1000µg/ml.  The EdU was vortexed in a small volume of MilliQ 
water until completely dissolved.  Once dissolved, tap water was added to dilute the 
EdU to its final concentration in the water bottles of mice.  Water bottles were 
covered with foil as EdU is light sensitive, and the water was replaced every 2-3 days 
to ensure that the EdU was active throughout the experiment.  EdU was used at 
200μg/ml of H2O for the majority of experiments. 
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2.8  Histology 
 
2.8.1  Generation, maintenance and fixation of OLP primary cultures 
Mice were euthanized by steadily increasing exposure to CO2.  Brains were removed 
into Earles Buffered Saline Solution without Ca+ or Mg+ (EBSS; Invitrogen).  
Olfactory bulbs were dissected away from the brain.  Brains were then sliced 
coronally using a scalpel blade at the level of the optic chiasm.  The septum was 
removed by pinching with forceps clearly exposing the edge of the corpus callosum.  
Cortex was dissected by pinching a small region from each hemisphere with forceps.  
The corpus callosum between the lateral ventricles was then dissected excluding all 
SVZ and adjacent cortical tissue.  The collected tissue was transferred into sterile 
EBSS. 
 
The isolated tissue was incubated at 37
o
C for 40-50 minutes in EBSS with Trypsin 
(62.5ng/ml) and DNase (56.25ng/ml).   To inactivate trypsin DMEM/10% FBS was 
added to the tube, which was then gently tapped to dissociate some of the cells.  
Most of the medium was removed after allowing the larger tissue pieces to settle to 
the bottom of the tube. More medium was then added and the tube tapped sharply.  
This medium was then pooled with the first and centrifuged for 5 minutes at 
1000rpm. The medium was aspirated using glass pipette and the cells were 
resuspended in DMEM/10% FBS and bFGF before being poured through a 70µm 
cell sieve.  The cell concentration was determined using a haemocytometer.  1.5 µl 
per well of cell suspension was plated at a concentration of 105 cells/µl in 300µl of 
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SATO medium (Appendix I) onto polyD-lysine coated 13mm glass coverslips.  Cells 
were grown for up to 2 days in a humid incubator at 37ºC and 5% CO2. 
 
For antigen detection, the culture medium was poured off cells and gently replaced 
with 4% PFA for 10 minutes at RT followed by two PBS washes.  
Immunohistochemistry and EdU detection was performed as described in section 
2.8.4 and 2.8.6. 
 
2.8.2  Perfusion fixation, tissue collection and freezing 
Mice were anaesthetized with pentobarbitone (2ml/kg body weight).  When they no 
longer reacted to applied pressure with scissor tips, an incision was made at the base 
of the sternum extending along the base of the rib cage and then up the side of the 
body through the ribs allowing the rib cage to lift up.  The diaphragm and connective 
tissue around the heart was blunt dissected away and a small incision was made in 
the atrium.  A needle (25g, 3/8‟‟) connected to a peristaltic pump containing 4% 
paraformaldehyde (wt/vol, PFA, Sigma, in PBS) was inserted into the apex (left 
ventricle).  4% PFA was delivered at a rate of 5ml/minute until there was no blood 
exiting the right atrium.  The brain was next dissected from the head and sliced using 
a cutting matrix.  The first blade cut at the level of the optic chiasm and another two 
blades cut 2mm either side.  The brain slices were then immersed in 4% PFA w/v in 
PBS for 45 min at 20–25 °C (for antibodies requiring short fixation) or else overnight 
at 4 °C (for antibodies requiring long fixation).  Tissue was then cryoprotected by 
replacing the 4% PFA with diethylpyrocarbonate-treated 20% sucrose (wt/vol) in 
PBS.  The issue was then incubated overnight at 4°C and subsequently embedded in 
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Tissue-Tek OCT (optimal cutting temperature) compound, frozen on dry ice and 
stored at –80 °C.  
 
2.8.3  In situ hybridization 
Tissue blocks were sectioned using a Bright OTF5000 cryostat.  20µm sections were 
cut and transferred into DEPC-treated PBS.  Sections were collected onto 
SuperFrost® Plus slides (VWR International) and dried for 30 minutes.  The slides 
were placed onto a nescofilm and laid in a hybridization chamber, the base of which 
contained 2 sheets of Whatman paper wetted with a 50% formamide 1x SSC 
solution.  DIG and FITC RNA probe aliquots were thawed on ice before diluting in 
1/1000 in hybridization buffer containing 50% formamide, 100 mg/ml dextran  
sulphate, 1 mg/ml tRNA, 1x Denhardt‟s solution (50x stock, 1% Ficoll 400, 1% 
polyvinylpyrrolidone, 1% BSA), and 1x salt solution (10x salt stock, 2M NaCl, 
50mM EDTA, 100mM Tris-HCl pH 7.5, 50mM NaH2PO42H2O, 50mM Na2HPO4, 
DEPC treated).  The diluted probe was denatured by placing in a 70ºC heat block for 
5 minutes before applying to the slides.  After application of 200µl of the probe 
solution, each slide was covered with a coverslip.  The hybridization box was sealed 
closed and incubated in a 65ºC oven overnight. 
 
After hybridization, slides were placed in wash solution (50% formamide, 1x SSC, 
0.1% Tween-20) in a coplin jar for 15 minutes at 65ºC to remove the coverslips.  The 
slides were then washed twice for 30 minutes each at 65ºC, before continuing to 
wash at room temperature in 1x MABT (5x stock, 0.5M maleic acid, 0.75M NaCl, 
1M NaOH, 0.5% Tween-20) twice for 30 minutes.  The sections were then blocked 
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in blocking solution (8g blocking reagent, Roche cat no 1-096-176, 100ml 5x 
MABT, 200ml distilled water, heated to 65ºC to dissolve, 80ml heat inactivated 
sheep serum added and MQ water to 400ml) was applied to slides for one hour at 
room temperature.  Next, an anti-Digoxigenin alkaline phosphatase conjugated 
antibody (Roche) was diluted 1/1500 in blocking solution and applied to the sections 
overnight at 4ºC.  The sections were then washed thrice for 20 minutes in 1 x MABT, 
followed by 2x 10 minute washes in staining buffer (0.1M NaCl, 0.05M MgCl2, 
0.1M Tris pH 9.5, 0.01% Tween-20).  The color reaction was developed by placing 
the slides in a solution containing 20ml staining buffer, 0.025M MgCl2, 87μl NBT 
(1g 4-nitro blue tetrazolium chloride crystals, plus 7ml dimethyl formamide and 3ml 
distilled water), 67μl BCIP (BCIP from Roche, 1g plus 20 ml dimethyl formamide), 
and 20ml of a 10% w/v polyvinyl alcohol in MQ water.  Reactions were incubated in 
the dark at 37ºC and periodically checked for the development of a blue precipitate 
on the sections.  For less abundant transcripts, reactions were allowed to proceed at 
32 ºC overnight.  Once cells could be clearly visualized, the reaction was quenched 
by immersing the slides in tap water.  After this, the sections were dehydrated 
through an alcohol series before being treated with xylene and mounted with DPX 
mountant (Fluka) and coverslipped. 
 
2.8.4  Immunohistochemistry 
Frozen tissue was sectioned on a cryostat (Leica, Bright) to produce 30μm coronal 
brain sections.  These were collected with a damp paint brush and floated onto the 
surface of PBS.  Alternatively, sections were collected directly on SuperFrost® Plus 
slides and air dried.  Immunohistochemistry followed. 
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Non-specific binding sites were blocked by tissue exposure to blocking (10% (v/v) 
sheep or cow serum/0.1% (v/v) Triton X-100 (BDH)/PBS) for 1 hour at room 
temperature.  Sections were incubated overnight at 4ºC in primary antibody diluted 
in blocking solution.  Sections were washed 3 times in PBS for 10 minutes each.  
Secondary antibody diluted in blocking solution was applied for 2-4 hours at room 
temperature.  Sections were again washed thrice in PBS.  Floating sections were then 
transferred onto Superfrost® Plus glass slides and dried.  All slides were then 
coverslipped with mounting medium (Dako) and stored in the dark at 4°C.  When 
staining to detect CC1, sections were collected in TBS (Tris buffered saline: 10x 
TBS is 0.5M Tris, 9% NaCl), the blocking solution was replaced with TBS/0.5% 
triton/10% fetal calf serum blocking solution and all washes performed in TBS 
instead of PBS. 
 
2.8.5  BrdU Detection 
The detection of BrdU in tissue sections followed staining with any other primary 
and secondary antibodies as described in 2.8.4.  Sections transferred onto slides and 
dried were then fixed with 70% (v/v) EtOH/20% (v/v) acetic acid/MQ water for 10 
minutes at room temperature, followed by 20 minutes at -20ºC in 70% EtOH in MQ 
water.  Sections were next incubated for 15 minutes at room temperature, first in 1% 
(v/v) Triton-X100/PBS and then in 6M HCl/1% Triton-X100/PBS, and were 
subsequently washed 3 times for 5 minutes in PBS.  Anti-BrdU (Table 2.2), diluted 
in blocking solution was incubated overnight at 4ºC.  Washing, secondary antibody 
and mounting was carried out as above. 
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Primary Antibody Supplier Dilution
Rat anti-PDGFRα BD Pharmingen™ 1:400
Rabbit anti-GFP AbCam 1:6000
Rat anti-GFP Fine Chemical Products LTD 1:3000
Guinea pig anti-SOX10 Gift from M. Wegner 1:2000
Mouse anti-NeuN Chemicon 1:500
Mouse anti-PSA-NCAM IgM Chemicon 1:1000
Mouse anti-CNPase Chemicon 1:2000
Rabbit anti-Ng2 Chemicon 1:500
Rabbit anti-Olig2 Chemicon 1:1000
Rat anti-MBP AbD Serotec 1:100
Mouse anti-BrdU American Type Culture Collection (Manassas, VA) 1:10
Rat anti-BrdU AbD Serotec 1:500
Mouse anti-GFAP Sigma 1:2000
Rabbit anti-Tmem10/Opalin Gift from Or. Peles, Weissmann Institute 1:1000
Rabbit anti-Ermin Gift from Or. Peles, Weissmann Institute 1:400
Rabbit anti-Somatostatin Peninsular 1:200
Rabbit anti-Calbindin Swant, Bellinzona, Switzerland 1:1000
Rabbit anti-Calretinin Swant 1:1000
Rabbit anti-Palvalbumin Chemicon 1:1000
Mouse anti-Palvalbumin Chemicon 1:1000
Mouse anti-Tyrosine hydroxylase Chemicon 1:1000
Rabbit anti-NPY Insight 1:1000
Mouse anti-CC1 IgG2 Calbiotech 1:250
Guinea pig anti-Doublecortin Chemicon 1:3000
Secondary Antibody Supplier Dilution
Alexa 488 goat anti-rabbit IgG Invitrogen 1:1000
Alexa 488 goat anti-rat IgG Invitrogen 1:500
Alexa 568 goat anti-rabbit IgG Invitrogen 1:1000
Alexa 568 goat anti-rat IgG Invitrogen 1:500
Alexa 568 goat anti-mouse IgG1 Invitrogen 1:1000
Alexa 568 goat anti-mouse IgG H+L Invitrogen 1:1000
Alexa 568 goat anti-mouse IgM Invitrogen 1:1000
Alexa 647 goat anti-rabbit IgG Invitrogen 1:1000
Alexa 647 goat anti-rat IgG Invitrogen 1:500
Alexa 647 goat anti-mouse IgG1 Invitrogen 1:1000
Alexa 647 goat anti-mouse IgG H+L Invitrogen 1:1000
Goat anti-guinea pig Cy3 conjugated Chemicon 1:500  
Table 2.2 Table showing all the primary and secondary antibodies used for 
immunohistochemistry, their working solutions and sources. 
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2.8.5  EdU Detection 
In EdU the terminal methyl group is replaced with an alkyne group, which allows 
detection using a fluorescent azide that covalently binds to the alkyne group in a 
reaction called „click chemistry‟ (Chehrehasa et al., 2009).  Sections were collected 
and blocked as described for immunohistochemistry, followed by incubation at RT 
for 30 minutes in the dark.  The EdU developing cocktail was washed off by three 
PBS washes.  Non-specific binding sites were blocked with 10% (v/v) sheep or cow 
serum in 0.1% (v/v) Triton X-100 (BDH) in PBS for 1 hour at room temperature.  
Sections were then incubated in 0.5% (v/v) Triton X-100 in PBS for 15 minutes.  
EdU was detected using the Click-iT™ EdU Cell Proliferation Assay Kit according 
to the manufacturer‟s instructions.  A reaction cocktail of 500µl was prepared using 
43µl of 10x reaction buffer, 20µl of CuSO4, 1.2µl of Alexa Fluor® 488 or 647 azide, 
5µl of 10x reaction buffer additive and MQ H2O.  Sections (floating or on slides) 
were exposed to the reaction cocktail within 15 minutes of its preparation, and 
incubated for 30 minutes, at room temperature, in the dark.  Sections were washed 3 
times for 5 minutes in PBS, before continuing with immunohistochemistry as 
described previously. 
 
2.9  Microscopy, quantification and statistics 
 
2.9.1  Image collection 
Slides were examined under a light microscope (Zeis Axioplan) with a Hamamatsu 
digital camera and/or under a confocal microscope (UltraView microscope, Perkin 
Elmer) using standard excitation and emission filters for visualizing DAPI, FITC 
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(Alexa Fluor 488), CY3, TRITC (Alexa Fluor 568) and Far Red (Alexa Fluor 647).  
Confocal z stacks were captured for each section with 0.5-2μm increments.  
Reconstruction of xz and yz views was carried out using the Volocity software 
(Perkin Elmer). 
 
2.9.2  Quantification of histology 
For quantification of immunohistochemical staining/ cell labelling, cells were 
manually counted from low (20x) magnification, non-overlapping confocal image-
stacks, using Adobe Photoshop.  Quantification of cells was concentrated in the 
anterior forebrain (neocortex, corpus callosum and piriform cortex) at Bregma levels 
0-0.26 mm (Fig. 2.4) (Paxinos and Franklin, 2001)). 
 
Generally, co-localization was expressed as a percentage, that is, as the ratio of cells 
expressing two markers divided by the total number of cells expressing a single 
marker multiplied by 100 (e.g. (PDGFRα+YFP)/YFPx100). 
 
For all quantification a minimum of 2 sections from n=3 mice was examined.  The 
proportion of labeled cells was determined per mouse.  The average and standard 
deviation was then calculated for each group using Microsoft Excel.  All statistical 
comparisons (two-tailed t tests or ANOVA) were made using Microsoft Excel. 
 
2.9.3  Cell cycle calculation 
For a homogeneous population of cycling cells, the fraction of cells that label with 
BrdU/EdU (“labelling index”) is expected to increase linearly with the duration of  
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Figure 2.4 Coronal section through adult mouse forebrain at the level of the SVZ.  Images 
were collected at the coloured regions (Ctx in green, CC in blue, aPC in red). 
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BrdU/EdU exposure until all dividing cells are labelled (phase 1).  After this the 
labelling index cannot increase further and a plateau is reached (phase 2).  The rate at 
which cells incorporate BrdU/EdU is given by the slope (m) of phase 1 and was 
calculated by performing a linear regression analysis in Microsoft Excel.  This was 
an iterative process.  The maximum labelling index (phase 2 plateau value) is known 
as the “growth fraction” (GF), which is expressed as a percentage of the total cell 
population.  This was calculated only using points that were deemed not statistically 
significant from each other by ANOVA and not already included in the linear 
regression analysis.  GF is the average of all mice analysed on the plateau. 
 
From these data the length of the cell cycle Tc = GF/m was calculated (Nowakowski 
et al., 1989; see Fig. 2.5).  Since TC depends on the reciprocal of m, the standard 
error (s.e.Tc) is not symmetrical about the mean.  However, for simplicity s.e.Tc is 
shown as ± half of the full range, calculated as follows: 
 
s.e.Tc = [{(GF + s.e.GF) / (m - s.e.m)} – {(GF - s.e.GF) / (m + s.e.m)}] / 2 
 
Similarly, S phase can be calculated as (labelling index at t=0)/m.  This is equivalent 
to the intercept of the line (Phase 1) on the x-axis (labelled as Ts on the diagram, Fig. 
2.5). 
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Figure 2.5 Calculation of cell cycle time (TC).  The gradient (m) of the linear rising part of 
the graph (phase 1) was determined by the method of least squares (m=a/b).  The labelling 
index at plateau (phase 2) is the fraction of the population that is actively cycling (the 
growth fraction, GF). If the whole population were cycling GF would be 100%.  TC was 
calculated as GF/m.  Ts was calculated as (labelling index at t=0)/m. 
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Chapter 3:  
„Adult OLPs Generate New Myelinating 
Oligodendrocytes Throughout the Brain and New 
Projection Neurons in the Piriform Cortex‟ 
 
 
 
3.1  Introduction 
During CNS development, oligodendrocyte progenitor cells (OLPs) act as a source 
of oligodendrocytes, which in turn myelinate the neuronal circuits necessary for 
normal CNS function (Curtis et al., 1988; Levine et al., 1993; reviewed in McTigue 
and Tripathi, 2008).  OLPs are characterized by their expression of specific markers, 
such as the proteoglycan NG2 and the platelet-derived growth factor for receptor 
alpha (PDGFRα), which they down-regulate as they differentiate into myelinating 
oligodendrocytes and gradually start to express myelin-associated markers (Fig. 3.1; 
reviewed in Trotter et al., 2010 and Nishiyama et al., 2010; Kippert et al., 2008; 
Brockschnieder et al., 2006). 
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Figure 3.1 Schematic of oligodendrocyte maturation from progenitor to fully myelinating 
cell.  The antigenic properties of cells at the different maturation stages are depicted. 
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During adulthood, the core function of OLPs is thought to be as a source of 
remyelinating cells in demyelinating lesions and to replace oligodendrocytes lost due 
to ageing, injury or disease (Keirstead et al., 1998; Watanabe et al., 2002; Dawson et 
al., 2003). Their abundance and distribution, however, have raised questions 
associated with alternative functions they might serve in the adult CNS (Chapter 1). 
To shed light on the fates and behaviour of OLPs in the normal adult brain, OLPs 
and their progeny were labelled and traced by “Cre-lox” technology in adult 
transgenic mice.  This approach relies on expressing a tamoxifen-inducible version 
of Cre recombinase (CreER) under the transcriptional control of regulatory 
sequences associated with genes that are expressed specifically or preferentially in 
NG2 cells.  When a Cre-conditional reporter transgene such as the Rosa26-YFP is 
also present (see 2.7.1), brief administration of tamoxifen induces Cre 
recombination, activating the yellow fluorescent protein (YFP) reporter irreversibly 
in OLPs and all of their descendents (see Chapter 2 - Fig. 2.4). 
 
For this study I used the Pdgfrα-CreERT2 transgenic mouse line (Rivers et al., 2008; 
see 2.7.1), which, when crossed to the R26-YFP reporter mouse line, allowed me to 
follow the fates of OLPs in the adult mouse brain. 
 
3.2  Results 
 
3.2.1  Antigenic and proliferative properties of adult OLPs 
Adult OLPs are usually characterized as NG2+, process-bearing cells in the grey and 
white matter.  Expression of PDGFRα in NG2+ cells was confirmed by the 
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immunolabeling of adult brain sections, which showed that practically all 
nonvascular NG2-expressing cells co-express PDGFRα and vice versa (Fig. 3.2).  In 
particular, 99.6% ± 0.4% of NG2+ OLPs in the corpus callosum co-expressed 
PDGFRα and 98.9% ± 2% of PDGFRα+ OLPs were also NG2+ (>1,000 cells total 
from three mice; Fig. 3.2a, b, e).  These two OLP markers could therefore be used 
interchangeably depending on the specific experimental conditions (e.g. fixation 
conditions) required on each occasion.  For example, the antibody to PDGFRα 
worked only in lightly-fixed tissue, whereas the antibody to NG2 could be used in 
short- or long-fixed material.  
 
To further confirm that OLPs but not oligodendrocytes, express PDGFRα and NG2, 
cells were co-labelled with antibodies against CNP, an oligodendrocyte marker, and 
either PDGFRα or NG2. No PDGFRα+/CNP+ cell was detected in the corpus 
callosum or cortex (Fig.3.2e).  Only a very small proportion of NG2+ cells (0.3% ± 
0.4%) co-expressed CNP in the corpus callosum and none in the cortex (Fig.3.2e).  
CNP is an early myelination marker.  The small proportion of NG2+/CNP+ cells 
observed could correspond to cells that had just started differentiation and had not 
yet fully down-regulated NG2 expression.  Cells were also double-labelled with 
antibodies to NG2 and SOX10 (which works only in long-fixed tissue).  I found that 
all nonvascular NG2+ cells co-expressed SOX10 (no SOX10– cells out of >1,000 
NG2+ cells scored from three mice; Fig. 3.2c, e).  There were, however, many 
SOX10+/NG2– cells, especially in white matter, that presumably correspond to 
differentiated oligodendrocytes (Fig. 3.2c, e).  All SOX10+ cells were also OLIG2+ 
in the corpus callosum and cortex, which allowed the use of OLIG2 interchangeably  
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Figure 3.2 Antigenic properties of adult OLPs. (a–e) Cryosections of young adult (P45) 
brains were double-immunolabelled for different combinations of oligodendrocyte lineage 
markers PDGFRα (Ra), NG2, OLIG2, SOX10 and CNP. Representative images are shown in 
a–d, and cell counts (means ± s.d.) in e. Column headers refer to the labelled populations 
(e.g. PDGFRα/SOX10) and row headers refer to the co-expressed second marker. Certain 
antibody combinations were not possible because of incompatibilities between the required 
fixation conditions or the species origin of the antibodies. Kaylene M Young, Leanne E 
Rivers and Konstantina Psachoulia contributed data for this figure.  Scale bars represent 50 
μm in a and 10 μm in b–d.  
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with SOX10 as a general oligodendrocyte lineage marker in long-fixed material (Fig. 
3.2d, e).  The antibody to OLIG2 labelled only a subset of PDGFRα+ cells in short-
fixed tissue, a fact most likely attributed to failure of the OLIG2 antibody to work 
reproducibly under this fixation.  For this reason, the antibody to OLIG2 was not 
used in short-fixed material.  
 
3.2.2  Fate mapping adult oligodendrocyte progenitor cells in the adult CNS 
 
3.2.2.1  Characterization of PDGFRα-CreERT2/R26-YFP transgenic mouse 
In order to follow the fates of PDGFRα+ adult OLPs, a transgenic line was generated 
that expressed a tamoxifen-inducible form of Cre recombinase (CreER
T2
) under 
Pdgfra transcriptional control.  In situ hybridization revealed that CreER
T2
 RNA 
transcripts were expressed in scattered cells throughout the postnatal brain, similar to 
endogenous Pdgfra transcripts (Fig. 3.3).  In particular, the proportion of cells 
expressing Cre mRNA in the cortex was equivalent to the proportion of cells 
expressing PDGFRα mRNA (92% ± 19.9%; Fig. 3.3a-d).  Double-label in situ 
hybridization showed that there was near complete overlap between Pdgfra and cre 
expression in the neocortex (>99% of cre expressing cells co-expressed Pdgfra; Fig. 
3.3e).  In the corpus callosum, where in situ hybridization was less sensitive, >95% 
of cre-expressing cells expressed detectable Pdgfra (Rivers et al., 2008).  Therefore, 
expression of the Cre transgene appeared faithful to that of endogenous PDGFRα and 
this transgenic mouse was used to trace the behaviour of OLPs in the adult mouse 
brain. 
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Figure 3.3 Characterization of PDGFRa-CreERT2 transgenic mice.  To ensure appropriate 
expression of the transgene, in situ hybridization was performed to detect PDGFRa (a) and 
Cre mRNA (c) on P28 brain taken from PDGFRa-CreER
T2
 transgenic mice (b and d are 
taken from the brain regions, indicated by the small rectangle in a and c respectively.  The 
proportion of PDGFRα+ cells that co-expressed Cre was 92% ± 1.9%.  Co-expression of 
these mRNA transcripts was confirmed by double fluorescent in situ hybridization (e).  
Arrows indicate the double-labelled cells. 
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For these tracing studies, homozygous PDGFRα-creERT2 mice were crossed to 
homozygous Rosa26-YFP reporter mice to generate double-heterozygous PDGFRα-
creER
T2
/R26-YFP offspring (see 2.7.1).  Due to limitations in genotyping that 
prevent distinction between mice that are homozygous versus heterozygous for the 
PDGFRa-CreER
T2
 BAC transgene, the efficiency of recombination in 
PDGFRα:hom/R26-YFP could not be directly compared with PDGFRα:het/R26-YFP 
mice.  However, PDGFRa-CreER
T2
/R26-YFP double heterozygous transgenic mice 
from the above mating were mated with homozygous PDGFRα-CreERT2 mice and 
their offspring were genotyped for expression of the PDGFRα transgene (see 2.2.1).  
Of the mice that were positive for R26YFP, it was expected that 50% should be 
PDGFRα:het/R26-YFP and ~50% were PDGFRα:hom/R26-YFP.  Tamoxifen (TM) 
was administered to offspring of mixed litters of PDGFRα:het and PDGFRα:hom, 
and known PDGFRα:het/R26-YFP transgenic mice in young adulthood (P45).  
Tamoxifen induces nuclear translocation of CreER
T2
 and promotes Cre-mediated 
recombination, which in turn leads to YFP expression (see 2.7.1.3).  For both groups 
of mice, brain tissue was collected 7 days post-tamoxifen (P45 +7) and was 
immunolabelled with antibodies against YFP and PDGFRa (Fig. 3.4a-b).  The 
percentage of PDGFRa+ cells that were YFP+ in the corpus callosum was 
determined for 5 PDGFRα:het/hom/R26-YFP mice and 4 PDGFRα:het/R26-YFP 
mice.  For the PDGFRα:het/R26-YFP group, ~45% of PDGFRa+ cells were 
observed to express YFP, i.e. 45% recombination (Fig. 3.4c).  If the efficiency of 
recombination was increased for homozygous PDGFRa-CreER
T2
 mice compared to 
heterozygotes, we would expect to see an increase in the proportion of PDGFRα+ 
cells labeled in some mice, which would increase the variability within the group.   
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Figure 3.4 Recombination efficiency in the PDGFRa-CreERT2/R26-YFP transgenic mice.   
PDGFRa-CreER
T2
/R26-YFP mice were crossed with homozygous PDGFRa-CreER
T2
 and 
their offspring were administered TM at P45. Brain sections from P45 +7d mice was 
examined in the corpus callosum (a) and cortex (b) by double fluorescent 
immunohistochemistry with antibodies against YFP and PDGFRa.  The proportion of 
PDGFRa+/YFP+ cells in the total PDGFRa+ cell population in the corpus callosum was 
quantified.  ~50% OLPs were YFP-labelled with no statistically significant difference 
between PDGFRa:het/R26-YFP mice and PDGFRa:het/hom/R26-YFP mice (t test; P=0.19; 
c). However, both the mean and standard deviation in the hom/het mice were higher that in 
uniformly het mice, suggesting that generating homozygous PDGFRa-CreER
T2
/R26-YFP 
mice might be useful to increase recombination efficiency if required in future studies.  White 
arrows and arrowheads show YFP+/PDGFRα+ and YFP-/PDGFRα+ cells respectively. 
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We detected no overall significant change (two-tailed t test; P=0.19).  However, 
within the group the highest level of recombination detected (highest proportion of 
YFP-labeled OLPs) in an individual mouse was 68%.  This experiment suggests that 
generating PDGFRα:hom/R26-YFP mice might be able to increase recombination 
from ~45% to ~70% for future studies.  However, in the studies described in this 
Thesis I used PDGFRa-CreER
T2
/R26-YFP double heterozygous transgenic mice to 
keep the breeding strategy simple. 
 
3.2.3  Adult OLPs give rise to myelinating oligodendrocytes in the postnatal brain 
In experiments conducted by Leanne Rivers, tamoxifen was administered to adult 
(P45) PDGFRα-creERT2/R26-YFP transgenic mice in order to label and follow the 
fates of adult-born OLPs.   Mice were sacrificed at several time-points post-
tamoxifen and tissue sections immunostained to detect PDGFRα and YFP.  An 
accumulation of PDGFRα-/YFP+ cells was observed over time (Fig. 3.5).  This 
accumulation was noted to be much faster in the corpus callosum than in the motor 
cortex (Fig. 3.5).  These data suggested that PDGFRα+ OLPs were differentiating 
and turning off PDGFRα expression during the time course of the experiment. 
 
When I administered tamoxifen to more mature PDGFRa-CreER
T2
/R26-YFP mice 
(P60) and examined brain sections at various time-points thereafter by 
immunostaining for YFP and PDGFRα (Fig.3.6a; Fig.3.7a), I also observed a 
decline in the proportion of YFP+ cells that were PDGFRα-labelled in the corpus 
callosum with time (Fig. 3.6c).  This was also detected in the motor cortex (Fig. 
3.7c).  To determine the identity of the differentiated OLPs, I labelled brain sections 
from P60 PDGFRa-CreER
T2
/R26-YFP mice for YFP and CC1 (Fig.3.6b; Fig.3.7b).   
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Figure 3.5 Tracing studies of OLPs in early adulthood. TM was administered to PDGFRa-
CreER
T2
/R26-YFP transgenic mice at P45. The brains were immunolabelled with antibodies 
against YFP and PDGFRa.  The number of differentiated (PDGFRa-negative) YFP+ cells 
was counted in the corpus callosum and cortex at 5, 14, 28 and 90 days post tamoxifen.  The 
numbers of YFP+/PDGFRa-negative cells increases with time (cells/mm
2
 in a 14μm section, 
n=4) in both brain regions. (Rivers et al., 2008; data from Leanne E Rivers) 
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Figure 3.6 Oligodendrogenesis by adult-born OLPs in the corpus callosum. TM was 
administered to PDGFRa-CreER
T2
/R26-YFP transgenic mice at P60. Brain sections were 
immunolabelled with antibodies against YFP (green) and either PDGFRα (c; red) or CC1 
(d; red).  White arrowheads show double-positive YFP+/PDGFRα+ or YFP+/CC1+ cells 
and white arrows single-positive YFP cells.  The proportions of OLPs that have 
differentiated versus the proportion of OLPs that remained at the progenitor stage were 
plotted as percentages of YFP+/CC1+ and YFP+/PDGFRα+ cells, respectively, from the 
total number of YFP cells present in the corpus callosum (e). 
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Figure 3.7 Oligodendrogenesis by adult-born OLPs in the motor cortex. TM was 
administered to PDGFRa-CreER
T2
/R26-YFP transgenic mice at P60. Brain sections were 
stained with YFP (green) and either PDGFRα (c; red) or CC1 (d; red).  White arrowheads 
show double-positive and white arrows single-positive YFP cells.  The proportions of 
differentiated and undifferentiated OLPs were plotted as percentages of YFP+/CC1+ and 
YFP+/PDGFRα+ cells, respectively, from the total number of YFP cells present in the 
cortex (e). 
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I found that the decline in YFP+ cells co-expressing PDGFRα observed with time, 
was roughly in line with the increase in YFP+ cells co-expressing CC1 in both the 
corpus callosum (Fig. 3.6e) and the motor cortex (Fig. 3.7e).  These data support the 
interpretetion that the YFP+/PDGFRα-negative cells in both the corpus callosum and 
motor cortex are differentiated oligodendrocytes.  Furthermore, Kaylene Young 
found that YFP+ cells in the corpus callosum and motor cortex co-express OLIG2 
but not NeuN or GFAP (Rivers et al., 2008) indicating that OLPs in these regions of 
the adult brain produce oligodendrocytes but not neurons or astrocytes. 
 
To determine whether the differentiated YFP+ oligodendrocytes produced in the 
corpus callosum and cortex were myelinating, I performed double 
immunohistochemistry on tissue from P45 PDGFRa-CreER
T2
/R26-YFP mice 
sacrificed 210 days post-tamoxifen (P45+210), to label for YFP and either Opalin or 
Ermin.  Opalin is a marker for early myelinating oligodendrocytes and Ermin is a 
marker for fully mature, myelinating oligodendrocytes (Fig. 3.1; Kipper et al., 2008; 
Brockschnieder et al., 2006).  Numerous YFP+/Opalin+ and YFP+/Ermin+ cells 
could be identified in both the corpus callosum and the motor cortex (Fig. 3.8).  In 
fact, ~50% of YFP+ cells were found to be Opalin+ and ~30% of YFP+ cells were 
Ermin+ when quantified in the corpus callosum (Fig. 3.8).  The expression of the 
more mature oligodendroglial marker, Ermin, by YFP+ cells strongly supports the 
notion that OLPs in the normal adult brain continue to produce myelinating 
oligodendrocytes until at least P60. 
 
YFP is a useful tool for the labelling of cells for fate-mapping studies, but, as YFP 
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Figure 3.8 Adult-born OLPs generate myelinating oligodendrocytes in the adult brain. TM 
was administered to PDGFRa-CreER
T2
/R26-YFP transgenic mice at P45. The brains were 
co-stained to detect YFP and either Opalin (a) or Ermin (b) at P255. Within the corpus 
callosum, the proportion of YFP+ cells that co-expressed Opalin or Ermin was determined 
against the total number of YFP+ cells present (c). Arrowheads show double-positive 
YFP+/Opalin+ or YFP+/Ermin+ cells; arrows show YFP+/Opalin- or YFP+/Ermin- cells. 
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does not travel into thin cellular processes of oligodendrocytes or to the myelinating 
sheath, it cannot be used to obtain morphological evidence of myelination.   
 
Therefore, the morphology of adult-born oligodendrocytes was examined by 
administering tamoxifen to P45 PDGFRa-CreER
T2
 transgenic mice crossed with 
Tau-mGFP knock-in reporter mice (see 2.7.1), in which membrane-targetted GFP 
(mGFP) is expressed under the transcriptional control of the Tau promoter 
(Hippenmeyer et al., 2006).  Tau is expressed in oligodendrocytes and neurons, but 
not in OLPs (Richter-Landsberg and Gorath, 1999).  Therefore, in PDGFRa-
CreER
T2
/Tau-mGFP transgenic mice, tamoxifen administration induces 
recombination in the OLPs, but GFP is only expressed if the OLP differentiates into 
an oligodendrocyte and turns on Tau expression.  This has two advantages: 1) as the 
mGFP is membrane targeted it will reveal the full external morphology of 
oligodendrocytes and 2) the OLPs will remain mGFP-negative, such that, unlike 
YFP+ cells in the PDGFRα-CreERT2/R26-YFP mice, all mGFP+ cells should be 
differentiated cells. 
 
Sections from P45+150 PDGFRa-CreER
T2
/Tau-mGFP transgenic mice were 
immunolabelled to detect mGFP expression.  By performing conventional (Fig. 3.9) 
and confocal (Fig. 3.10) fluorescence microscopy, the morphology of the mGFP+ 
cells in the corpus callosum, motor cortex, striatum, piriform cortex and external 
capsule of these mice was examined.  The mGFP+ cells in all regions resembled 
oligodendrocytes.  In particular, mGFP+ cells in the white matter had small, circular 
cell  bodies with  numerous, dense  and  extensive  processes that run parallel to the  
Chapter 3 Adult OLPs Generate New Myelinating Oligodendrocytes Throughout 
the Brain and New Projection Neurons in the Piriform Cortex 
 
87 
 
 
 
 
 
Figure 3.9 Cells with the morphology of oligodendrocytes are generated from OLPs in the 
adult CNS.  TM was administered to PDGFRa-CreER
T2
/Tau-mGFP transgenic mice at P45. 
The brains were stained to detect GFP at P195. The morphology of mGFP+ cells was 
examined under the conventional microscope in the corpus callosum (a), motor cortex (b), 
striatum (c), piriform cortex (d) and external capsule (e). 
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Figure 3.10 GFP+ cells form thin cytoplasmic processes that resemble oligodendrocytes in 
the adult mouse brain.  Forebrain sections from PDGFRa-CreER
T2
/Tau-mGFP (P45 
T+150d) were prepared and immunolabelled for mGFP. Compressed confocal images were 
captured to show the many thin cytoplasmic extensions (arrowheads) of the mGFP+ cells in 
the corpus callosum (a), anterior commisure (b), motor cortex (c) and piriform cortex (d). 
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white matter tract (Fig. 3.9a).  In the grey matter, the cell processes were less dense 
and less numerous but myelin profiles were still visible (Fig. 3.9b-e).  By confocal 
microscopy it was clear that in contrast to the parallel processes of mGFP+ cells in 
the corpus callosum (Fig. 3.10a) the myelinating processes of mGFP+ cells in the 
cortex were oriented randomly.  This is the anticipated morphology of an 
oligodendrocyte in the cortex, as axons are not closely aligned in grey matter.  
Higher magnification images clearly show the cellular processes of the mGFP+ cells 
(Fig. 3.10).  The identity of the mGFP+ cells in the PDGFRa-CreER
T2
/Tau-mGFP 
transgenic mice was next confirmed by immunolabelling with the oligodendrocyte 
progenitor marker NG2 (Fig. 3.11a), the oligodendrocyte marker CC1 (Fig. 3.11b), 
the general oligodendroglial-lineage marker OLIG2 (Fig. 3.11c) in combination with 
the astrocyte marker, s100 (Fig. 3.11c) and the neuronal marker NeuN (Fig. 3.11d).  
mGFP+ cells were never s100+/OLIG2-, indicating that astrocytes are not labelled in 
PDGFRα-CreERT2/R26-YFP (Rivers et al., 2008) or PDGFRα-CreERT2/Tau-mGFP 
transgenic mice (Fig. 3.11c, e).  As predicted from tracing OLPs previously using the 
PDGFRα-CreERT2/R26-YFP transgenic mice, the mGFP+ cells detected using Tau-
mGFP reporter mouse were negative for NeuN (Fig. 3.11d, e).  However, all mGFP+ 
cells were found to be positive for OLIG2, which reflects the notion that they all 
belong to the oligodendrocyte lineage (Fig. 3.11c, e).  Of the mGFP+ cells present in 
the corpus callosum, a small proportion (~5%) expressed the OLP marker NG2 (Fig. 
3.11a, e).  This proportion was greater in the motor cortex (~35%) (Fig. 3.11a, e).  
The vast majority of mGFP+ cells clearly expressed the oligodendrocyte marker CC1 
both in the corpus callosum (~96% of all mGFP+ cells were CC1+) and in the motor 
cortex (~85% of all mGFP+ cells were CC1+) (Fig. 3.11b, e).  The apparent overlap  
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Figure 3.11 Identity of GFP+ cells in the motor cortex of the PDGFRα-CreERT2/Tau-
mGFP transgenic mice.  Brain sections from P60 PDGFRα-CreERT2/Tau-mGFP transgenic 
mice were immunolabelled with antibodies against GFP and NG2 (a), CC1 (b) OLIG2+s100 
(c) and NeuN (d).  Double positive mGFP+/CC1+ and mGFP+/OLIG2+/s100- cells (white 
arrowheads) were detected in the corpus callosum and motor cortex.  A small number of 
double positive mGFP+/NG2+ cells were also present in both brain regions.  No double 
positives were detected by staining for GFP and NeuN. White arrows show the single 
positive mGFP cells.  The proportion of mGFP+ cells that co-expressed the aforementioned 
markers was quantified (e). 
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of NG2+ and CC1+ expression by cells in the motor cortex may reflect the differing 
rate of cell production in the white versus the grey matter and a corresponding slower 
differentiation rate, with NG2 being downregulated more slowly in the cortex than in 
the corpus callosum. 
 
In addition to staining for cell body markers of oligodendrocytes, expression of 
mGFP in what appears to be the myelin internodes of oligodendrocytes labelled in 
PDGFRα-CreERT2/Tau-mGFP transgenic mice allowed, unlike with the R26YFP, 
co-staining for GFP and myelin markers such as MBP.  Both in the corpus callosum 
(Fig. 3.12b) and motor cortex (Fig. 3.12a) the “bars” of mGFP co-localized with 
MBP. 
 
Collectively, tracing from PDGFRα-CreERT2/R26-YFP and PDGFRα-CreERT2/Tau-
mGFP transgenic mice has provided strong evidence that adult OLPs are generating 
a significant number of myelinating oligodendrocytes in both the grey and white 
matter in adult life.  Furthermore, oligodendrocytes are the only cell type being 
produced by OLPs in the corpus callosum and motor cortex. 
 
These findings raise questions concerning the necessity of adult oligodendrogenesis 
in such a significant amount under healthy conditions.  To determine whether the rate 
of adult oligodendrogenesis was plastic, we attempted to trigger activity-dependent 
oligodendrocyte production by voluntary exercise (wheel running), which requires 
inter-hemispherical communication, and might potentially stimulate 
oligodendrogenesis  in  the  corpus  callosum.  For this,  PDGFRα-CreERT2/R26-YFP  
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Figure 3.12  mGFP+ cells in the PDGFRa-CreERT2/Tau-mGFP transgenic mice are 
myelinating oligodendrocytes.  Brain sections from adult (P45+150) PDGFRa-
CreER
T2
/Tau-mGFP were immunolabelled with antibodies against GFP and MBP and 
single-scan confocal images were taken in the motor cortex (a) and corpus callosum (b).  
Large arrowheads show the cell bodies of the cells and small arrowheads follow the 
cytoplasmic extensions. 
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transgenic mice were given tamoxifen at P80 and were housed individually either 
with access to a running wheel for 1 month, or in equivalent housing with a non-
functional running wheel.  Mice housed in voluntary exercise conditions ran ~7km 
per day between 6pm and 6am.  Brain sections from these mice were then 
immunolabelled with antibodies against YFP and PDGFRα, and the percentage of 
YFP+ cells that were PDGFRα- was quantified in the corpus callosum (Fig. 3.13).  
The production of differentiated cells (YFP+/PDGFRα-) was elevated in male 
running mice when compared to controls (two-tailed t-test; P<0.002; n=6 controls, 
n=10 runners).   
 
 
Similarly, an elevated production of differentiated cells was noted in female running 
mice when compared to controls (two-tailed t-test; P<0.002; n=6 controls, n=11 
runners).  Since the data were not noticeably affected by sex, i.e. there was no 
statistically significant difference between male and female control groups (P=0.95) 
nor between male and female running groups (P=0.90), data from the control and 
running groups of both genders were pooled (two-tailed t-test; P=0.015x10
-5
; n=12 
controls, n=21 runners).  ~30% of YFP+ cells had down-regulated PDGFRα in the 
control group compared to ~40% in the running group suggesting that the rate of 
adult oligodendrocyte production in the corpus callosum increased as a result of 
exercise that requires inter-hemispherical communication (Fig.3.13).  This finding 
indicates that the behaviour of adult OLPs is dynamic and under environmental 
control. 
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Figure 3.13 Voluntary exercise increases oligodendrocyte production by adult OLPs.  
Tamoxifen was administered to P80 PDGFRα-CreERT2/R26-YFP transgenic mice, which 
were then individually housed either with non-functional running wheel (controls) or with 
normal running wheels (runners).  Oligodendrogenesis by adult OLPs is expressed as the 
percentage of YFP+/PDGFRα- cells in the total YFP+ cells.  Males and females were first 
plotted separately and were subsequently merged (t-test; *P<0.0002, ***P=0.015x10
-5
).  
Data for this figure was contributed by Ian McKenzie and Konstantina Psachoulia. 
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3.2.4  Adult OLPs give rise to cortical projection neurons 
When examining brain regions, outside of the corpus callosum and motor cortex in 
tamoxifen-dosed Pdgfra-creER
T2
/R26-YFP mice, it was noted that some of the YFP+ 
cells in the anterior piriform cortex did not have the typical OLP or oligodendrocyte  
morphology, but rather resembled neurons, and co-stained for NeuN (Fig. 3.14a).  
These cells were either labelled by direct recombination in the neurons, or were 
produced by differentiation of PDGFRα+ OLPs.  Labelling by direct recombination 
was unlikely as NeuN+ piriform cortical neurons did not express PDGFRα by protein 
staining (Fig. 3.14b) nor did they express Cre mRNA by double in 
situ/immunohistochemistry (Rivers et al., 2008).  When Pdgfra-creER
T2
/R26-YFP 
transgenic mice were dosed with TM at P45 and YFP+ cells were traced for up to 
210d, the number of YFP+/NeuN+ cells  in the anterior piriform cortex was found to 
significantly increase with time (Fig. 3.14c-d).  ~1.4% of the NeuN+ cells present in 
layers II and III of the piriform cortex at 8 months (P45 + 210) were generated after 
P45 (~250 surviving YFP+/NeuN+ neurons found in 18 sections containing an 
estimated 4×10
4
 NeuN+ projection neurons; 250x1/0.45x4x10
4
x100, where 0.45 
corresponds to the recombination efficiency in the Pdgfra-creER
T2
/R26-YFP 
transgenic mice).  The same experiment was performed using the Fgfr3-
iCreER
T2
/R26-YFP transgenic mice to examine the contribution of SVZ stem cells 
and brain astrocytes to neurogenesis in the piriform cortex.  No accumulation of 
YFP+/NeuN+ cells was noted (Fig. 3.14c).  Therefore, we are confident that the 
YFP+ neurons detected derive from differentiating PDGFRα-expressing precursors, 
most probably OLPs. 
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Figure 3.14 OLPs generate cortical projection neurons in vivo.  TM was administered to 
PDGFRa-CreER
T2
/R26-YFP transgenic mice at P45.  Ventral forebrain sections were 
prepared and immunolabelled for YFP and neuronal lineage (NeuN; a) OLP (PDGFRα; b) 
markers at P255.  YFP+/NeuN+ cells appeared in the anterior piriform cortex (a).  Co-
localization of PDGFRα and NeuN was never observed (b) excluding the possibility of 
expression of PDGFRα in neuron driving the transgene expression. YFP+/NeuN+ cells 
accumulated over time (c, d) in contrast to Fgfr3-iCreER
T2
/R26-YFP transgenic mice (YFP 
labels for all SVZ stem cells and many protoplasmic) (c), supporting the conclusion that 
adult-born neurons are formed outside the SVZ.   Arrowheads point to the YFP+/NeuN+ 
cells.  Leanne E Rivers, Kaylene M Young and Konstantina Psachoulia contributed data for 
this figure. 
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To determine which type(s) of neuron was being produced from OLPs in the piriform 
cortex of adult mouse brains, brain sections from PDGFRa-CreER
T2
/R26-YFP 
transgenic mice (P45 T+210) were triple labelled for YFP, NeuN and a variety of 
interneuron markers; calbindin (Cb), calretinin (Crt), neuropeptide-Y (NPY), 
parvalbumin (Pv) nitric oxide synthase (nNOS), tyrosine hydroxylase (TH), 
somatostatin (SST) and reelin (Fig. 3.15).  No triple positive cells were found among 
an average of about 120 YFP+/NeuN+ cells counted for each interneuronal marker.  
Therefore, it is extremely unlikely that these cells are cortical interneurons (Fig. 
3.15g).  In addition, for brain sections stained with tyrosine hydroxylase and 
somatostatin, no cells were detected that stained for these markers in layer II of the 
anterior piriform cortex. 
 
Therefore, we examined the morphology of OLP-derived YFP+ neurons in the 
piriform cortex in more detail.  High magnification images revealed that YFP+ cells 
appeared to be of two morphological types, reminiscent of the two types of 
projection neurons known to reside in layer II of the anterior piriform cortex: 
semilunar and superficial pyramidal (Fig. 3.16).   As YFP does not penetrate fine 
processes, we again switched to analysing tissue from Pdgfra-CreER
T2
/Tau-mGFP 
(P45 +150d).   As we previously observed using the Pdgfra-CreER
T2
/R26-YFP 
transgenic mice, a considerable number of neurons were found in the piriform cortex 
of the Pdgfra-CreER
T2
/Tau-mGFP mice.  The mGFP+ neurons detected had their 
cell bodies in layer II, but their dendritic arbors projected to the pial surface, which is 
the location of the lateral olfactory tract.  This is consistent with the notion that the 
neurons derived from adult OLPs are projection neurons, as projection neurons of the 
Chapter 3 Adult OLPs Generate New Myelinating Oligodendrocytes Throughout 
the Brain and New Projection Neurons in the Piriform Cortex 
 
98 
 
 
 
 
Figure 3.15 Adult-born piriform neurons do not express interneuron markers.  Images in a-
d show layer 2 of the piriform cortex immunolabelled for YFP, NeuN and one of the 
interneuron markers (arrowheads) Calbindin (Cb), Calretinin (Crt), Neuropeptide-Y (NPY) 
or Parvalbumin (Pv). YFP+/NeuN+ neurons are indicated by arrows. No immunolabelled 
interneurons were YFP+. Two other interneuron markers, Tyrosine Hydroxylase (TH) and 
Somatostatin (SST) were also tested but no immuno-positive interneurons were detected, 
either YFP+ve or YFP–ve, in this part of the piriform cortex. YFP+ neurons (NeuN+ or 
Sox10-) did not label for Nitric Oxide Synthase (nNOS) (e) or Reelin (f). Numbers of cells 
scored are tabulated in g. 
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Figure 3.16 Morphologies of YFP-labeled neurons in the piriform cortex.   TM 
administration to PDGFRa-CreER
T2
/R26-YFP transgenic mice at P45 or P60 and  
immunostaining of brain section to detect YFP and NeuN 75 or 210 days post-TM, revealed 
two types of principal neurons; semilunar neurons and superficial pyramidal (a–c).  
Semilunar neurons are often located more superficially than superficial pyramidal neurons 
(layer 2a and 2b, respectively).  From morphology and their positions in layer 2, 
YFP+/NeuN+ neurons observed are considered to correspond to semilunar (a) and 
superficial pyramidal (b,c) neurons. Scale bars represent 30 μm. 
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piriform (olfactory) cortex receive input from the olfactory bulb along the lateral 
olfactory tract (Fig. 3.17).  To be completely confident that these new neurons were 
indeed projection neurons, it would have been ideal to trace their axonal projections.  
However, due to the significant number of mGFP-labelled oligodendrocytes with 
highly complex morphology that were present in layer III of the piriform cortex, it 
was not possible to trace the mGFP+ neuronal axons.   
 
Collectively, these data indicate that OLPs in the adult piriform cortex do not 
produce interneurons, but produce projection neurons at a steady rate throughout 
adult life.  To examine whether these neurons were newly-born, i.e. produced from a 
recent cell division, Pdgfra-CreER
T2
/R26-YFP transgenic mice were tamoxifen-
dosed and given BrdU into their drinking water for a period of 100 days.  BrdU is 
taken up by cells as they divide (see 2.7.2), and brain sections from these mice were 
subsequently stained with antibodies against YFP, NeuN and BrdU (Fig. 3.18).  It 
was not possible to find a single BrdU+/NeuN+/YFP+ cell.  Therefore, we conclude 
that these neurons are most likely formed by direct trans-differentiation of PDGFRα+ 
cells, i.e. without an intervening cell division.  
 
3.3  Discussion 
Adult OLPs have been implicated in the generation of new myelinating 
oligodendrocytes in adulthood under demyelinating conditions, due either to 
mechanical injury or chemically-induced acute experimental demyelination (Gensert 
et al., 1997; Watanabe et al., 2002).  However, the extent to which OLPs add new 
myelinating  oligodendrocytes  to  the  healthy  adult  CNS  has  not  previously been 
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Figure 3.17 GFP+ neurons in the CNS of PDGFRa-CreERT2/Tau-GFP. Forebrain sections 
from P45 T+150d mice were prepared and immunolabelled for GFP and NeuN. Compressed 
(a) and single-scan (b-c) confocal images were captured to show the neuronal morphology, 
orientation and extent of the GFP+ neuronal processes. 
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Figure 3.18 YFP+/NeuN+ cells are not labelled with BrdU.  In order to determine whether 
YFP+ neurons arise from the dividing OLP population, BrdU was administered to 
PDGFRa-CreER
T2
/R26-YFP transgenic mice at P45 for a period of 100 days.  No 
YFP+/NeuN+/BrdU+ cell was found in the anterior piriform cortex across three 30µm 
brain sections from 3 mice examined. 
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investigated.  This has been clearly addressed here using PDGFRa-CreER
T2
/R26-
YFP transgenic mice to label and trace OLPs in the adult brain.  We show that 
PDGFRα+ cells generate new myelin-forming oligodendrocytes in the adult corpus 
callosum.   The importance of this finding is two-fold: firstly, it indicates that adult 
OLPs in the white and grey matter generate progeny that persist in the brain for at 
least one year after birth, a remarkable amount of time considering the average 
lifespan of mice (~2 years in captivity).  Secondly, when taken alongside our P45 
tracing data which indicated that all YFP+ cells were oligodendrocyte lineage cells 
(SOX10+/OLIG2+; Rivers et al., 2008), these data suggest that OLPs exclusively 
produce oligodendrocytes in the corpus callosum and motor cortex of the normal 
adult brain.  That the new cells are truly myelinating oligodendrocytes was further 
confirmed using PDGFRa-creER
T2
/Tau-mGFP transgenic mice.  While OLPs were 
not mGFP labelled in this reporter mouse, all neurons and oligodendrocytes 
generated from OLPs were clearly labelled by the membrane targeted mGFP, which 
highlighted the myelin internodes of the adult born oligodendrocytes.  Many new 
differentiated cells (PDGFRα- and NG2-negative) were also produced in the motor 
cortical grey matter of the PDGFRa-CreER
T2
/R26-YFP transgenic mice.  An 
independent study using Olig2-CreER
 T2
 transgenic mice (in which transgene activity 
in adulthood marked NG2 cells but not differentiated oligodendrocytes) came to 
similar conclusions (Dimou et al., 2008).  
 
There were prominent differences when comparing adult oligodendrogenesis in the 
white versus grey matter:  1) the rate of oligodendrocyte production was less in the 
grey versus white matter and 2) the morphology of the adult-born oligodendrocytes 
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in white matter was that of classical myelinating oligodendrocytes with parallel 
processes, whereas those that formed in the motor cortex had processes resembling 
myelin internodes, but these were fewer in number and they were randomly oriented 
with respect to the cell body. 
 
Similarity between oligodendrocytes, in white and grey matter, lies with their 
expression of the oligodendrocyte protein CC1 and the myelin protein MBP, which 
in turn means that adult OLPs are capable of generating myelinating 
oligodendrocytes under normal conditions in both grey and white matter.  
Nevertheless, the fact that in the PDGFRa-CreER
T2
/Tau-mGFP mouse there were 
significantly more mGFP+ cells that expressed NG2 in the motor cortex than in the 
corpus callosum might imply that, in the grey matter, OLPs differentiate more slowly 
allowing overlap between NG2, Tau and possibly CC1 expression.  These data are 
consistent with those from the PDGFRa-CreER
T2
/R26-YFP transgenic mice, where 
there was an overlap between YFP+ cells that expressed PDGFRα and YFP+ cells 
that expressed CC1. 
 
We report that a substantial number of oligodendrocytes are added to the adult brain.  
The function of adult oligodendrogenesis however is still not understood, yet, it 
could be serving two roles in the adult CNS: 1) new oligodendrocytes might replace 
oligodendrocytes that die through normal wear-and-tear and 2) OLPs might generate 
new, additional oligodendrocytes in the mature brain.  The functional necessity of 
oligodendrocyte addition is still unclear.  However, evidence for activity-dependent 
changes in white matter volume in humans suggests that it may be necessary for 
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motor learning, adding to the notion of cellular plasticity for the adult brain 
(Bengtsson et al., 2005).  It is interesting to note that the corpus callosum is a 
mixture of both myelinated and unmyelinated axons.  Even in P240 mice, ~70% of 
corpus callosal axons remain unmyelinated (Sturrock et al., 1980).  Therefore, OLPs 
might differentiate into oligodendrocytes that myelinate previously naked axons.  
This would represent a new form of neural plasticity.  As myelination speeds up 
axonal conduction, it could therefore enhance/alter the functional significance of 
neuronal circuits.  The running wheel experiment is consistent with this concept, as it 
demonstrates that oligodendrogenesis can be increased in the corpus callosum of the 
adult brain as a result of exercise that involves inter-hemispherical communication.  
However, this experiment does not determine how running is altering 
oligodendrogenesis.  It is known that running increases neurogenesis in the brain by 
increasing neurotrophin release (Wolf et al., 2006).  As oligodendrocyte lineage cells 
can also respond to neurotrophins and other growth factors (reviewed in Du and 
Dreyfus, 2002), these might be responsible for the 20% increase in oligodendrocyte 
production observed.  Further experiments would be required to determine what 
physiological changes are induced by exercise and how they promote 
oligodendrogenesis. 
 
It is important to note that no astrocyte production by OLPs was observed in 
adulthood.  In contrast, Zhu et al. (2008) showed a small population of protoplasmic 
astrocytes in the ventro-lateral forebrain of Ng2-Cre/CAGG-Z/EG double- transgenic 
mice (Zhu et al., 2008).  As this experiment collectively traced the fate of OLPs over 
the lifetime, it is likely that the GFP+ astrocytes cells identified in adulthood were 
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generated embryonically or early in postnatal development as was reported by Guo et 
al. (2009) using the PLP-CreER
T2
 transgenic mouse to trace the developmental 
behaviour of OLPs.  Similar to our findings, fate mapping adult OLPs using Olig2-
iCreER
T2
/CAGG-Z/EG transgenic mice detected no production of astrocytes by adult 
OLPs under normal conditions (Dimou et al., 2008). 
 
In addition to oligodendrogenesis, we found constitutive neurogenesis from OLPs in 
part of the normal adult brain.  In the anterior piriform cortex of the PDGFRa-
creER
T2
/R26-YFP mice, YFP+ neurons emerged a few weeks after tamoxifen 
administration and accumulated with time.  mGFP+ neurons were also detected in 
the piriform cortex of PDGFRa-creER
T2
/Tau-mGFP transgenic mice.  These neurons 
did not express any of the investigated interneuron markers (calbindin, calretinin, 
neuropeptide-Y, parvalbumin, somatostatin, reelin or tyrosine hydroxylase).  
Consistent with this, their morphology resembled that of projection neurons, having 
large cell bodies in layer II and long dendritic arbors directed towards the pial 
surface, where piriform cortical projection neurons are known to make synaptic 
connections with axons of the (unmyelinated) lateral olfactory tract (Haberly et al., 
2001; Suzuki et al., 2006).   
 
The fact that there was no co-localization of the proteins PDGFRα and NeuN by cells 
within the piriform cortex, strongly suggests that the YFP+ neurons were not labelled 
in the piriform cortex directly by the expression of PDGFRα.  It does not, however, 
rule out the possibility of ectopic expression of the PDGFRa-creER
T2
/R26-YFP 
transgene by some neurons in this region.  However, if piriform cortical neurons did 
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express the transgene, then YFP+ neurons would be expected to appear soon after 
tamoxifen treatment, not to accumulate slowly over several months, as observed.  
Another possibility is that YFP+ neurons might be formed by the fusion of unlabeled 
neurons with YFP+ non-neuronal cells, but this is also less probable as YFP+ 
neurons start to appear a few weeks after tamoxifen treatment.  Moreover, the fact 
that YFP is expressed in a particular subset of neurons in the piriform cortex, would 
imply that the putative fusion event must be highly cell-specific.  This still is highly 
unlikely, especially since YFP+ projection neurons were not observed in Fgfr3-
iCreER
T2
/Rosa26-YFP mice, despite the fact that many YFP+ protoplasmic 
astrocytes were present as potential fusion partners.  The simplest scenario is that the 
YFP+ neurons are formed by differentiation of local, PDGFRα+ OLPs and this 
explanation has been given further credibility by recent fate mapping studies using 
other transgenic mice that label OLPs.  For example, Guo et al. (2010) recently used 
Plp-CreER
T2
/R26-YFP transgenic mice to label and fate map adult OLPs (Guo et al., 
2010).  Approximately 3 weeks post-tamoxifen treatment, they observed EYFP+ 
neurons primarily in layer II of the piriform cortex with pyramidal and to a lesser 
extent semilunar morphology (Guo et al., 2010). These neurons expressed the 
vesicular glutamate transporter 1 (vGLUT1) and glutaminase, showing that they 
were glutamatergic pyramidal neurons (Guo et al., 2010).  Additionally, while 
Dimou et al. (2008) published that they observed no neurogenesis in Olig2-
Cre/CAGG-GFP transgenic mice, subsequent examination of Olig2-CreER
T2
/R26-
YFP transgenic mice revealed neuron production in the piriform cortex, comparable 
with our own (M. Götz, unpublished communication).  Therefore, OLPs in the adult 
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brain have been labelled using three different transgenes and shown to produce 
piriform cortical projection neurons in each case. 
 
The fact that no YFP+/NeuN+/BrdU+ cells were detected in animals given BrdU for 
a 100 days period suggests that YFP+ neurons are derived by the direct 
differentiation of post-mitotic OLPs into neurons.  In vitro studies have proven the 
ability of OLPs from perinatal optic nerve to generate neurons and astrocytes in 
addition to oligodendrocytes (Kondo et al. 2000).  Another study has shown that 
SVZ cells that express a CNP-GFP transgene, co-express NG2 and generate 
olfactory bulb interneurons and hippocampal and striatal neurons in vitro and in vivo 
(Aguirre et al., 2004).  In addition, there have been several reports of adult 
neurogenesis outside of the olfactory bulb and hippocampus, both in rodents 
(Tamura et al., 2007; Dayer et al., 2005; Kokoeva et al., 2005; Shapiro et al., 2007) 
and primates (Gould et al., 1999; Zhao et al. 2003), indicating that typical 
neurogenic regions are not the sole source of neurons in the brain. 
 
The scale of neurogenesis observed in the present study was small, when compared 
to the overall population of projection neurons.  The physiological importance of this 
adult neurogenesis is unclear, however, it is particularly intriguing in light of the 
known plasticity of the olfactory bulb, which provides the main input to this region 
of the piriform cortex.  Moreover, small numbers of neurons, even single neurons, 
are capable of producing a considerable behavioural effect (Houweling and Brecht, 
2008; Huber et al., 2008).  At present, we have been unable to investigate whether 
these YFP+ neurons manage to extend their axons to their neuronal targets and form 
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active connections.  Unfortunately, this process, as well as electrophysiological 
phenotyping of these neurons, has not been possible using the Pdgfra-creER
T2
/Tau-
mGFP mouse due to the large number of GFP-labelled oligodendrocytic processes, 
which mask the relatively small number of neurons.  Electrophysiological 
experiments could only be carried out by generating a neuron specific reporter mouse 
line, such as NSEΔSTOPΔYFP, where expression after recombination would be 
driven by NSE (Neuron Specific Enolase). 
 
It has been reported that defined cortical neurons can be regenerated by endogenous 
precursors after experimental ablation and the replacement neurons can extend long-
range axons toward their original targets (Magavi et al., 2000).  Therefore, it could 
be possible that OLPs, like those present in the piriform cortex, are responsible for 
generating those replacement neurons.  If this notion is correct, it might mean that 
local OLPs could be a potentially useful resource for neuronal replacement during 
neurodegenerative disease. 
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Chapter 4 
 „Cell Cycle Dynamics of OLPs in the Postnatal 
Mouse Brain‟ 
 
 
 
4.1  Introduction 
In addition to their on-going role in adult oligodendrogenesis in the healthy mouse 
brain (Chapter 3), OLPs are thought to be crucial for remyelination following 
demyelinating injury or disease.  For example, during cytotoxin-induced focal 
demyelination and subsequent re-myelination of the mouse spinal cord, the dynamic 
behaviour of OLPs in and around the lesion suggests that they are the source of the 
remyelinating oligodendrocytes (Keirstead et al., 1998; Watanabe et al., 2002; 
Dawson et al., 2003).  The efficiency of remyelination following experimental 
demyelination is observed to decrease with ageing, which might be attributed to an 
age-related decline in the regenerative properties of OLPs (Sim et al., 2002), while 
the factors that cause these age-related changes are unknown they could result from 
changes in the ability of OLPs to proliferate and generate new oligodendrocytes as 
the brain matures and ages. 
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There is strong evidence that myelin production is compromized in aged mice 
(Shields et al., 2000).  Oligodendrocyte and OLP cell intrinsic changes are likely to 
play a role in this process.  Alterations at the level of micro-RNA have not been 
investigated, but recent studies implicate age related changes in epigenetic control 
(Shen et al., 2008; Shen et al., 2008b).  Histone deacetylase (HDAC) enzymes are 
generally inhibited in OLPs present in the developing and adult CNS (Marin-
Husstege et al., 2002; Shen et al., 2005; Liu et al., 2007) and therefore histones in 
OLPs tend to be acetylated and associated with open, active chromatin.  This is in 
contrast to the histones of myelinating oligodendrocytes which tend to be 
deacetylated and associated with compact chromatin.  The significance of the 
different HDAC levels in OLP differentiation is reflected by the increased expression 
of HDAC1 by OLPs in the corpus callosum of young adult mice, following 
cuprizone exposure.  HDAC1 binds to the promoters of anti-myelination genes, 
reducing their expression and promoting oligodendroglial differentiation in order to 
induce remyelination.  These modifications were not observed in OLPs of 
equivalently treated aged mice (Shen et al., 2008), which had correspondingly 
impaired re-myelination (Shen et al., 2008).  These data suggest an impaired ability 
of OLPs to differentiate in the aged brain, but say nothing of their proliferative 
capacity. 
 
Work by van Heyningen et al. (2001) has shown that at E13 all OLPs are mitotically 
active, however their cell division rate slows as their numbers increase in late 
embryogenesis (van Heyningen et al., 2001).  For example, E17 OLPs cycle more 
slowly (Tc ~78h) than E13 OLPs (Tc ~12h) in vivo (van Heyningen et al., 2001).  A 
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similar trend has been noted when perinatal and adult OLPs were compared in vitro.  
An increase in the cell cycle time from ~38 hours to 60-65 hours was observed for 
cultured OLPs taken from optic nerves of P3 and P21 rats respectively (Wren et al., 
1992).  A lengthening of OLP cell cycle time as the demands of developmental 
oligodendrogenesis subside is hardly surprising.  But, how and why the behaviour of 
NG2 cells alters beyond development with normal ageing is a very important 
question that must be addressed in order to know whether OLPs in the aged brain can 
act as a reservoir of new cells for neural repair.  In this chapter, changes to the cell 
cycle kinetics of OLPs and their rate of oligodendrocyte production will be examined 
throughout postnatal life. 
 
4.2  Results 
 
4.2.1  Dividing and non-dividing OLP sub-populations in the P60 brain 
OLPs are the major dividing cell population in the adult rat CNS.  However, neither 
the proportion of cells in cycle (growth fraction) nor their cell division times have 
been determined to date.  To gain a more detailed understanding of the in vivo cell 
cycle dynamics of adult OLPs, cumulative BrdU-labelling experiments were carried 
out using two different methods of administration.  BrdU was administered to young 
adult mice in their drinking water continuously for up to 21 days (see 2.7.2), starting 
at P60.  Alternatively, cumulative BrdU administration was achieved by the 
subcutaneous implantation of mini osmotic pumps that continuously release BrdU.  
Coronal forebrain sections were analyzed after various BrdU-labelling periods by 
immunohistochemistry for BrdU and PDGFRα (see 2.8.5; Fig. 4.1a-d).  The 
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proportion of PDGFRα+ OLPs that had incorporated BrdU was counted in defined 
regions of the corpus callosum and medial cortex in confocal micrographs (see 2.9).  
For each time point and labelling method, the proportion of OLPs (PDGFRα+ cells) 
that incorporated BrdU was calculated in the corpus callosum and the motor cortex 
(Fig. 4.1e-f).  These data were plotted as BrdU labelling index versus labelling 
period in order to compare the rate of labelling of proliferating OLPs by each 
methodology (see 2.9.3).  Both BrdU delivery methods produced similar results, that 
is, a similar rate of BrdU incorporation and similar proportion of labelled cells (Fig. 
4.1).  Therefore, the data were combined for analysis. 
 
In the corpus callosum, the labelling index (% of BrdU+ OLPs) increased with time 
for 7–10 days, but then reached a plateau at ~55% (Fig. 4.1c).  The plateau indicates 
the point at which all dividing cells within the population have been labelled and 
therefore these data suggest that only ~half of the PDGFRα+ cells are actively 
engaged in the cell cycle.  These data were also used to calculate the cell cycle time 
(Tc; see 2.9.3), which indicated that the dividing cell population had a Tc of 
approximately one week.  In the cortex, the labelling index increased steadily over 
the labelling period (Fig. 4,1f).  At 21 days, nearly 40% of PDGFRα+ cells in the 
cortex had incorporated BrdU.  If the labelling index continues to increase at the 
same rate until all cortical OLPs are labelled, then that would imply that the whole 
population divides with an average cycle of ~50 days.  However, with the data 
available, it can only be concluded that 40% or more of cortical adult OLPs are 
dividing with an average cell cycle time of at least 21 days.  
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Figure 4.1 Cumulative BrdU labelling of adult OLPs  in vivo. BrdU was administered to 
young adult (P60) mice for up to 21 consecutive days via osmotic mini-pumps (Rivers et al. 
2008) or by including BrdU in the drinking water for up to 21 d. Double immunolabelled 
brain sections for BrdU and PDGFRA revealed double-positive (replicating) OLPs in both 
corpus callosum (a-b) and cerebral cortex (d-e). Both routes of BrdU delivery gave 
comparable data.  In corpus callosum (c), the BrdU labelling index increased to ~55% in 7–
10 d, but did not increase further. In the cortex (f), the labelling index increased linearly for 
21 d until ~40% of OLPs were BrdU+.  The cumulative BrdU experiment was extended by 
BrdU in the drinking water administration for up to 100d.  Data were graphed as the 
percentage of BrdU+ OLPs in the total OLP population in the corpus callosum (g) and 
motor cortex (h).  At each time point, the labelling index was determined from cell counts 
(means ± s.d.) on at least three sections from each of three animals. The 2-h time point is 
from a single intra-peritoneal injection of BrdU. 
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To determine the Tc and GF for OLPs in the motor cortex, it was necessary to extend 
the period of BrdU labelling.  As BrdU administration via the drinking water or mini 
osmotic pump produced similar labelling of OLPs, BrdU was subsequently 
administered to the mice via the drinking water, so that the mice did not have to 
undergo surgery to replace mini-pumps every 10-11 days.  BrdU in the drinking 
water was administered for up to 100 days.  Coronal brain sections were double-
immunolabelled for PDGFRα and BrdU to visualize OLPs that had undergone DNA 
replication during the labelling period.    
 
For the corpus callosum, an accumulation of PDGFRα+/BrdU+ cells with time was 
detected until ~8 days, when a plateau was reached (Fig. 4.1g).  Once the ~45% 
plateau was reached, it remained stable for the remaining 92 days of BrdU 
administration.  This was true for the cortex as well (Fig. 4.1h). Although the 
labelling plateau was reached later in the cortex (~21 days) it was reached when 
~40% of OLPs had incorporated BrdU and then remained stable for the remainder of 
the 100 day labelling period.  These data were used to calculate the Tc according to 
the formula given in 2.9.3, and indicate that OLPs in the brain white matter 
proliferate more rapidly (Tc ~9 days; Fig. 4.7) than their counterparts in the grey 
matter (Tc ~18 days; Fig. 4.7).  Furthermore, there appear to be 2 sub-populations of 
OLPs in both regions of the postnatal mouse brain that can be distinguished 
depending on their proliferative behaviour, that is, mitotically active versus inactive.  
4.2.2  Mitotic status of OLPs is unrelated to their developmental site of origin 
It is known that adult OLPs in the forebrain derive embryonically from both the 
cortical and striatal VZs (Kessaris et al., 2006).  Since ~50% of SOX10+ cells in 
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adulthood come from each of the two embryonic VZ regions (Kessaris et al., 2006), 
and ~50% of OLPs are actively engaged in the cell cycle (see above), this suggests 
the possibility that there might be a connection between the developmental origin of 
OLPs in the forebrain and their cycling behaviour in adulthood.  To examine this 
possibility, P60 forebrain sections from Gsh2-iCre/R26-YFP and Emx1-iCre/R26-
YFP transgenic mice were first immunolabelled for PDGFRα and GFP (Fig. 4.2a, b) 
to identify OLPs that had originated from stem cells in the embryonic LGE or cortex 
respectively.  PDGFRα+ cells that had originated from each region were 
intermingled in both the corpus callosum and cortex and were found to be present in 
similar proportions (~40% from each) (Fig. 4.2a-e).  In both corpus callosum and 
cortex there was a modest fraction of PDGFRα+ cells (10-20%) that appeared not to 
be derived from either ventral or dorsal forebrain.  
 
Having confirmed the embryonic origins of OLPs in the adult cortex and corpus 
callosum, I administered BrdU to P60 Gsh2-iCre/R26GFP and Emx1-iCre/R26GFP 
transgenic mice via their drinking water for 6 or 35 days, and then immunolabelled 
brain sections for GFP, PDGFRα and BrdU.  Triple-labelled cells were counted in 
the corpus callosum and cortex and expressed as a percentage of the total number of 
(GFP+, PDGFRα+) cells in the same region (Fig. 4.3a-d).  The fraction of (GFP+, 
PDGFRα+) cells that incorporated BrdU was similar in both Gsh2-iCre/R26GFP and 
Emx1-iCre/R26GFP animals and each was representative of the PDGFRα+ cell 
population as a whole (Fig 4.3a-d).  It can therefore be concluded that the 
developmental origin has no influence on the proliferative behaviour of NG2 cells. 
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Figure 4.2 OLPs derived from both the dorsal and ventral VZ contribute equally to the 
population of NG2 cells.  By crossing Gsh2-iCre and Emx1-iCre transgenic mice with Cre-
sensitive R26GFP reporter mice we were able to trace GFP+ (green), PDGFRα+ (red) 
OLPs that originated from the embryonic LGE/MGE and cortical VZ, respectively (a, b).  (c) 
Numbers of GFP+, PDGFRα+ OLPs in the corpus callosum or cortex (3 sections from each 
of 6 mice) was expressed as a percentage of all PDGFRα+ OLPs in the same region.  Gsh2- 
and Emx1-derived OLPs were found in approximately equal numbers in both corpus 
callosum and cortex (d, e). Grey arrowheads indicate (GFP+, PDGFRα+) double-positive 
cells (a, b). White arrows indicate a PDGFRα+ single-positive cell (a, b). CC, corpus 
callosum; Ctx cortex.  Scale bars: a-b, 40 µm; d-e, 10 µm. 
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Figure 4.3 OLPs derived from both the dorsal and ventral VZ contribute to both the cycling 
and non-cycling populations of NG2 cells.  To determine whether both Gsh2- and Emx1- 
derived adult OLPs were cycling, BrdU was administered via the drinking water for 6 or 35 
days starting on P60 and brain sections were triple immuno-labelled for BrdU (blue), 
PDGFRα (red) and GFP (green) (a, b).  GFP+/PDGFRα+ OLPs were scored as BrdU-
positive or –negative by examining confocal images with orthogonal projections (c); 
numbers of OLPs in corpus callosum and cortex were expressed  as a percentage of all  
OLPs in the same area.  Both Gsh2- and Emx1- derived NG2 cells contributed equally to the 
cycling and non-cycling sub-populations.  Grey arrowheads indicate 
(BrdU+/GFP+/PDGFRα+) triple-positive (a, b) cells.  White arrows indicate 
(GFP+/PDGFRα+) double-positive (a, b) cell.  CC, corpus callosum; Ctx cortex.  Scale 
bars: a-b, 17 µm; c, 6 µm.    
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4.2.3  The OLP cell cycle slows dramatically with age 
As mentioned previously, van Heyningen et al. (2001) reported that 100% of OLPs 
in the spinal cord proliferate at E13.  As we report that only ~half of OLPs are 
dividing in the adult brain, there presumably is a switch in OLP cycling behaviour 
that occurs sometime after E13 and before P60.  To determine the age at which this 
switch occurs, I performed cumulative BrdU-labelling experiments on P6 mice.  As 
P6 mice are too small for mini pump implantation and BrdU does not pass from the 
mother‟s drinking water through the milk to her pups (data not shown), BrdU was 
administered to wild type mice by injecting them subcutaneously every 3.5 hours for 
up to 3 days.  Brain sections were immunolabelled to detect PDGFRα and BrdU and 
immuno-positive cells were quantified (Fig. 4.4).  We found that the labelling index 
plateaued in the corpus callosum and cortex after ~55% of OLPs had incorporated 
BrdU+. This is slightly higher than the GF of OLPs present at P60, perhaps 
indicating that some non-dividing OLPs are still being generated and OLPs are sub-
divided into two populations (mitotic and non-mitotic) within the first postnatal 
week. 
 
Using the cumulative BrdU labelling data, the cell cycle time was calculated for 
OLPs at P6 using the method previously outlined (see 2.9.3).  Interestingly, Tc was 
found to be much more rapid at P6 (CC: 1.7 days ± 0.2; Ctx: 2 days ± 0.2) than at 
P60 (CC: 9 days ± 0.2; Ctx: 18 days ± 3), demonstrating that Tc is slowing with age 
even during the early postnatal period (Fig. 4.7a).   
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Figure 4.4 Post-mitotic OLPs are born before the end of the first postnatal week.  BrdU 
was administered by sequential subcutaneous injections at P6.  (a) At various times after the 
start of BrdU administration, BrdU+, PDGFRα+ OLPs were counted in the corpus callosum 
and cortex and the number of dividing OLPs expressed as a percentage of the total number 
of OLPs.  BrdU+ (green), PDGFRα+ (red) OLPs could be detected readily in the grey and 
white matter after all BrdU labelling periods examined (b-c).  Grey arrowheads indicate 
cycling, BrdU+ OLPs and white arrowheads non-cycling OLPs.  The white dashed line 
indicates the border between the corpus callosum (CC) and cortex (Ctx). Scale bars: a-b, 
60 µm        
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To further examine the effect of ageing on the cell cycle kinetics of OLPs, coronal 
brain sections of P6 and P60 mice were stained with Ki67 (Fig. 4.5).  The Ki67 
monoclonal antibody identifies a nuclear antigen that is expressed during the late G1, 
S, M and G2 phases of the cell cycle while its expression diminishes quickly after 
mitosis (Siitonen et al. 1993; Gasparini et al. 1994; Pena et al. 1998). It was found 
that ~29% of PDGFRα/NG2 cells in the P6 mouse corpus callosum were Ki67+ (154 
double +ve PDGFRα+/Ki67+ cells out of 535 PDGFRα+ cells), compared to only 
~15% at P60 (31 PDGFRα+/Ki67+ cells out of 206 PDGFRα+ cells).  In the P6 
cortex, 7% of PDGFRα+ cells were Ki67+ (41 double +ve PDGFRα+/Ki67+ cells 
out of 589 of total PDGFRα+), while only 4% of the total PDGFRα+ cells were also 
stained with Ki67 in the P60 cortex (10 double +ve PDGFRα+/Ki67+ cells out of 
242 of total PDGFRα+).  Thus, the Ki67 labelling index does not match the growth 
fraction estimated by cumulative BrdU labelling (~50% at both ages) but it does 
decline in parallel with the increase in the length of the cell cycle. 
 
Having observed that the Tc of OLPs lengthens between P6 and P60, I further 
determined the Tc of OLPs in the brain of mice at various postnatal ages to see 
whether Tc is influenced by ageing.  For this, BrdU was administered to wild type 
mice via their drinking water for up to 100 days starting from P240 (eight months) 
and P540 (eighteen months) and brain sections were immunostained to detect 
PDGFRα and BrdU (Fig 4.6b-d, f-h). In the corpus callosum, TC increased from <2 
days at P6 to ~70 days at P240 and older (Fig. 4.7).   In the cortex, TC increased 
steadily from ~2 days at P6 to >100 days at P540 (Fig. 4.7).   It was not possible to 
determine TC in the P540 cortex with confidence because the GF is not known; even 
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Figure 4.5 Ki67 staining showed increase in the length of Ng2 cell cycle with age. Brain 
sections of P6 (a) and P60 (b) mice were stained with antibodies against Ki67 (green), 
PDGFRα (red) and DAPI (blue). Arrows and arrowheads indicate Ki67+/PDGFRα+ and 
Ki67-PDGFRα+ cells respectively in the corpus callosum of these mice.  
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Figure 4.6 OLPs continue to proliferate throughout postnatal life in the corpus callosum 
and cortex. BrdU was administered to mice via their drinking water for up to 100 days 
starting on P6 (P4-P7), P60 (2 months), P240 (8 months) or P540 (18 months).  At various 
times after the start of BrdU administration, the number of BrdU+, PDGFRα+ OLPs was 
counted in the corpus callosum (a) and cerebral cortex (e) and expressed as a percentage of 
the total number of PDGFRα+ OLPs.  BrdU+ (green), PDGFRα+ (red) OLPs could be 
detected readily in the grey (b-d) and white (f-h) matter at all ages.  The point at which a 
plateau is reached indicates the fraction of the OLP population that is actively cycling.  Grey 
arrowheads indicate BrdU+, cycling OLPs and white arrowheads indicate non-cycling 
OLPs.  CC, corpus callosum; Ctx, cortex.  Scale bars: b-d and f-h, 20 µm 
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at P540 +100 days of BrdU labelling the labelling index still appeared to be on the 
increase (Fig. 4.6e).  If I assume that GF = ~0.4 at P540, as it is at P240, then TC 
(P540)  170 days.  It is likely that most of the increase in TC observed with age 
results from an increase in the amount of time cells remain resting in early G1, that 
is, when Ki67 is not expressed. 
 
When we investigated a possible relationship between postnatal age and cell cycle 
length for cortical OLPs, it was found to be linear (Fig. 4.7b).  With every extra day 
after birth, the cell cycle increases by around one third of a day.  This relationship 
allows the estimation of TC for any given postnatal age.  In the corpus callosum there 
is no simple relationship between age and TC (Fig. 4.7b).  In contrast to the cortex, it 
seems that in the corpus callosum TC reaches its maximum around P240 and does not 
increase significantly after that. 
 
Despite the considerable increase in TC with age, the GF was relatively invariant 
(Fig. 4.6a, e; Fig 4.7a).  In the corpus callosum, GF was not significantly different 
from 50% at any age.  In the cortex, the growth fraction fell from ~54% at P6 to 
~40% at P60 and older.  These data imply that in both the white and grey matter of 
the postnatal forebrain only around half of all NG2 cells are actively engaged in the 
cell cycle at any age, the other half being post-mitotic.  Furthermore, these separate 
dividing and non-dividing populations are already present in the brain shortly after 
birth at P6.  
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Figure 4.7 The OLP cell cycle slows down during postnatal life.  BrdU was administered to 
mice via their drinking water starting on P6, P60, P240 or P540 and the fraction 
(percentage) of OLPs that was BrdU+ was plotted versus the BrdU labelling period. (a) GF, 
m and TC for OLPs in the corpus callosum and cortex at the ages examined.  (b)  There was 
a linear relationship between age and cell cycle length of OLPs in the cortex (Ctx) at all 
ages.  In the corpus callosum (CC) cell cycle time reached a plateau after ~P240. 
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4.2.4  EdU incorporation by OLPs in vitro 
In contrast to these findings, research conducted by Carlos Parras‟ laboratory 
indicated that over half of the OLPs present in the adult mouse cortex underwent cell 
division (unpublished communication).  After trialling a variety of antigen retrieval 
methods for BrdU detection, to verify our data we decided to adapt an alternative 
method for labelling proliferating OLPs.  EdU is another thymidine analogue, which 
like BrdU, is incorporated into the DNA of cells as they undergo cell division.  
However, EdU detection does not require DNA denaturation or antigen retrieval for 
detection (see 2.8.6).  As EdU has been previously used for labelling dividing cells in 
vitro, we first determined whether it could be used to label dividing OLPs in culture.  
Therefore, OLPs were isolated from the cortex of P15 mice as described in 2.8.1.  
These culture conditions select for cells of the oligodendroglial lineage, as confirmed 
by co-staining of these cultures to detect OLIG2 and NeuN (Fig.4.8a).  ~99% of cells 
were OLIG2+, while no cell was found to be NeuN+.  When EdU was added into the 
medium of P15 mouse cortical OLP cultures for 18 hours (2.7.3) and the cells were 
fixed and co-stained to detect EdU and the OLP marker NG2 (2.8),  ~99% of cells in 
the culture were NG2-positive and around half of these cells were also EdU-positive 
(Fig. 4.8b, c).  These data indicate that EdU can be incorporated by OLPs, and 
therefore used to identify proliferating OLPs.  
 
4.2.5  EdU incorporation by OLPs in vivo 
EdU can be administered as a single intraperitoneal injection in order to acutely label 
cells that are proliferating in vivo (Chehrehasa et al., 2009; Fig. 4.9f).  However for 
the cumulative labelling of proliferating OLPs in vivo it was necessary to first 
determine whether EdU could be detected after administration through the drinking  
Chapter 4 Cell Cycle Dynamics of OLPs in the Postnatal Mouse Brain 
 
127 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8 EdU incorporation by OLPs in vitro. P15 cortical cultured cells were stained 
for NeuN (green) and OLIG2 (red) to establish their identity (a).  EdU was next added to the 
cultured cells and left for 18 hours. Cultured cells were immunolabelled for NG2 (green) 
and EdU (red) and imaged at 20x (b) and 40x magnification (c). 
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Figure 4.9 Cumulative EdU labelling in vivo. EdU was administered to mice via their 
drinking water at P21 for up to 2 days. Different EdU concentrations were tested in order to 
determine optimal EdU labelling (a-g). A single subcutaneous injection of 25mg/kg body 
weight acted as a positive control for the EdU staining (h). Dividing cells had incorporated 
EdU (red) and were then counterstained with DAPI (blue).  The absolute number of EdU+ 
cells in 3 non-overlapping regions in the corpus callosum were counted in mice dosed with 
0.1 and 1mg/ml EdU for 48hrs (i). 
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water, whether there was toxicity associated with long-term EdU administration and 
if so, decide upon the optimum EdU concentration to use for these experiments.  
Therefore, P21 mice were exposed to different EdU concentrations in their drinking 
water for a 48hr period and brain sections processed to detect EdU as described in 
2.8.6.  To screen for detectable in vivo labelling of proliferating cells, the SVZ, 
which contains a population of rapidly proliferating progenitor cells, was first 
imaged for EdU incorporation.  Concentrations of 0.001mg/ml and 0.01mg/ml EdU 
produced no detectable labelling of the SVZ (Fig. 4.9a, b).  However at 
concentrations of 0.1mg/ml EdU and above, EdU-positive cells could be readily 
detected (Fig. 4.9c).  Doses of 0.2mg/ml, 0.5mg/ml and 1mg/ml produced 
significantly brighter cell labelling (Fig. 4.9e, f, g).  The number of dividing EdU+ 
cells labelled by each dosing regime was quantified, within a fixed corpus callosal 
area.  This did not vary significantly from 0.1mg/ml to 1mg/ml EdU administration 
(Fig. 4.9i).  These data suggested that any dose between 0.1mg/ml and 1mg/ml of 
EdU in the drinking water of mice could label proliferating cells in the brain, 
including those of the corpus callosum. 
 
When 1mg/ml EdU was maintained in the drinking water of n=3 mice from P21, by 
13 days we observed evidence of toxicity: n=1 mouse lethal, n=2 mice exhibited 
hunched posture and were therefore euthanized.  Similarly when 1mg/ml EdU was 
maintained in the drinking water of mice from P60 it was also found to be toxic by 
13 days; n=1 mouse lethal, n=2 mice exhibited hunched posture and were therefore 
euthanized, n=6 mice appeared normal and were therefore perfusion fixed at 14 and 
21 days for histological analysis.  No such side effects were observed by 
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administering a dose of 0.2mg/ml EdU to P21 and P60 mice, even when it was 
provided for 50 days (n=3 of each).  Doses longer than 50 days were not tested. 
 
Brain sections from P60 mice that received either 0.2mg/ml or 1mg/ml of EdU were 
processed to detect EdU and PDGFRα (see 2.8) in order to determine the proportion 
of OLPs labelled in each instance.  EdU incorporation by OLPs in the motor cortex 
increased linearly with time with an EdU dose of 0.2mg/ml, as we would expect 
from our BrdU studies.  EdU incorporation by OLPs did not exceed ~20% in mice 
that received a dose of 1mg/ml EdU, even when it was administered for 21 days (Fig. 
4.10).  As ~40% of OLPs become labelled by 0.8mg/ml of BrdU and 0.2mg/ml of 
EdU in an equivalent time frame, these data indicate that even mice that do not 
present visible symptoms of toxicity were still experiencing toxic side effects of EdU 
labelling at a concentration of 1mg/ml (Fig. 4.10).  Therefore, since 0.2mg/ml EdU 
was found to provide very bright, clear labelling of proliferating cells, including 
OLPs in the corpus callosum (Figure 4.9e) and cortex (Fig. 4.10), without detectable 
toxicity, this concentration was used for further cumulative labelling experiments, 
described below.     
 
4.2.6  Proliferative behaviour of OLPs in adolescent (P21) and young adult (P60) 
mice as determined by cumulative EdU administration 
EdU was administered into the drinking water (0.2mg/ml) of P21 mice for various 
periods of time for up to 50 days.  After each labelling period, the proportion of 
proliferating OLPs was determined in the corpus callosum and motor cortex, as well 
as the piriform cortex. 
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Figure 4.10 Toxic effects of cumulative EdU labelling in vivo. EdU was administered to 
P60 mice via their drinking water at a concentration of 1mg/ml and 0.2mg/ml for up to 21 
days.  Toxicity of high EdU concentration in vivo is shown by the decreased proportion of 
EdU+ OLPs after 21 days of EdU administration in the motor cortex.   
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EdU+ OLPs had already accumulated in significant quantities in the corpus callosum 
within 2 days after EdU administration (Fig. 4.11a).  The proportion of EdU+ OLPs 
in the corpus callosum increased rapidly (at a rate of ~18% per day; Fig. 4.11; 4.13) 
and reached a plateau by 3 days at ~75%.  The growth fraction of dividing OLPs 
remained unaltered for the rest of the labelling period (Fig. 4.11b, c, j).  Even after 
50 days of continuous EdU administration, EdU-/PDGFRα+ cells were visible in the 
CC (Fig. 4.11c).  These data confirm that both a proliferating and a non-proliferating 
population of OLPs exist and that the BrdU labelling/detection method under-
estimated the size of the proliferating population. 
 
In the motor cortex and piriform cortex, EdU+ OLPs were detected soon after EdU 
administration commenced, but their rate of accumulation was significantly less 
(~5% and ~6% per day respectively; Fig. 4.13a) than in the corpus callosum (Fig. 
4.11d, g), but similar to the corpus callosum, a plateau in EdU labelling of 
PDGFRα+ cortical OLPs was reached at ~75% (Fig. 4.11f, i, j).  In the motor cortex, 
a plateau was reached after ~2 weeks, while in the piriform cortex it took ~20 days 
(Fig. 4.11j).  These data support our previous findings using cumulative BrdU 
labelling that OLPs in the white matter proliferate more rapidly than those in grey 
matter.  However, they also suggest that the previous methodology underestimated 
the GF of the OLP population. 
 
Cumulative EdU-labelling of OLPs was also carried out in mice aged P60 and the 
proportion of proliferating OLPs was examined for the three aforementioned brain 
regions.  The proportion of EdU-labelled PDGFRα+ cells detected increased more 
rapidly with time in the corpus callosum than the motor or piriform cortex (Fig. 4.12;  
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Figure 4.11 OLP proliferation at P21:  Dividing OLPs were labelled by continuous EdU 
administration to P21 mice for 50 days.  At various times after commencing EdU 
administration, the number of EdU+ (green), PDGFRA+ (red) adult OLPs was counted in 
the corpus callosum (a-c) and medial (primarily motor) cortex (d-f) and piriform cortex (g-
i).  Yellow, white and blue arrowheads show EdU+/PDGFRα+, EdU-/PDGFRα+ and 
EdU+/PDGFRα- cells respectively. The number of EdU+ OLPs at various days of EdU 
administration was expressed as a percentage of the total number of PDGFRA+ OLPs (j).  
The point at which a plateau is reached indicates the fraction of the OLP population that is 
actively cycling (growth fraction).   
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Figure 4.12 OLP proliferation at P60:  Dividing OLPs were labelled by continuous EdU 
administration to P60 mice for 50 days.  The number of EdU+ (green), PDGFRA+ (red) 
adult OLPs was counted after various points of EdU administration in the corpus callosum 
(a-c) and medial (primarily motor) cortex (d-f) and piriform cortex (g-i).  Yellow, white and 
blue arrowheads show EdU+/PDGFRα+, EdU-/PDGFRα+ and EdU+/PDGFRα- cells 
respectively. The number of EdU+ OLPs at various days of EdU administration was 
expressed as a percentage of the total number of PDGFRA+ adult OLPs (j).  The point at 
which a plateau is reached indicates the fraction of the OLP population that is actively 
cycling (growth fraction).   
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Fig. 4.13a).  By 50 days of EdU, ~75% of PDGFRα+ cells was EdU labelled in all 
three regions examined, consistent with data obtained from P21 mice (Fig. 4.12c, f, 
i). In all regions, OLPs were found to be proliferating more slowly at P60 when 
compared to their counterparts at P21 (Fig. 4.13a).  For example, EdU labelling at 
P21 OLPs in the corpus callosum have a Tc of ~4 days, while at P60 OLPs in the 
same region have a Tc of ~8 days.  These data are consistent with our previous 
observations using BrdU that the cell cycle time of OLPs declines progressively with 
postnatal age (Fig. 4.7). 
 
A direct comparison was made between P60 cumulative labelling experiments with 
BrdU and EdU (Fig. 4.13b, c).  While the GF determined by each methodology was 
significantly different, the rate of accumulation of labelled OLPs was consistent for 
BrdU and EdU within the corpus callosum (Fig. 4.13b) and the motor cortex (Fig. 
4.13c).  Therefore, the effect of underestimating GF using BrdU is the 
underestimation of the cell cycle time Tc.  Assuming that GF remains roughly 
constant at ~75% (rather than to ~50% as estimated earlier), this implies that Tc 
could be re-calculated more accurately at all ages.  For example, at P240 OLPs in the 
corpus callosum are likely to be cycling every 125 days (=75/0.6) instead of every 
~72 days (Fig. 4.7).  Similarly, in the motor cortex of P240 mice, OLPs divide every 
~147 days (=75/0.51) instead of every ~76 days (Fig. 4.7).   
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Figure 4.13  OLP cell cycle slows with ageing irrespective of the GF determined by BrdU 
vs EdU administration.  (a) EdU was administered to P21 and P60 mice via their drinking 
water for up to 50 days.  m, GF, Tc and S was calculated for OLPs in the corpus callosum, 
motor cortex and piriform cortex.   A direct comparison of the rate of accumulation of BrdU 
and EdU labelled OLPs in the corpus callosum (b) and motor cortex (c) of P60 mice.  *To 
allow comparison with 50 day EdU data on a truncated scale, BrdU data plotted at 50 days 
was actually acquired from mice that had received BrdU for 100 days. 
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4.2.7  Oligodendrocyte production declines in parallel with the lengthening of the 
OLP cell cycle 
We previously showed that many new myelinating oligodendrocytes are formed in 
the corpus callosum during young adulthood (Rivers et al., 2008).  In that study we 
treated Pdgfra-CreER
T2
/R26YFP mice with tamoxifen at P45 (Rivers et al., 2008) 
and P60 (Chapter 3) and followed the subsequent differentiation of labelled NG2 
cells (YFP+/PDGFRA+) into oligodendrocytes (YFP+/SOX10+/PDGFRA-negative) 
over the following months.  By this means we found that ~29% of the myelin-
forming oligodendrocytes present at P240 were formed after P45 (Rivers et al., 
2008).  As OLPs continue to proliferate, albeit more slowly, in the aged brain, we 
asked whether oligodendrocyte production continues after P240.  Tamoxifen was 
administered to P240 Pdgfra-CreER
T2
/R26YFP mice and the subsequent appearance 
of differentiated YFP+ progeny was followed for up to 100 days post-tamoxifen 
(P240+100).  It was first determined that ~48% of all PDGFRA+ cells became YFP-
labelled following tamoxifen administration (Fig. 4.14a-c) – very similar to the 
fraction that became labelled after tamoxifen administration at P45 (Rivers et al., 
2008).  No difference was detected in the proportion of YFP-labelled cells in the 
corpus callosum versus the cortex (Fig. 4.14).  Maximal YFP-labelling of OLPs was 
achieved by 10 days after the first dose of tamoxifen (6 days after the final dose) 
(Fig. 4.14a).  We previously found that maximal labelling in P45 mice took ~8 days  
(Rivers et al., 2008), which might indicate that tamoxifen is metabolized to the 
biologically active form (4-hydroxy tamoxifen) more rapidly in younger mice or that 
accumulation of YFP takes longer in older cells.  Nevertheless, at early times (10 
days) post-tamoxifen the great majority of YFP-labelled cells in both white and grey  
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Figure 4.14 YFP is expressed by PDGFRα+ cells in the Pdgfra-CreERT2 / R26YFP 
transgenic mice at P240.  To trace the fate of OLPs in the mature brain, tamoxifen was 
administered to Pdgfra-CreER
T2
 / R26YFP mice starting on P240.  (a) The proportion of 
PDGFRA+ OLPs that became YFP-labelled is plotted against time post-tamoxifen.  Within 
~10 days post-tamoxifen ~45% of PDGFRA+ (red) cells in the corpus callosum (b) and 
cortex (c) become stably labelled with YFP (green).   
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matter were also PDGFRα+, as predicted (Fig. 4.14b, c).  The great majority of 
YFP+ cells continued to co-label for PDGFRα at all time points examined post-
tamoxifen (Fig. 4.15a).  However, there was a slow but steady accumulation of 
YFP+/PDGFRα-negative cells in the grey and white matter so that by P240+100 
approximately 18% of YFP+ cells in both corpus callosum and cortex were 
PDGFRA-negative, presumably differentiated cells (Fig. 4.15b-d).  The 
YFP+/PDGFRA-negative cells in the corpus callosum had the appearance of 
oligodendrocytes (Fig. 4.15c) and they co-immunolabelled for CNPase, a marker of 
differentiated oligodendrocytes (Fig. 4.15e).  This confirmed that new 
oligodendrocytes continue to be generated from NG2 cells even after eight months of 
age. 
 
 
4.3  Discussion 
The cell cycle dynamics of NG2 cells and their contribution to cell genesis in the 
postnatal forebrain were studied and the following conclusions were reached. Firstly, 
the cell cycle time in both white and grey matter increases dramatically from ~2 days 
to >70 days between ~P6 to P240. Secondly, oligodendrocyte differentiation 
continues throughout adulthood but declines in parallel with the rate of precursor cell 
division. Thirdly, there are two distinct populations of OLPs; apart from the 
mitotically active population there is a separate population that never undergoes cell 
division. And lastly, the subdivision into dividing and non-dividing NG2 cell 
populations is not related to their developmental origins in the ventral or dorsal 
telencephalon. 
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Figure 4.15 OLPs continue to produce oligodendrocytes after 8 months of age.  The 
proportion of YFP+ cells that were PDGFRA-negative increased slowly with time (b).  
YFP+, PDGFRA-negative cells with the morphology of differentiating oligodendrocytes 
were generated in both the corpus callosum (c) and cortex (d).  Grey arrowhead indicates a 
YFP+, PDGFRA+ NG2 cells, white arrow indicates a YFP+, PDGFRA-negative 
oligodendrocyte. CC, corpus callosum; Ctx, cortex.  Scale bars: b-d, 35 µm; f-g, 30 µm. 
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We have demonstrated that the cell cycle duration for OLPs in the postnatal mouse 
brain lengthens with ageing.  It is likely that most of the increase in TC observed with 
age results from an increase in the amount of time cells remain resting in early G1, as 
even when Tc was significantly different, often S phase was unchanged.  For 
example, at P21 Tc was much shorter for white matter OLPs than grey matter OLPs, 
however, both had an S phase of ~1.3 days (Fig. 4.13a).  These data are supported by 
a recent study, analysing human surgical specimens derived from healthy adult 
human brain (mean, 50 years old) which has provided evidence that, at any one time, 
a substantial fraction of cycling adult human OLPs is in the early G1 phase of the 
cycle (Geha et al., 2010).  This study exploited the fact that the cell cycle-related 
antigen Ki67 is detectable in cells from late G1 through to M-phase but not in early 
G1, whereas the mini-chromosome maintenance protein-2 (Mcm-2) is expressed at 
all stages of the cycle.  Geha et al. (2010) found that cycling cells identified by either 
Ki67 or Mcm-2 in the cortical grey or white matter all co-expressed NG2 and 
OLIG2.  However, Mcm-2+ cells outnumbered Ki67+ cells ~3-fold, consistent with 
a long cell cycle and an extended G1.  In my own studies, only 29% of PDGFRα+ 
cells co-labelled with Ki67 (less than the ~75% that could be labelled by EdU), 
which also suggests that many of the cycling PDGFRα+ cells were in early G1. 
 
Taking into consideration previous reports that all embryonic OLPs are proliferating 
and our data that indicate that ~75% of OLPs proliferate in adulthood while 25% 
remain quiescent, it is understood that there should be a switch in the OLP cycling 
behaviour that occurs sometime between E13 and P60.  Work by Kukley et al. 
(2008) combined BrdU labelling and PCNA immunohistochemistry and placed the 
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growth fraction of OLPs in P7 mice at ~50% (Kukley et al, 2008).  In contrast to our 
initial BrdU study that shows the GF of OLPs in the P6 brain to be ~55%, EdU 
studies carried out by Kaylene Young in the Richardson laboratory indicate that 
>90% of OLPs can be labelled by EdU injections between P4 and P9 (unpublished).  
Thus, it seems likely that the mitotically quiescent population of OLPs forms during 
the first ~2 weeks of postnatal life. 
 
Mitotically active cells can be labelled in vivo and in vitro using a variety of 
methods.  Though different in their application, BrdU, EdU, Ki67 and PCNA are the 
most commonly used methods.  PCNA expression increases in late G1, peaks in S 
phase and remains high during G2 and M phase (Bravo et al., 1987).  Due to its long 
half life, some non-degraded protein still remains in cells that have recently left the 
cell cycle (Bravo et al., 1987).  The two patterns of immunostaining for PCNA 
described to date reflect this; nuclei of cells in the S phase of the cell cycle are 
stained strongly while nuclei of cells in other cell cycles phases are stained weakly.  
Another marker used to identify cells that are mitotically active is Ki67.  Ki67 
distinguishes highly proliferative cells (G1, S and G2 phases) from cells in remission 
(Bacus et al., 1989; Gaglia et al., 1993).  Due to its short half life which is 
approximately 1 h, it is rarely detectable in resting cells (G0), a fact that can provide 
a reliable means of evaluating growth fraction (Gerdes et al., 1984; Gerdes et al., 
1991; du et al., 1991).  Overestimation of the growth fraction is more likely with 
PCNA than with Ki67 analysis, due to the involvement of PCNA in DNA repair 
(Bravo and McDonald-Bravo 1987; Toschi and Bravo 1988) and to its presence in 
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early G0 due to its relatively long half-life of 8-20 h (Scott et al., 1991; Bruno and 
Darzynkiewicz 1992). 
 
Staining for BrdU required an antigen retrieval protocol to allow the anti-BrdU 
antibody access to the DNA strand (2.8.5).  There are several BrdU treatment 
protocols available that differ in terms of the acid concentration used, ranging from 
2M to 6M HCl, and the duration and the temperature of the acid treatment.  For my 
study, BrdU+ cells were scored as positive only when the fluorescence signal clearly 
delineated the whole nucleus (though not necessarily uniformly).  This however 
might exclude cells that had just entered S phase during the BrdU labelling period, or 
exited from S→G2 early during BrdU exposure.  Therefore, my criteria for scoring 
BrdU positive cells might have tended to under-estimate GF.  This seems all the 
more likely since repeating the cumulative label experiments with EdU rather than 
BrdU gave consistently higher GFs (~75% rather than ~50%).  The signal intensity 
and signal-to-noise with EdU was higher than with BrdU, rendering the labelling 
procedure less prone to false negatives.  I, therefore, put more faith in the higher EdU 
estimates of GF.  
 
Although the growth fraction estimates increased, the main conclusions of my 
cumulative labelling experiments remained.  Firstly, there are two distinct 
populations of OLPs in the adult mouse brain, one that is mitotically active and one 
that is not (75% : 25% respectively).  Secondly, there is significant slowing of the 
OLP cell cycle with postnatal age.  Thirdly, the OLP cell cycle length can differ 
between brain regions e.g. grey versus white matter. 
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The discovery of two different categories of NG2 cells and the demonstration that the 
mitotically active cells function as oligodendrocyte precursors raises the question of 
what is the function of the non-dividing NG2 cells?   Two categories of NG2 cells in 
the P7 cerebellar white matter have been identified on the basis of their electrical 
properties; one class expresses voltage-gated sodium and potassium channels and can 
fire action potentials in response to a depolarizing stimulus whereas the other class 
does not express voltage-gated channels and displays a linear voltage-current 
relationship (Karadottir et al., 2008).  These two types of OLPs were also identified 
in the corpus callosum (Karadottir et al., 2008).  These two electrophysiological 
subtypes of OLPs are present in approximately equal proportions.  It has been 
reported that mitotically active NG2 cells form morphological synapses with axons 
and maintain those synapses during and after mitosis (Kukley et al., 2008; Ge et al., 
2009), suggesting that the electrically active sub-class of Karadottir et al. (2008) 
might correspond to our dividing sub-population.  This hypothesis is now being 
directly investigated and the electrically active and dividing OLPs do appear to 
correlate (Clarke et al., manuscript in preparation). 
 
It is possible that during perinatal development all newly-generated OLPs attach to 
unmyelinated axons, some of which fire action potentials and deliver a mitogenic 
signal to the associated OLP.  These OLPs consequently divide, renewing themselves 
and producing myelinating oligodendrocytes.  The other OLPs are associated with 
axons that never fire, or do not fire above a sufficient threshold, so these cells are 
destined to remain mitotically inactive (Fig. 4.16).   They might also lose their 
expression of voltage-gated ion channels, rendering them electrically passive.   It is  
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Figure 4.16 The birth and behaviour of OLPs.  From the data presented here, we conclude 
that forebrain OLPs are initially derived from embryonic VZ stem cells located in both the 
dorsal (cortical) and ventral (LGE/MGE) telencephalon.  Their embryonic origin does not 
have any bearing on their mitotic activity as adult OLPs.  A population of post-mitotic OLPs, 
comprising approximately half of all OLPs, is born some time before the end of the first 
postnatal week and persists throughout life.  The function of these cells is unknown.  The 
other half of the OLP population remains in cycle throughout life, although their cell cycle 
length increases with age (e.g. from ~2 days at P4-7, to ~70 days at 8 months and >150 days 
at 18 months in the cortex).  One major function of the proliferating OLPs is to generate new 
oligodendrocytes throughout life.  However, the rate of oligodendrogenesis progressively 
slows with age, roughly in parallel with the slowing cell cycle. (Figure drawn by Kaylene M. 
Young) 
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possible that they contribute in some other way to the neuronal circuitry – for 
example they might perform some essential homeostatic function at nodes of Ranvier 
or at neuron-neuron synapses (Butt et al., 2002). 
 
Are the non-dividing cells permanently post-mitotic, or can they ever re-enter the cell 
cycle?  It seems very likely that they never divide under normal conditions because, 
once the labelling plateau was reached, there was no sign of any further increase 
even after a very long labelling period.  For example, at P60 the EdU labelling index 
in the corpus callosum reached 75% after ~8 days (~20 days in cortex) but did not 
increase further than that even after 50 days of continuous EdU exposure (until 
P110).  Kukley et al. (2008) also demonstrates a major functional sub-division in the 
NG2+/PDGFRα+ OLP population, suggesting heterogeneity based on the mitotic 
activity of OLPs.  By immunolabelling for the proliferating cell nuclear antigen 
(PCNA), Kukley et al. (2008) show that the growth fraction of P7-P12 mouse 
hippocampal OLPs is also close to 50% (Kukley et al., 2008).  Moreover, Keirstead 
et al. (1998) found that ~50% of OLPs in the adult rat spinal cord were resistant to 
killing by X-irradiation, suggesting that they were dividing very slowly or not at all. 
 
OLPs have been suggested to fall into two (or more) categories on the basis of a 
range of criteria.  These include: 1) cell morphology, in white matter there are 
bipolar and multipolar NG2+ cells (Lytle et al., 2009); 2) their immunohistochemical 
profile, a small proportion of NG2+/PDGFRα+ cells have been demonstrated to co-
express markers such as s100beta (Rivers et al., 2008; Lytle et al., 2009) and nestin 
(Lytle et al., 2009); 3) their electrophysiological properties, white and grey matter 
oligodendrocyte progenitor cells have been reported to differ in their K+ and Na+ 
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channel expression profiles (Chittajallu et al., 2004); 4) their embryonic origins, with 
all major forebrain regions containing OLPs derived from the embryonic cortical and 
striatal VZs (Kessaris et al., 2006); 5) proliferative status (Kukley et al., 2008; Rivers 
et al., 2008; Psachoulia et al., 2009; this Thesis).  Both proliferative activity and 
embryonic origin split the OLP population in two.  It is evident from my studies that 
the dividing and non-dividing OLPs do not correspond directly to ventrally- or 
dorsally-derived OLPs in the forebrain at least.  It will be interesting and important to 
discover how the different OLP populations arise and what their functional 
specializations are, if any. 
 
Whether the non-dividing NG2 cells are intrinsically incapable of division or else are 
segregated into a different environmental compartment than their dividing 
counterparts is another question.  This might be answered by culturing dissociated 
cells in saturating concentrations of mitogens (e.g. PDGF), which would be expected 
to override environmental regulation.  PDGF is a potent mitogenic stimulant for 
OLPs (Richardson et al., 1988; Pringle et al., 1989; Wolswijk et al., 1991; Noble et 
al, 1998) and increasing the supply of PDGF in vivo (van Heyningen et al., 2001) 
and in vitro (van Heyningen et al., 2001; Wolswijk et al., 1991; Wolswijk and Noble, 
1992; Baron et al., 2002) can increase the proliferation rate and reduce cell cycle 
length.  For example, Van Heyningen et al. (2001) previously showed that the cell 
cycle time of OLPs in the embryonic mouse spinal cord increases from ~30 hours to 
70-100 hours between E13 and E17, but that both E13 and E17 cells can accelerate 
their cycle to ~20 hours when cultured in medium containing saturating PDGF-AA.  
This demonstrated that slowing of the OLP cell cycle during late embryogenesis 
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results from a change in their mitogenic environment, not a shift in the intrinsic 
properties of the cells (van Heyningen et al., 2001).  Similarly, in the presence of 
PDGF adult OLPs take ~60hrs to divide (Wolswijk et al., 1991).  This cell cycle time 
can be reduced to ~30hrs, more similar to embryonic OLPs, by co-stimulating with 
FGF2 (Wolswijk and Noble, 1992).  FGF2 is a mitogen for neural stem cells, as well 
as OLPs, and these cells have also been reported to senesce in ageing (Jin et al., 
2003; Kuhn et al., 1996; Tropepe et al., 1997; Fiore et al., 2002; Maslov et al., 
2004).  In vivo neural stem cells in the aged brain are able to respond to 
intraventricularly administered EGF and bFGF by increasing their proliferation and 
exhibiting up to a 450% increase in BrdU incorporation (Jin et al., 2003).  This 
suggests that proliferative cells in the CNS, including OLPs, maybe slowing down 
with ageing, due to limitations or changes in the availability of mitogens.  This could 
imply that exogenous administration of mitogens might be able to rescue the 
diminished proliferative properties of these cells. 
 
It is likely that PDGF acts in concert with other mitogenic factors including electrical 
stimulation; there is evidence that proliferation of OLPs in the perinatal rat optic 
nerve depends on the electrical activity of retinal ganglion cell axons, one effect of 
which might be to stimulate release of PDGF from astrocytes within the nerve 
(Barres and Raff, 1993).  The fact that NG2 cells receive synaptic input from axons, 
together with previous evidence that the neurotransmitter glutamate can inhibit  
proliferation and differentiation of OLPs in culture suggests that neurotransmitter 
release at axon-glial synapses might directly or indirectly influence the OLP cycle 
and the myelination program.   
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The dividing population of OLPs in white matter tracts generates new myelinating 
oligodendrocytes.  Since the number of OLPs stays relatively constant during the 
first year (Rivers et al., 2008), it follows that half of the daughters of cell divisions 
must either differentiate or die.  For example, at P45 the cell cycle time in the corpus 
callosum is ~7.3 days (extrapolating from the data in Fig. 4.7 and 4.13), so it will 
take ~14.5 days (two cell cycles) for the OLPs that are dividing to generate a number 
of differentiated cells equal to the starting population of OLPs.  Put another way, the 
fraction of YFP+ cells that is differentiated (therefore PDGFRα-negative) 14.5 days 
after administering tamoxifen to P45 Pdgfra-CreER
T2
/R26YFP mice is predicted to 
be 50%.  At 14 days post-tamoxifen the predicted fraction is ~49% 
[(14/14.5)  {1+(14/14.5)}].  It was found experimentally that 45% of YFP+ cells 
were PDGFRα-negative at P45+14 days post-tamoxifen, which is close to 
expectation, so it appears that there is rather little death of newly differentiated cells 
in the 14 days after P45 (Fig. 4.17).  
 
By applying a similar calculation for P240 (TC ≈125 days), it is predicted that at 100 
days post-tamoxifen ~40% of YFP+ cells should be PDGFRα-negative.  The 
observed value in this case was only 18%, suggesting that less than half of the 
differentiated progeny of OLPs survive long-term between P240 and P340.  
Nevertheless, the rate of oligodendrocyte production in the corpus callosum depends 
on the rate of OLP cell division.  The cell cycle slows down ~10-fold between P45 
and P240 and the rate of oligodendrocyte production slows ~20-fold in the same 
period (Fig. 4.17).  A similar relationship between cell cycle and oligodendrogenesis 
applies to the cortex, although both cell division and production of YFP+/PDGFRα- 
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 Figure 4.17 OL production declines in parallel with increasing NG2 glia cell cycle.  
Tamoxifen was administered to Pdgfra-CreERT2/R26YFP transgenic mice at P45 (L. E. 
Rivers) and P240 (K. Psachoulia).  Brain sections were examined at various time-points 
post-tamoxifen administration. By plotting the proportion of YFP+ cells that no longer 
express PDGFRα, it was possible to compare oligodendrocyte production in the CC and Ctx 
in young and middle-aged mice. (P45 data adapted from Rivers et al., 2008). 
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negative cells are slower in the cortex than in the corpus callosum at most ages.  It is 
important to note, however, that although oligodendroglial production at P45 is 
slower in the cortex than in the corpus callosum, this difference is diminished by 
P240, when the rate of oligodendrocyte production becomes similar for the two brain 
regions (Fig. 4.17).  This comes into agreement with cell cycle length when looking 
at the same brain regions from mice of similar ages.  At P60, the cell cycle length of 
NG2 cells in the corpus callosum is 3-times faster compared to the cortex, while at 
P240 the cell cycle is the same for both brain regions.  These comparisons further 
raise confidence in the reliability of my data.  My present estimates of cell cycle time 
(~73 days) in older (8 month old) mice are also compatible with long term retroviral 
tracing experiments that indicate an oligodendroglial cell doubling time in the 3-8 
month old rat cortex of around three months (Levison et al., 1999).  An age-related 
increase in the cell cycle of OLPs in the mouse spinal cord was also noted by Lasiene 
et al. (2009).  These authors also observed that the OLP cell cycle started to speed up 
again in aged mice (21 months of age) but I did not observe this phenomenon in the 
forebrain of 18 month old animals. 
 
The age-related reduction in the proliferative rate of OLPs and the corresponding 
reduction in the rate of production of new oligodendrocytes could play an important 
role in the ageing process.  For example, it is becoming clear that white matter 
volume starts to decline in humans after the fourth decade of life and that this white 
matter loss correlates with general deterioration of cognitive and motor ability.  A 
recent study on rhesus monkeys came to similar conclusions (Bowley et al., 2010).  
Even though there is evidence of remyelination in the aged brain and spinal cord 
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(Lasiene et al., 2009; Bowley et al., 2010), it could be that myelinating 
oligodendrocytes have a finite lifetime and, beyond this, the rate of new 
oligodendrocyte production cannot keep pace with accelerating oligodendrocyte loss.  
If so, finding ways to maintain NG2 cells in a more proliferation-competent state or 
promote the survival of newly formed oligodendrocytes might help maintain white 
matter integrity and slow down age-related mental decline.   
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Chapter 5 
„The regulation and function of life-long 
oligodendrogenesis‟ 
 
 
5.1  Introduction 
In Chapters 3 and 4 I presented data showing that adult OLPs proliferate and 
differentiate to form myelinating oligodendrocytes throughout life.  This observation 
raises questions about the function of this ongoing oligodendrogenesis.  It has been 
reported that only 28% of corpus callosal axons are myelinated in mice, even by 
eight months of age (Sturrock, 1980).  This suggests that capacity remains for further 
myelination of axons across the lifespan.  Therefore, new adult born 
oligodendrocytes may be myelinating previously un-myelinated axons.  If this were 
true, it could represent an added and previously unexpected level of neural plasticity, 
perhaps with a role in some form(s) of learning and memory. 
 
In Chapter 3 I demonstrated that voluntary exercise, on a running wheel, increases 
oligodendrocyte production in the corpus callosum of adult mice.  It is interesting to 
speculate that these oligodendrocytes may be myelinating naked callosal axons 
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involved in the acquisition of this new motor task.  The idea of activity dependent 
myelination is supported by reports that extensive piano practise during childhood 
can cause long-term changes to the structure of white matter tracts, including parts of 
the corpus callosum (Bengtsson et al., 2005).  Another study that used diffusion 
tensor imaging to look at professional musicians who started their musical training 
before or after the age of 7 years found enlarged anterior callosa in the early onset 
group compared to the late onset and control group, suggesting that white matter 
might be more receptive to the influence of sensorimotor training at younger age 
(Imfeld et al., 2009).  However, changes in the white matter architecture of adults 
have also been reported.  Scholz et al. (2009) showed (using diffusion tensor 
imaging) that juggling training resulted in a significant increase in white matter 
density in the right posterior intraparietal sulcus (Scholz et al., 2009).  The 
differences observed between controls and jugglers correlated with the time of 
training rather than the training outcome, i.e. juggling proficiency (Scholz et al., 
2009).   
 
In addition to changes in white matter, juggling induced detectable changes in the 
grey matter density in the medial occipital and parietal lobe cortical regions (Scholz 
et al., 2009).  However, these changes were not detected using T1-weighted MRI 
scans (Driemeyer et al., 2008), which may not be surprising given that diffusion 
tensor imaging is a more sensitive method for the detection of non-volume related 
changes, such as synaptic and dendritic changes.   
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Supporting these human MRI studies, when adult Japanese macaques were trained to 
use tools and monitored by MRI and voxel-based morphometry, white matter 
changes were observed in the cerebellar white matter beneath lobule 5 in both 
hemispheres (Quallo et al., 2009).  In relation to this, it is important to find out 
whether the cerebellar output axons are myelinated, as in the optic nerve, or not, as in 
the corpus callosum.  This could impact on how to interpret the cerebellar white 
matter changes.  Grey matter changes were also recorded in the right superior 
temporal sulcus, the intraparietal sulcus and the anterior intraparietal area (Quallo et 
al., 2009).  These two regions that showed significant volume changes, correspond to 
the areas of the human brain that fMRI studies indicate become activated by tool use 
(Quallo et al., 2009). 
 
These changes in brain architecture with training do not appear to be limited to the 
young.  It is known that cognitive ability and white matter volume increase in 
parallel until the fourth decade of life, when they start to decline (Bartzokis et al., 
2001; Mabbott et al., 2006; Hasan et al., 2008; Ullen et al., 2008; Bartzokis et al., 
2008; Zahr et al., 2009).  However, there is evidence supporting the existence of 
some brain plasticity in old age.  When a group of elderly (~60 years old) volunteers 
was trained in juggling, their performance was poorer than that of young adults (~20 
years old), trained for a similar period.  However, the structural changes observed 
(using T1-weighted MRI and VBM) were similar with the addition of grey matter 
changes in the hippocampus and the nucleus accumbens (Boyke et al., 2008).  These 
data suggest that age does not preclude structural plasticity, but might reduce it. 
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There are now many MRI, VBM and diffusion imaging correlations between activity 
and white matter changes, but it has not been clearly demonstrated whether these 
white matter changes correspond to altered myelination or oligodendrogenesis.  
Furthermore, the necessity of this plasticity and the function of adult 
oligodendrogenesis have not yet been addressed.  To begin answering these 
questions requires a different experimental approach in an animal model.  To this 
end, we have embarked on a line of experimentation in mice that necessitates the 
generation of certain genetically manipulated mice.  One such line of transgenic mice 
should allow the labelling and conditional ablation of adult-born mature myelinating 
oligodendrocytes.  For this, it was necessary to identify a gene that could be used to 
restrict expression of transgenes to mature myelinating oligodendrocytes.  Potential 
candidates included MAG, MBP, PLP and Opalin but these genes were excluded as 
they were either expressed by Schwann cells in the peripheral nervous system (PNS) 
or were expressed too early in the oligodendroglial cell maturation process (Dubois-
Dalcq et al., 1986; Kippert et al., 2008; Fulton et al., 2009). 
 
Ermin is a gene that was identified as being exclusively expressed by postnatal 
oligodendrocytes in the mouse and rat brain and spinal cord (Brockschnieder et al., 
2006; Zhang et al., 2005). Ermin consists of 3 exons spanning a region of 7.7 kb on 
mouse chromosome 2 (Fig. 5.1, 5.3).  The amino acid sequence of Ermin has some 
similarity to the ERM (erzin, radixin, moesin) proteins, which are widely distributed 
membrane-associated proteins that regulate the structure and function of specific 
domains of the cell cortex, and Ermin is therefore regarded as a distant member of 
this protein family (Bretscher et al., 2002; Ramesh et al., 2004). 
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Within oligodendrocytes, the Ermin protein is found in the cell bodies, processes and 
along the myelinating fibres (Brockschnieder et al., 2006).  Ermin is found in the 
abaxonal, cytoplasmic pocket of the myelin sheath and around the internodes but is 
undetectable in compact myelin. It is involved in cytoskeletal rearrangements, 
supporting a role for F-actin in regulating the dynamic morphology of 
oligodendrocytes during myelination (Brockschnieder et al., 2006).  The role of 
Ermin is to regulate cytoskeletal changes at the end of the wrapping and/or 
compaction phases of myelin assembly, as well as to maintain and stabilize the 
myelin sheath in the adult (Brockschnieder et al., 2006).  As such, ermin is expressed 
along white matter tracks in the brain and spinal cord, including the corpus callosum, 
medulla and cerebellum (Brockschnieder et al., 2006).  In mice, ermin expression is 
completely absent for the first postnatal week.  Its expression emerges around P8 and 
increases dramatically until P14 (Brockschnieder et al., 2006), a period when 
oligodendrocytes are actively myelinating axons in the CNS (Jordan et al., 1989).  
Ermin expression is always confined to MBP-expressing oligodendrocytes and is not 
present in myelinating Schwann cells of the PNS (Brockschnieder et al., 2006).  In 
summary, Ermin is a protein that is restricted to myelinating oligodendrocytes of the 
CNS, making the ermin promoter an excellent candidate for targeting the expression 
of a transgene that will allow the labelling and conditional ablation of mature 
myelinating oligodendrocytes. 
 
This chapter describes the generation and characterization of the 
ErminΔdsred·STOPΔDTR·Ires·Venus BAC transgenic mouse, which will be used to 
investigate the generation and function of adult oligodendrogenesis. 
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5.2  Results 
 
5.2.1  Selecting BAC clones 
Three bacterial artifical chromosomes (BACs) that contained the Ermin gene were 
selected from the published mouse genomic database (www.ensemble.org; Fig. 5.1).  
The BAC clones chosen covered a large region of DNA flanking the gene, to ensure 
the greatest likelihood of having all of the regulatory elements that control the 
faithful expression of ermin, which will ultimately control the appropriate expression 
of the transgene. 
 
To ensure the BAC clones obtained contained the expected DNA sequence, the DNA 
was amplified, extracted, digested with the restriction enzymes PacI or PmeI (sites 
internal to the genomic region contained in the BAC) and analysed by PFGE as 
described in 2.3.2.  All of the clones analysed produced the expected pattern of DNA 
fragments (data not shown). RP23-384J16 covered the largest genomic region 
compared to RP23-260D20 and RP23-370M17.  Therefore, RP23-384J16 (hereafter 
referred to as the Ermin BAC) was selected and used in all subsequent work for the 
generation of the ErminΔdsred·STOPΔDTR·Ires·Venus transgenic mouse. 
 
Ermin BAC DNA (circular) was electroporated into EL250 cells.  Of the bacterial 
colonies that formed, ~12 were selected and grown as mini-prep cultures as 
described in 2.1.1.  DNA was purified from each mini-culture and again digested 
with either PacI or PmeI.  Incorporation of the correct Ermin BAC DNA into the 
EL250 bacteria cells was confirmed by PFGE (Fig. 5.2). 
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Figure 5.1 (a) Schematic of mouse chromosome 2 with a higher magnification of the region 
containing the ermin gene (adapted from: http://www.ensembl.org).  The three BACs 
initially selected are shown in blue.  The yellow-highlighted BAC was ultimately selected to 
generate the ErminΔdsredSTOPΔDTRIresVENUS transgenic mouse. 
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Figure 5.2 PFGE analysis of BAC DNA digested with PacI and PmeI.  BAC DNA was 
obtained from clones grown following electroporation of the Ermin BAC DNA into EL250 
cells.  Clones 1-8 represent bacteria that underwent correct transformation, while clone 9 
did not. 
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Digesting the BAC DNA with PacI should yield fragments of 83,279, 19,028, 
16,071, 11,836, 10,362, 9,471, 7,531, 4,530, 3,994, 2,686 and 2,206 base pairs.  By 
comparison, digesting with PmeI should produce DNA fragments of 121,554, 40,859 
and 8,581 base pairs.  DNA obtained from clones 1-8 produced the expected digest 
pattern.  Clone 4 was selected for further work. 
 
5.2.2  Construction of the targeting vector 
Manipulation of the ermin coding sequence through homologous recombination in 
bacteria required the generation of a targeting vector. The targeting vector was 
designed by Ian McKenzie to contain 5 major elements: the fluorescent protein 
DsRed and a stop sequence (this will stop the transcription of the sequences located 
downstream) located between two loxp sites, the human form of the diphtheria toxin 
receptor (Saito et al., 2001), the fluorescent protein Venus (Nagai et al., 2002) and 
the 5‟ and 3‟ sequences that are homologous to the ermin gene (Fig. 5.3). 
 
The first fluorescent protein, DsRed, is a recently cloned 28-kDa fluorescent protein 
responsible for the red colouration around the oral disk of a coral of the Discosoma 
genus (Matz et al., 1999). It has a high extinction coefficient and quantum yield, plus 
excellent resistance to pH extremes and photobleaching (Baird et al., 2000).  
However, DsRed has major drawbacks, such as strong oligomerization and slow 
maturation (Baird et al., 2000).  The second fluorescent protein, Venus, is an 
improved version of YFP (Nagai et al., 2002).  It contains a novel mutation, F46L, 
which at 37°C greatly accelerates oxidation of the chromophore, the rate-limiting 
step of maturation.  As a result of other mutations, F64L/M153T/V163A/S175G,  
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Figure 5.3 Schematic depicting the position at the beginning of exon I in the ermin gene 
where the targeting vector will be inserted following homologous recombination. 
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Venus folds well and is relatively tolerant of exposure to acidosis and Cl– (Nagai et 
al., 2002).  DsRed and Venus should therefore allow robust fluorescent labeling of 
targeted cells.  However, the DsRed and stop sequences are located between 2 loxP 
sites (Fig. 5.3), and the loxP sites must be recombined and the intermediate sequence 
removed in order for Venus (and the DTR) expression to be turned on.  Therefore the 
two fluorescent proteins will never be co-expressed by the same cell. 
 
Expression of the human form of DTR selectively renders the targeted cells 
susceptible to death by controlled administration of diphtheria toxin (DT) (Cha et al., 
2003; Buch et al., 2005; Chen et al., 2005).  Mice are naturally resistant to the effects 
of DT as their endogenous DTR contains a mutation that renders it incapable of 
internalizing the toxin (Saito et al., 2001).  In order to ensure that DsRed (and 
following recombination), DTR and Venus are only ever expressed by mature 
myelinating oligodendrocytes, the targeting vector was inserted into the chosen BAC 
by homologous recombination, directing insertion to exon 1 of the Ermin gene due to 
the presence of the flanking 5‟ and 3‟ homologies and deleting the endogenous ATG 
and most of the coding region of exon 1 (Fig. 5.4).  The 5‟ untranslated region 
(UTR) was left largely untouched, as was intron 1 in the event that regulatory 
elements are present within these regions (Fig. 5.4). 
 
The targeting vector was generated by a series of cloning and ligation steps (2.5.1.2 
and 2.5.1.3; Fig. 5.4).  The first step resulted in DsRed, a nuclear localization signal 
(NLS) and the STOP sequence being ligated between the two loxP sequences (Fig. 
5.4a).  Initially, DsRed2 was amplified by PCR from pIRES-DsRed2 (Clontech), 
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adding XbaI and XhoI to the 5‟ and 3‟ flanks respectively (forward primer, 5‟-TCT 
AGA TAA TAT TGG CCA CAA CCA TGG CCT CC-3‟; reverse primer, 5‟-CTC 
GAG CCC CAG GAA CAG GTG GTG GCG GC-3‟).  This PCR product was 
isolated and cloned directly into pCRII-TOPO® and sequenced as described in 2.1.3 
and 2.3.4 respectively.  DNA from bacteria containing the vector was isolated and 
digested with XbaI and XhoI to excise the Dsred sequence.  The NLS was annealed 
from complementary oligonucleotides by gradual cooling from 95ºC for 1 hour: 
NLStop (5‟-TCG AGC CTA AGA AGA AAC GGA AGG TTG AAG ATC CTT 
AGC TGC A-3‟) and NLSbot (GCT AAG GAT CTT CAA CCT TCC GTT TCT 
TCT TAG GC-3‟), leaving an XhoI 5‟-overhang and a PstI 3‟-overhang.  3xPolyA (3 
consecutive polyadenylation sequences) was excised from the Sox10GFPDTA 
construct (Kessaris et al., 2006) by digesting with PstI and SpeI.  The vector 
containing the two required loxP sites (pLoxP2) was opened by digesting with XbaI 
and SpeI. The 4 purified DNA fragments were ligated together to produce 
ΔDsRed2·nls-STOPΔ (Fig 5.4a). 
 
The second step added the DTR·IRES-Venus to the end of the ΔDsRed2-NLS-STOPΔ.  
The pblueIRES·Venus vector was opened by digesting with BamHI and NotI.  DTR 
was excised from DTR-TOPO by digesting with BamHI and MfeI (compatible sticky 
ends with EcoRI).  ΔDsRed2·nls-STOPΔ was excised by digesting with NotI and 
EcoRI (Fig 5.4b). 
 
The third step added another STOP sequence and a Kanamycin resistance cassette to 
the construct.  ΔDsRed2·nls-STOPΔDTR·IRES·Venus, was opened by digesting the 3‟  
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Figure 5.4a Construction of the Ermin-DTR targeting vector. The first step in construction 
was a 4-way ligation step combining the 280bp nls, the 707bp DsRed from pIRES-DsRed2, 
the 136bp pLoxP2 and the 3xPolyA from Sox10GFPDTA to make DsRed·nls-
3xPolyApLoxP2 
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Figure 5.4b Construction of the Ermin-DTR targeting vector. The second step in 
construction was a triple ligation step combining 1576bp DsRed·nls-3xPolyApLoxP2 
produced from the previous ligation, the 4257bp pblueIRESVenus and the 683bp DTR from 
the DTR-TOPO to make pblueIRESVenusDsRed·nls-3xPolyApLoxP2DTR 
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of the Venus sequence ClaI, blunting with T4 DNA Polymerase and further digesting 
with EcoRV.  The polyAfrt-Kan-frt cassette was removed from the vector backbone 
by digesting with SpeI, blunting with T4 DNA Polymerase and further digesting with 
EcoRV as described in 2.5.1.3.  The resulting DNA fragments were ligated to 
produce ΔDsRed2·nls-STOPΔ DTR·IRES·Venus- polyA·frt-Kan-frt (Fig. 5.4c). 
 
The final step involved the addition of the Ermin homology regions at either end of 
the construct, and the insertion of the construct into the ΔpBluePacAsc vector.  For 
the final ligation, the 5‟ homology region was amplified by PCR from purified Ermin 
BAC DNA, adding PacI and NotI sites to the flanks (forward primer, 5‟- TTA ATT 
AAG CTT CCT GAG AGC ACA CTA TG-3‟; reverse primer, 5‟-GCG GCC GCC 
TGA GGT CTG ATT TAA GGA CGC-3‟).  This PCR product was isolated and 
cloned directly into pCRII-TOPO® to make 5‟ Hom.  The 3‟ homology region was 
also amplified by PCR from purified Ermin BAC DNA, adding AscI and SalI sites to 
the flanks (forward primer, 5‟-GTC GAC GCC TGA AGA TGA GAA GAT CCT 
CA-3‟; reverse primer, 5‟-GGC GCG CCG GGA GAA ACA CAA GCA CTG TAA 
C-3‟).  The PCR product was isolated and cloned into pCRII-TOPO® to make 3‟ 
Hom. Both 5‟ Hom and 3‟ Hom were fully sequenced to ensure that their sequences 
were correct.  To create the final targeting vector ΔDsRed2·NLS-
STOPΔDTR·IRES·VenusSTOP·frt-Kan-frt was excised from pbluescript by digesting 
the purified DNA with NotI and SalI.  The pBluePacAsc vector was constructed by 
modifying the multiple cloning site of pBluescript to add PacI and AcsI restriction 
sites (gift from N. Kessaris and M. Grist).  pBluePacAsc vector DNA was cut with 
PacI and AscI and then ligated with the purified 5‟ Hom, 3‟ Hom and ΔDsRed2·NLS- 
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Figure 5.4c Construction of the Ermin-DTR targeting vector. The third step in construction 
was a double ligation step combining 6484bp pblueIRESVenusDsRed·nls-
3xPolyApLoxP2DTR produced from the previous ligation and the 1807bp Kan R to make 
KanRpblueIRESVenusDsRed·nls-3xPolyApLoxP2DTR.  
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STOPΔDTR·IRES·VenusSTOP·frt-Kan-frt to make the final targeting vector (Fig 
5.4d). 
 
All cloning steps were verified by digesting DNA from transformed bacteria using 
restriction enzymes followed by gel electrophoresis.  When the targeting vector was 
complete, it was linearized from the vector backbone by digesting with the restriction 
enzymes PacI and AscI, purified and electroporated into EL250 bacteria containing 
the modified Ermin BAC. 
 
5.2.3  BAC modification 
The BAC vector (pBACe3.6; Fig. 5.5a) contains an SV40 and a CMV promoter as 
well as a loxP site which might interfere with some downstream applications of the 
gene of interest.  Therefore the mouse genomic fragment with the transgene must 
first be isolated before microinjection.  As the final recombined Ermin BAC DNA 
sequence contains internal NotI, EcoRI and BamHI sites, it cannot be from the BAC 
vector using its existing cloning sites.  For that reason, homologous recombination 
was first carried out in EL250 bacteria containing the Ermin BAC, in order to replace 
a 2618bp region from pBACe3.6 with an ampicillin selection cassette and an 
additional PISceI restriction enzyme site.  The targeting vector for this step 
(pPISceAmp; Fig. 5.5b) was a gift from N. Kessaris and P. Iannarelli.  
Recombination was carried out according to the protocol outlined in Chapter 2.  
Ampicillin resistant colonies were verified to contain the modified Ermin BAC by 
restriction enzyme digestion of the BAC DNA with PacI and PmeI (Fig. 5.6).                   
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Figure 5.4d Construction of the Ermin-DTR targeting vector. The final step in construction 
was a 4-way ligation step combining the 2878bp pBluePacAsc, the 646bp ermin 5’ Hom, the 
664bp ermin 3’ Hom and the 5301bp KanRpblueIRESVenusDsRed·nls-3xPolyApLoxP2DTR 
fragments produced from the previous ligation to make the targeting vector. 
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Figure 5.5 Schematic depicting the pBACe3.6 vector, into which the genomic BAC insert 
was cloned between the two EcoRI sites removing the intervening 2618bp (a). The orange 
arrows show the antibiotic resistant sites, the green arrow the region that the gene of 
interest is inserted and the small red arrows the sites that the T7 and Sp6 primers cut for 
genotyping purposes (a). Recombination with the targeting vector pPISeAmp introduced an 
ampicillin resistance cassette (red arrow) to the BAC insert (b). The restriction sites are also 
indicated around the periphery (a, b). 
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The second BAC modification inserted the final targeting vector.  Part of the coding 
region of exon I in the Ermin gene was replaced with the linearized targeting vector 
(Fig. 5.6).  Homologous recombination in bacteria was carried out as described in 
2.5.2.1 and bacteria containing the recombined DNA sequence had acquired 
Kanamycin resistance.  Next, the kanamycin resistance cassette was removed from 
the recombined clones by transient induction of flpe in EL250 cells using arabinose 
as described in 2.5.2.1.  The final recombined Ermin BAC DNA product was found 
to be correct by PFGE following restriction enzyme digestion again with PmeI (Fig. 
5.7). 
 
5.2.4  Generation of ErminΔdsred·STOPΔDTR·IRES·VENUS-STOP (Ermin-
DTR) transgenic mice 
 
5.2.4.1  Introduction of the recombinant BAC DNA into mouse ova 
The modified Ermin-DTR BAC clone was liberated from the vector backbone with 
pISceI and purified by PFGE as described in 2.6.1.  Purified Ermin-DTR BAC DNA 
was quantified by PFGE (Fig. 5.8) as per section 2.6.1 and injected into fertilized 
mouse ova at a concentration of around 200ng/µl. All pronuclear injections were 
carried out by U. Dennehy as described in 2.6.2. 
 
5.2.5  Characterising the expression of the Ermin∆dsred-STOP∆DTR-IRES-
Venus-STOP transgene in each founder line 
Three rounds of micro-injection generated 7 Ermin-DTR transgenic mice, as 
determined by successful PCR amplification of the Venus sequence from genomic  
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Figure 5.6 PFGE analysis of DNA Ermin BAC following the 2 recombination events: first 
to remove unwanted sequences from the pBACe3.6 vector backbone and insertion of an 
ampicillin resistance cassette, and second to insert the targeting vector. The DNA was 
digested with PacI and PmeI. 
 
 
 
Figure 5.7 PFGE analysis of Ermin BAC DNA following arabinose treatment to remove the 
kanamycin resistance cassette. The DNA was digested PmeI. All 6 clones selected were 
correct. 
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Figure 5.8 Ermin BAC DNA linearization and purification.  (a) 90% and 10% of Ermin 
BAC DNA were subjected to PFGE.  The DNA required for microinjection and the vector 
DNA (red arrows) were excised from the gel prior to ethidium bromide staining.  (b) The 
Ermin BAC DNA and the vector DNA were run on 4% (w/v) LMP agarose gel.  The BAC 
DNA insert band was cut away from the gel (red arrow), which was then stained with 
ethidium bromide.  (c) Following dialysis, 1µl, 5µl and 10µl of the Ermin BAC DNA was 
subjected to PFGE along with a quantity of BSX-iCre BAC DNA that has previously been 
used for microinjection. 
  
Chapter 5 The regulation and function of life-long oligodendrogenesis 
 
175 
 
DNA as described in 2.2.1.  In order to screen for the correct expression of the 
transgene and demonstrate that it can functionally recombine, each founder mouse 
was crossed with an Emx1-iCre transgenic mouse.  ~50% of SOX10+ cells and 
~40% of PDGFRα+ cells in the corpus callosum and motor cortex of adult mice are 
derived from the Emx1+ cortical stem cells embryonically (Kessaris et al., 2006, 
Psachoulia et al., 2009 – Chapter 4).  Therefore in the progeny of these crosses, Cre 
Recombinase will be active in all Emx1+ cells and should induce recombination of 
the Ermin-DTR transgene in the DNA of all Emx1+ stem cells (Fig. 2.2), excising the 
DsRed coding sequence and the STOP sequence.  In the adult brain (cortex and 
corpus callosum), when the Ermin gene is expressed by all mature, myelinating 
oligodendrocytes, we would expect ~50% of the oligodendrocytes to express DsRed 
(not recombined) and ~ 50% to express Venus (recombined by Emx1-Cre).   
 
All seven founders successfully passed the transgene onto their offspring (PCR 
genotyping).  Coronal brain sections from P50 mice were processed for 
immunohistochemistry to detect DsRed and Venus protein expression.  Offspring 
from five of the founders had no detectable DsRed+ or Venus+ cells (data not 
shown).  In tissue from offspring of the sixth founder, a few faint DsRed+ cells could 
be seen, but no Venus+ expression, indicating that the transgene had not recombined 
in this mouse and that the transgene was not efficiently expressed (data not shown).  
Progeny from the seventh founder had poor DsRed expression but importantly, 
robust expression of Venus, indicating successful recombination of the transgene 
(Fig. 5.9).  Therefore, the seventh founder was selected for more detailed analysis 
and will now be referred to as the Ermin-DTR transgenic mouse. 
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Figure 5.9 Expression of DsRed and Venus protein in the forebrain of adult Ermin-
DTR/Emx1-iCre transgenic mice.  Coronal brain sections from P50 Ermin-DTR/Emx1-iCre 
transgenic mice were immunolabelled to detect Venus and DsRed. Venus+ cells 
(arrowheads) were found in the corpus callosum (a), motor cortex (b), septum (c), and 
striatum (d). Clearly labelled DsRed+ cells were not detected in any of the regions 
examined. 
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At P50 DsRed was weakly expressed in the callosal white matter of Ermin-DTR 
transgenic mice.  Furthermore, the red fluorescence did not appear to be localized to 
the nucleus as would be expected if the NLS was functional.  Additionally, clear 
DsRed staining was absent from the grey matter (Fig. 5.9a, b).  In contrast, in the 
corpus callosum, a substantial number of Venus+ cells were detected, which 
presumably correspond to the Emx1-derived oligodendrocytes.  Adult Emx1-derived 
oligodendrocytes are found dorsally and are rarely present in the ventral brain 
(Kessaris et al., 2006).  Appropriately, Venus+ cells were found in small numbers in 
the dorsal striatum and dorsal septum (Fig. 5.9c, d) but were absent from more 
ventral parts of these structures (data not shown). 
 
As the distribution of the Venus cells appeared correct in all brain regions examined, 
the molecular identity of the Venus+ cells was investigated.  For this, brain sections 
of P50 Ermin-DTR/Emx1-iCre transgenic mice were immunolabelled with antibodies 
against Venus (anti-GFP) and either the differentiated oligodendrocyte marker CC1, 
the oligodendroglial lineage marker OLIG2 or the oligodendrocyte progenitor marker 
NG2.  In the corpus callosum, Venus expression co-localized with CC1 (Fig. 5.10a) 
and OLIG2 (Fig. 5.10b) but never with NG2 (Fig. 5.10c).  The proportion of Venus+ 
cells that expressed each of these three markers was quantified relative to the total 
number of Venus+ cells.  100% of Venus+ cells in the corpus callosum expressed 
CC1 and OLIG2, indicating that Venus is exclusively expressed by oligodendrocyte 
lineage cells and, in particular, by differentiated oligodendrocytes (Fig. 5.10d).  
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Figure 5.10 Venus+ cells in the corpus callosum of Ermin-DTR/Emx1-iCre transgenic 
mice.  Brain sections from P50 Ermin-DTR/Emx1-iCre transgenic mice were 
immunolabelled with antibodies against Venus and CC1 (a), OLIG2 (b) and NG2 (c).  
Double positive cells (white arrowheads) were detected in the corpus callosum when stained 
with GFP and CC1 or OLIG2.  No GFP+ cells (white arrowheads) co-labelled with NG2 
(yellow arrowheads).  The proportion (%) of Venus+ cells that co-expressed either CC1, 
OLIG2 or NG2 was quantified (d). 
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In the motor cortex, the identity of Venus+ cells was similarly restricted to 
oligodendrocytes.  Venus+ cells were labelled solely for Olig2 and CC1, but 
NG2+/Venus+ double-positive cells were not found (Fig. 5.11). 
 
Collectively, these data indicate that Venus expression is appropriately restricted to 
oligodendrocytes in the adult brain.  However we would expect Venus to be 
expressed by ~half of all oligodendrocytes present in the corpus callosum and motor 
cortex in Ermin-DTR/Emx1-iCre transgenic mice.  To confirm this, I examined brain 
sections from P50 Ermin-DTR/Emx1-iCre transgenic mice already stained to detect 
Venus and CC1 protein expression (Fig. 5.12a, b).  54% ± 9% of all CC1+ cells in 
the corpus callosum were Venus+/CC1+ cells compared with 37% ± 10% in the 
motor cortex (Fig. 5.12).  Therefore, while the DsRed component of the transgene 
cannot be used, the Ermin-DTR transgene is correctly expressed by oligodendrocytes 
and recombines successfully in the presence of iCre to permit expression of Venus. 
 
5.2.6  Testing DTR expression in the Ermin-DTR/Emx1-iCre transgenic mice 
The correct expression of DTR in the Ermin-DTR/Emx1-iCre transgenic mice is 
presently being examined by Dr. Ian McKenzie.   
 
5.3  Discussion 
This study generated a transgenic mouse that, after recombination, correctly 
expressed a fluorescent protein (Venus) and possibly the human diphtheria toxin 
receptor under the control of the Ermin promoter.  This transgenic mouse should  
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Figure 5.11 Venus+ cells in the motor cortex of Ermin-DTR/Emx1-iCre transgenic mice.  
Brain sections from P50 Ermin-DTR/Emx1-iCre transgenic mice were immunolabelled with 
antibodies against Venus and CC1 (a), Olig2 (b) and Ng2 (c).  Double positive cells (white 
arrowheads) were detected in the motor cortex when stained with GFP and CC1 or OLIG2.  
No GFP+ cells (white arrowheads) co-labelled with NG2 (yellow arrowheads).  The 
proportion (%) of Venus+ cells that co-expressed either CC1, OLIG2 or NG2 was quantified 
(d). 
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Figure 5.12 Venus labelling in CC1+ cells of Ermin-DTR/Emx1iCre transgenic mice.  The 
corpus callosum (a) and motor cortex (b) of adult (P50) mice were stained with antibodies 
against Venus (green) and CC1 (red).  The proportion of all CC1+ cells present in the two 
brain regions that co-expressed Venus was quantified from confocal scans (c). 
  
Chapter 5 The regulation and function of life-long oligodendrogenesis 
 
182 
 
potentially permit oligodendrocyte-specific labelling and, after diphtheria toxin 
administration, killing of myelinating oligodendrocytes.   
 
The Ermin-DTR transgenic mouse generated failed to express DsRed effectively.    
This could result from a combination of factors.  Firstly, DsRed is less bright than 
Venus.  Secondly, failure of the NLS meant that the protein was not concentrated in 
the nucleus of the cell resulting in weak DsRed signal and thirdly, there may only be 
a low level of activity of the Ermin promoter in adult mice.  The limited DsRed 
expression detected in the white matter showed evidence of cytoplasmic and not 
nuclear-specific expression as was expected due to the presence of the NLS sequence 
in the transgene, indicative of a defective NLS.  Ermin transcription, like that of 
many mature oligodendrocyte genes, may only occur at a low level in adulthood 
resulting in a low level of transgene expression.  In any case, the failure to detect 
DsRed expression in oligodendrocytes is a small drawback considering that DsRed 
was the least necessary component of the construct, only included as a marker of all 
oligodendrocytes, which can instead be achieved by antibody labelling. 
 
This transgenic will be a very useful tool for addressing a number of different 
questions. For instance, if Ermin-DTR transgenic mice are crossed to mice that 
express an inducible form of Cre recombinase under the control of an 
oligodendrocyte progenitor cell specific promoter, e.g. PDGFRα-CreERT2 transgenic 
mice, it would be possible to limit recombination of the transgene to adult OLPs and 
selectively ablate adult born oligodendrocytes.  Tamoxifen would be given to adult, 
double heterozygous offspring, which would activate Cre in adult OLPs and induce a 
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DNA recombination event.   Initially this will result in no visible change in the CNS.  
However all new cells produced from these recombined adult OLPs, that 
subsequently differentiate to become mature myelinating Ermin+ oligodendrocytes 
will become labeled with Venus and express human DTR.  Subsequently, these mice 
will be traced for various periods of time to observe the accumulation of newly 
generated, functionally myelinating oligodendrocytes in the CNS.  To test the 
importance of these cells to adult CNS function, DT could be administered at various 
periods following tamoxifen treatment.  As 17% of all oligodendrocytes in the corpus 
callosum are generated between P45 and P135 (Rivers et al., 2008) ablating these 
cells may cause visible motor and detectable cognitive impairments. 
 
As was hypothesized in Chapter 3 and in 5.1, adult oligodendrogenesis may be an 
important component of motor learning and memory.  Therefore the rate of 
oligodendrogenesis could be compared between Ermin-DTR/PDGFRα-CreERT2 
transgenic mice that were regularly housed and those that have been provided access 
to a running wheel (as previously – Chapter 3).  A third group of mice could be 
provided with a more complex running wheel representing a more complex motor 
test that requires more practice for the mouse to become proficient (Liebetanz et al., 
2006).  An example of such an experiment is described in Figure 5.13.  The plan 
would be to ablate oligodendrocytes generated from OLPs during the motor learning 
period, by DT administration, and determine whether that has an impact on motor 
performance when mice are re-exposed to the same task.    
 
Similar to the running wheel experiment, using this transgenic mouse to eliminate 
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Figure 5.13 An experimental plan for complex motor learning. Tamoxifen would be 
administered at P60 and motor training commenced at P64.  All trained mice would initially 
run on the training wheel, which has regular rung spacing as shown in the above schematic.  
Training wheel mice will continue under these conditions until P95.  Training and complex 
wheel mice will run on the training wheel for 7 days and subsequently on a wheel that has 
increasingly complex patterns of rung spacing as shown in the schematic.  Mice that would 
be trained using the complex wheel would have the rung spacing altered every week of the 
training period.  From P95 to P100, mice will be given either DT or PBS before their 
running performance is re-evaluated. 
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adult-born oligodendrocytes generated prior to or during a multitude of other 
behavioral tasks, could shed light on the function of adult oligodendrogenesis and 
indicate how significant role it plays in memory formation/retention and brain 
plasticity.  Additionally, crossing this transgenic mouse line with another that 
induces recombination in neural stem/progenitor cells would specifically identify 
oligodendrocytes derived from these cells in the adult brain by Venus labelling and 
could also be used to remove these cells from the adult brain. 
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Chapter 6: Final Discussion 
 
 
 
Oligodendrocyte progenitor cells (OLPs), also known as „NG2 cells‟, persist in the 
adult brain in great abundance (~5% of brain cells) and are distributed more-or-less 
evenly throughout the brain.  Until recently it was presumed that the function of 
these adult OLPs was to act as a reservoir for the production of new myelinating 
oligodendrocytes in order to replace those that are lost as a result of injury, disease or 
ageing. 
 
My studies have generated strong evidence for the production of myelinating 
oligodendrocytes in apparently healthy, young adult mice.  This could contribute to 
some forms of neural plasticity, for example motor learning and memory.  I have 
also shown that the differentiation rate of adult OLPs decreases with age, but 
nevertheless new oligodendrocytes are still being produced even in mice aged P240 
+100d.  This could be important for the maintenance of myelination with age. 
 
Interestingly, adult OLPs were also found to generate a small proportion of 
projection neurons in the anterior piriform cortex.  The functional importance of this 
finding is still unknown.  However, it does reflect the multiplicity of roles that adult 
OLPs can serve in the CNS. 
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OLP contribution to brain plasticity was directly addressed by the behavioural testing 
of adult mice.  This study showed that OLPs respond to exercise that requires inter-
hemispherical communication, thus presumably involving the corpus callosum, by 
stimulating the generation of oligodendrocytes in this brain region.  Though this 
observation requires further confirmation, it raises the possibility that OLPs might 
contribute to brain plasticity during adulthood.  To address this directly, I generated a 
transgenic mouse that will allow labelling and conditional ablation of adult-born 
oligodendrocytes.  Though characterization of this mouse was not completed during 
the timeframe of this PhD, initial evidence suggests correct expression of the 
transgene (Ermin-loxDsRedSTOPlox-DTR-IRESVenus) and encourages us to believe 
that this transgenic tool will be useful for behavioural tests aimed at assesing the 
involvement of adult-born oligodendrocytes in brain function and plasticity. 
 
These new and unexpected functional roles of OLPs in the adult brain would be 
expected to require the generation of a substantial number of new oligodendrocytes 
through proliferation of OLPs.  Though it is known that adult OLPs proliferate in 
vivo, their rate of proliferation and how this changes with age was not previously 
examined.  Therefore, I investigated the cell cycle kinetics of OLPs by cumulative 
administration of two different thymidine analogues, BrdU and EdU.  Strikingly, 
OLPs were found to proliferate even in very old age (P540+100d) both in the brain 
grey matter (motor cortex) and the white matter (corpus callosum).  In addition, a 
linear relationship between cell cycle time and age was determined for OLPs present 
in the motor cortex, which allows prediction of the cell cycle of cortical OLPs at any 
given postnatal age.  Both BrdU and EdU cumulative labelling experiments showed 
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that Tc is greater in the grey than in the white matter and increases with age due to 
longer cell cycle arrest at the G0 or G1 phase rather than a slower S phase.  
Furthermore, the decrease in OLP proliferation rate with age was roughly parallel to 
the decrease in their rate of production of new oligodendrocytes.  This finding 
suggests that if OLPs could be triggered to proliferate more rapidly in the aged brain, 
they could potentially generate more oligodendrocytes and therefore respond more 
productively to demyelination.  Whether the change in proliferation and 
differentiation rates of OLPs is an intrinsic phenomenon or else depends on 
extracellular signals is yet to be determined. 
 
Using both BrdU and EdU, I detected two sub-populations of OLPs.  A proportion of 
OLPs (20-50%) did not undergo cell division even after 50 days of EdU/BrdU 
administration, indicating the existence of a quiescent OLP population, which 
persists throughout life in both the grey and white matter.  The splitting of OLPs into 
two populations has already been suggested by other OLP characteristics, such as 
electrical activity and the ability to fire action potentials in response to a depolarizing 
stimulus (Chittajallu et al., 2004; Karadottir et al., 2008), formation of glutamatergic 
synapses with un-myelinated axons (Kukley et al., 2007; Ziskin et al., 2007), as well 
as their developmental origins (Kessaris et al., 2006).  The latter was directly 
addressed in this study but failed to show any relevance between proliferating 
behaviour and embryonic origins of forebrain OLPs.  However, the other 
characteristics that split OLPs into two sub-populations remain to be correlated with 
their differing cycling behaviour. 
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Overall, the findings of this study emphasize the potential importance of OLPs in the 
healthy adult brain and the variety of roles that OLPs serve to preserve normal brain 
function and integrity throughout life.  While their chief role in adulthood is to act as 
a source of new myelinating oligodendrocytes, the fact that they also seem capable of 
generating certain projection neurons does raise the possibility that it might become 
possible to manipulate OLPs in order to enhance their pluripotent properties for a 
variety of repair processes in neurodegenerative diseases.  Enhancing their 
proliferation rate or steady-state numbers could conceivably improve some types of 
learning and/or memory.  While this is highly speculative at present, it is an exciting 
prospect that should stimulate a lot of further work on adult myelinogenesis. 
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Appendix I 
 
Media and Solutions 
 
 
 
Blocking solution  10% (v/v) sheep or horse serum, 0.1% (v/v) Triton X-
100 in PBS  
 
Denhardt‟s Solution  1% Ficoll 400, 1% polyvinylpyrrolidine, 1% bovine 
serum albumin 
 
EDTA   0.5M Na2EDTA, pH8.0 
 
EdU reaction cocktail For 500μl: 43μl 10x reaction buffer, 20μl CuSO4, 1.2μl 
Alexa Fluor® 647 azide, 5μl 10x reaction buffer 
additive, dH2O 
 
Extraction Buffer  100mM Tris-HCl pH8.5, 5mM EDTA pH8.0, 200mM 
NaCl, 0.2% SDS 
 
LB (1 litre)   10g bacto-tryptone, 5g yeast extract, 10g NaCl 
 
MABT  0.5M maleic acid, 0.75M NaCl, 1M NaOH, 0.5% 
Tween-20 
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Microinjection Buffer 1M Tris-HCl pH7.5, 0.5M EDTA pH8.0, 5M NaCl 
 
NBT  1g 4-nitro blue tetrazolium chloride crystals, 7ml 
dimethyl formamide, 3ml dH2O 
 
P1 Solution   50mM glucose, 25mM Tris pH8.0, 10mM EDTA pH8.0 
 
P2 Solution   0.2N NaOH, 1% SDS 
P3 Solution   0.3M Potassium Acetate, 11.5% w/v glacial acetic acid 
 
PBS    0.2 M phosphate, 1.5 M NaCl, pH7.5 
 
10x PCR Buffer 500mM KCl, 100mM Tris-HCL pH9.0, 1% (v/v) Triton 
X-100 
 
Protease K   10mM Tris pH8, 0.1M EDTA pH8, 0.5% SDS 
 
Salt solution  2M NaCl, 50mM EDTA, 100mM Tris-HCl pH7.5, 
50mM NaH2PO42H2O, 50mM Na2HPO4, DEPC treated 
 
SATO  DMEM-Glutamax medium (Invitrogen) supplemented 
with: 100µg/ml Transferrin (Sigma), 100µg/ml BSA 
(Sigma), 60ng/ml Progesterone (Sigma), 40ng/ml 
Sodium selenite (Sigma), 16µg/ml Putrescine (Sigma), 
5µg/ml Insulin (Sigma), 1x Penicillin/Streptomycin 
(Invitrogen), 10ng/ml bFGF (Invitrogen), 10ng/ml 
CNTF (Peprotech EC Ltd), 10ng/ml PDGF-AA (R & D 
Systems Europe), 1ng/ml NT3 (Peprotech EC Ltd), 
10µM Forskolin (Enzo), 5µg/ml N-acetyl-L-cysteine 
(Sigma), 1x B27 Supplement (Invitrogen) 
 
SSC    3.0 M NaCl, 0.3 M sodium citrate, pH7.0 
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Staining Buffer  0.1M NaCl, 0.05M MgCl2, 0.1M Tris pH9.5, 0.01%  
     Tween-20 
 
TAE    400mM Tris, 1mM EDTA, 0.35% glacial acetic acid 
 
TBE    45mM Tris-borate, 1mM EDTA pH8.0 
 
TE    5mM Tris pH7.5, 2.5mM EDTA pH8 
 
Wash solution  50% formamide, 1x SSC, 0.1% Tween-20 
 
